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Abstract

ITAGGG Repeat Binding Factor 2 (TRF2) is a ubiquitous human telomeric

protein present at all telomeres throughout the cell cycle. TRF2 has been proposed
remodel telomeres into large lasso-like structures named t-loops. Removal of TRF2
from telomeres by expression of a dominant negative allele of TRF2 (TRF2ABAM) led
dissolution of these structures and appearance of end-to-end fusions visible in
metaphase and anaphase cells. Fusion formation was accompanied by the loss of Goverhang, but not by the loss of double stranded telomeric DNA, which can be

documented to persist at the sites of fusions. Fusions were covalent and their for
was dependent on the nonhomologous end-joining (NHEJ) pathway as evidenced by the

failure to form fusions in cells lacking Ligase IV. Furthermore, the fusions initi
genomic instability.
Expression of TRF2ABAM in primary human cells resulted in induction of
senescence. The arrested cells exhibited elevated levels of p53, stabilization of
was accompanied by induction of its downstream effectors p21 and Bax. The Rb

pathway was also affected, with pRb becoming hypophosphorylated. The importance of

both the p53 and the Rb pathways was further evident from the fact that the expres
of SV40 Tag alone bypassed the growth arrest. Separate elimination of p53 or Rb

function could not do so, and the activity of the ATM PI3 kinase was not necessary
the arrest.
Expression of a different truncation allele of TRF2, TRF2AB also resulted in

senescence but the growth arrest was accompanied by rapid loss of telomeric DNA. I
addition, this allele induced an unanticipated chromosome breakage phenotype.

Long-term overexpression of full length T R F 2 resulted in the gradual shortening
of telomeres, suggesting that TRF2 is a regulator of telomere maintenance. Although it
is clear that TRF2 acts through positively regulating the shortening activities at
telomeres, it is unknown at this time whether it influences the telomerase pathway.

Besides being present at telomeres, TRF2 also appears to be localized to
centrosomes. The functional consequences of such localization are not known at this
time; however, it is shown that telomere dysfunction can result in genome reduplication.

I n t r o d u c t i o n

The advent of linear chromosomes created an enormous problem for their
bearers. Conventional polymerases that replicate circular genomes are unable to

replicate the very ends of chromosomes. Each time the DNA is synthesized, a few ba

pairs are lost at one of the chromosome tips. This problem has been coined the "end

replication problem" (Watson 1972; Olovnikov 1973) and it stems from the enzymatic
characteristics of DNA polymerases, which need a short RNA primer to initiate

polymerization. Additionally, this primer can be extended only in the 5'-3' direct
These requirements give rise to different modes of replication of two DNA strands
(Figure i-1). One of the strands, the leading strand, is made continuously by the
extension of one primer and presumably results in the formation of a blunt-ended
molecule. The other strand, the lagging strand, is formed through the synthesis of
multiple RNA primers and their extension into Okazaki fragments. Eventually the
primers are removed and the Okazaki fragments are joined together resulting in a

continuous strand. Since the primer that is closest to the tip of the chromosome i

removed and the leftover gap cannot be filled in by any polymerase, the lagging st

synthesis cannot fully replicate the DNA end. Taking into consideration the length

RNA primer, each division would result in disappearance of a minimum of 3 bp of DNA
per end. The true losses are even greater in most organisms bearing linear

chromosomes. This is evident from the presence of single-stranded 3' extensions of
G strand, which can be from 12-16 nucleotides long in ciliates (Klobutcher et al.

Pluta et al. 1982; Henderson and Blackburn 1989), around 30 nucleotides long during

phase in S. cerevisiae (Wellinger et al. 1993; Wellinger et al. 1993), and as long a

nucleotides in human cells (Makarov et al. 1997). It also appears that the overhang
can be found on both chromosome ends. The most compelling evidence comes from

5'

chromosome
snd
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Figure i-1. Schematic of replication at the very end of a c h r o m o s o m e
The replication fork is moving from left to right.
.ia» RNA primer of leading strand
<=> RNA primer of lagging strand
<3 • Okazaki fragment

the findings that both termini of human chromosomes (Makarov et al. 1997), as well as
those of Trypanosoma brucei(Munoz-Jordan et al. 2001), and Tetrahymena (Jacob et
al. 2001), end in an overhang that has been estimated to be up to a few hundred

nucleotides in length. Such a long overhang on the lagging strand could be explain

the last RNA primer was laid down very far from the actual chromosome tip, but lea

strand synthesis should theoretically result in a blunt end. The finding that it d

suggests a nucleolytic activity that can create the single-stranded overhang, in t
of the leading strand, or extend the single stranded overhang, in the case of the

strand. If such activities were not counteracted, a substantial portion of chromos
DNA would be permanently lost with each division.

A second pronounced problem that needs to be overcome by organisms with
linear chromosomes is the physical presence of the DNA ends. Cells have evolved

elaborate pathways to recognize and repair double-strand breaks (reviewed in Haber
2000; Hoeijmakers 2001). These pathways are necessary to eliminate chromosomal
breaks that occur due to environmental stress, internal metabolism, including DNA

replication, and physiological breaks acquired during development. Natural ends sh

not participate in any of these repair transactions. Therefore, the cellular machin
to differentiate between telomeres and bona fide breaks within the genome.

These vital functions of compensating for DNA loss during replication as well as

the protection of chromosomal ends from the repair activities are integrated in th

telomere. First defined as a "free end" that has no ability to fuse with broken DNA

(Muller 1938), the telomere is a sophisticated complex of repetitive DNA and associ
proteins that can be found at all ends of linear chromosomes.

Telomeric D N A

Molecular studies of telomeres began with the finding that telomeric DNA was

highly repetitive. The first telomeric DNA to be sequenced was from the ends of rD

molecules of Tetrahymena and it was shown to consist of repeats of TTGGGG oriented
5' to 3' towards the chromosome terminus (the so called G strand), and of the
complementary sequence of CCCCAA on the opposite strand (C strand) (Blackburn and

Gall 1978). Soon, telomeric DNAs from other species were sequenced (Table i-1), and

generally they were found to be built from similar simple repeats. There exist som
exceptions, including the expanded telomeric repeat of K.lactis (McEachern and

Blackburn 1994) and the irregular repeats of S. cerevisiae (Shampay et al. 1984) a
S.pombe (Sugawara 1986). The greatest exception of all is the organism in which

Muller first defined the telomeres. Telomeres of Drosophila melanogaster consist o
repetitive sequences, but the repeats are retrotransposons of the non-LTR type

(Biessmann et al. 1990; Levis et al. 1993; Sheen and Levis 1994). Although dipteran
telomere structure and maintenance is unlike in any other organism, the telomeric
functions are conserved (see below).
The telomeric repeat arrays can extend for a considerable length. In
Tetrahymena, as in yeasts, telomeric tracts are approximately 300 bp in length

(Blackburn and Gall 1978; Shampay et al. 1984), in human cells TTAGGG repeats range

from 2 kbp to 25 kbp (Allshire et al. 1988; Moyzis et al. 1988; de Lange et al. 19

Saltman et al. 1993) and in some mouse species including the laboratory Mus muscul

the telomeric DNA is as long as 50 kbp (Kipling and Cooke 1990). Taking into accoun

the rate of replication-dependent telomere shortening, telomeric DNA can provide a

substantial buffer against the loss of essential sequences found in the more centr

Table i-1 Sequences of Telomeric D N A in Selected Species (adapted from (Henderson
1995))

Telomeric sequence

Species

Reference

Tetrahymena

(Blackburn and
Gall 1978)

II I IGGGG

Oxytricha, Euplotes

(Klobutcher et al.
1981)

TTAGGG

Trypanosoma brucei

(Blackburn 1984;
Van der Ploeg et
al. 1984)

T(G)2.3(TG)1.6

Saccharomyces
cerevisiae

(Shampay et al.
1984)

GGTTACA

Schizosaccharomyces
pombe

(Sugawara 1986;
Hiraoka et al.
1998)

ACGGAI I IGATTAGGTATGTGGTGT

Kluyveromyces lactis

(McEachern and
Blackburn 1994)

TTAGGC

Caenorhabditis elegans

(Cangiano 1993)

Het-A and T A R T retrotransposons*

Drosophila
melanogaster

(Biessmann et al.
1990; Levis etal.
1993; Sheen and
Levis 1994)

TTAGG

Bombyx m o d (silkworm)

(Okazaki et al.
1993)

I I IAGGG

Arabidopsis thaliana

(Richards and
Ausubel 1988)

TTAGGG

H o m o sapiens and other
vertebrates

(Moyzis et al.
1988)

TTGGGG

*These are non-canonical since they are not maintained by telomerase.

proximal regions. However, in order for the single-celled organisms or species to be

genetically immortal, telomeric DNA needs to be maintained at a stable length thro
the generations.

Core components of telomerase- R N A and the catalytic subunit

One of the most efficient and widely used ways of telomere maintenance is

provided by telomerase, a ribonudeoprotein (Greider and Blackburn 1985; Greider an
Blackburn 1987), which uses an RNA molecule as a template for addition of species
specific telomeric repeats (Shippen-Lentz and Blackburn 1990; Yu et al. 1990). The
RNA serves to align the telomeric 3' overhang with the template, and the catalytic

subunit of telomerase, telomerase reverse transcriptase (TERT) (Lingner et al. 1997
reviewed in Nakamura and Cech 1998) synthesizes one repeat specified by the RNA.

The enzyme can then relocate to the newly created end or to a different DNA substr

and continue synthesis. The synthesis of the G strand is closely followed by synth

the C strand (reviewed in Price 1997) to form the double stranded repeat array. Th

overhang found at chromosome ends could be made if the action of telomerase were n

followed by the C strand synthesis. However, G-overhangs can be found in cells tha

lack telomerase (Dionne and Wellinger 1996; Makarov et al. 1997; Hemann and Greide

1999; Nikaido et al. 1999) suggesting that the nucleolytic activities mentioned ea
responsible for their formation.
G-overhangs, as will be discussed later, have multiple functions. Chromosome
tails can recruit single-stranded DNA binding proteins and can invade the double-

stranded telomeric arrays. The overhangs are also necessary for telomerase-depende

telomere maintenance since at least in vitro, telomerase is not capable of extending a
blunt-ended DNA molecule (Greider and Blackburn 1987; Lingner and Cech 1996).

Telomerase is less selective about the exact sequence of the overhang, and it elon

single-stranded non-telomeric sequences both in vitro (Greider and Blackburn 1987;

Morin 1989; Harrington and Greider 1991; Morin 1991; Prowse et al. 1993), and in vi

(Shampay and Blackburn 1989; Wilkie et al. 1990; Lamb et al. 1993). This activity i

thought to be important for the "healing" function of telomerase, through which bro
ends can be capped by de novo addition of telomeric DNA (reviewed in Melek and
Shippen 1996).
In unicellular organisms telomerase has a housekeeping function, and its two

essential subunits are always expressed. However, It has been shown that the level
telomerase RNA can increase at a specific developmental stage, for example during
macronuclear development in Tetrahymena (Avilion et al. 1996). Mice express both

telomerase subunits (Blasco et al. 1995; Greenberg et al. 1998; Martin-Rivera et a

1998), as well as telomerase activity in most of their tissues (Prowse and Greider 1

The catalytic subunit of the mouse telomerase, in contrast to the RNA subunit, is h

insufficient so that cells heterozygous for mTERT gradually shorten their telomere
et al. 2000).
Telomerase activity is repressed in most normal human tissues (Kim et al. 1994).
Activity can be found only in ovaries and testis (Wright et al. 1996), and highly

proliferative tissues including hematopoietic cells (Broccoli et al. 1995; Counter

1995). Regulation of telomerase appears to be at the level of hTERT expression. hTR

is present in many telomerase negative cells (Feng et al. 1995; Nakamura et al. 199

hTERT message is only found in cells that express telomerase activity including mo
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the primary tumors and tumor cell lines tested to date (Kilian et al. 1997; Meyerson et al.
1997; Nakamura et al. 1997). Additionally, expression of hTERT alone in human

primary fibroblasts is sufficient to reconstitute functional telomerase activity (

al. 1998; Vaziri and Benchimol 1998) suggesting that hTERT is the limiting compone

telomerase in human cells. One of the outstanding questions in telomerase regulatio

how hTERT gets repressed in most of human somatic tissues and how it gets activated
in 90% of human tumors (reviewed in Shay and Bacchetti 1997).

Other telomerase components

Studies of telomerase components in many organisms have shown that many

proteins associate with the RNA and the catalytic subunit in vivo. The best unders

of those are the Estl and Est3 proteins which are necessary for the in vivo telome

function in S. cerevisiae but are dispensable for in vitro activity (Lingner et al.
Est proteins will be discussed later in the section on telomere length regulation.
Telomerase RNA from S. cerevisiae associates with Sm proteins in vivo (Seto et
al. 1999). This association has been proposed to be important in the biogenesis of

RNA. In particular, the poly A tail is not removed efficiently from the RNA if the

proteins are precluded from binding to this RNA (Seto et al. 1999). Sm proteins wer
found not to interact with human RNA (hTR) (Le et al. 2000). Instead, two other

proteins, hStau and L22 were found to interact with hTR in a three-hybrid screen a

as in vivo. Although their function is unknown, they are proposed to also play a r
hTR processing, assembly or localization (Le et al. 2000). Other components of the
telomerase RNP might be heterogeneous nuclear ribonudeoprotein AJ. (hnRNP A1)
(LaBranche et al. 1998), and heterogeneous nuclear ribonudeoprotein Cl and C2
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(hnRNP C1, h n R N P C2) (Ford et al. 2000). Immunoprecipitation of an amino-terminal
part of hnRNP A1 (LaBranche et al. 1998), or of hnRNP C1 and C2 (Ford et al. 2000)

brings down telomerase activity (LaBranche et al. 1998). In addition, all three hnR

are able to directly interact with hTR (Ford et al. 2000; Fiset and Chabot 2001) an
hnRNP A1 can influence telomere length in vivo (Fiset and Chabot 2001). The latest

addition to the proteins able to interact with telomerase RNA is La (Ford et al. 20

Antibodies directed against this protein precipitate telomerase from a number of s
and overexpression of La leads to telomere shortening.

Through extensive phylogenetic comparison, vertebrate telomerase RNA has

been found to contain four very well conserved motifs (Chen et al. 2000). So far, o
one of them, box H/ACA small nucleolar RNA-like domain (snoRNA), has been shown

to be important for hTR accumulation, hTR 3' processing, and telomerase activity i
human 293 cells transfection system (Mitchell et al. 1999). The H/ACA RNA motif
seems to be able to associate with dyskerin (Mitchell et al. 1999), a putative

pseudouridine synthase mutated in an X-linked form of the human disease dyskeratos
congenita (Heiss et al. 1998). Cells from patients with the disease show decreased
levels of hTR, produce lower levels of telomerase activity, and, although further
of telomere length regulation is necessary, seem to have difficulty with telomere
maintenance.
In Tetrahymena, two proteins, p80 and p95 copurify with telomerase activity and

the telomerase RNA (Collins et al. 1995). In contrast to the predictions, the two pr

are not necessary for the telomerase accumulation or in vitro activity, but seem t

role in telomere length regulation since removal of p80 or p95 lead to increased l
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micronuclear and macronuclear telomeres (Miller and Collins 2000). The mechanism of
their function in telomere length regulation is unknown.

A human homologue of p80 has been identified (Harrington et al. 1997;
Nakayama et al. 1997). Even though TEP1 interacts with the telomerase RNA and
immunoprecipitation with a specific antibody against TEP1 brings down telomerase

activity, complete removal of the protein in mice has no functional consequences o

in vivo telomerase activity or telomere maintenance (Liu et al. 2000), suggesting t
TEP1 is not required or has a redundant function in the expression of telomerase
function.
In general, telomerase associated proteins might be important in regulating

biogenesis, stability, as well as the catalytic activity of telomerase. Further stu

needed to elucidate the exact requirements for all of the proteins. It will be int

see if there are multiple telomerase complexes in the cell and if so how they infl
telomere function.

Alternative mechanism of telomere maintenance
In the absence of telomerase some cells are able to maintain their telomeres in
alternative ways. In yeast, such an alternative mode relies on rearrangement and
amplification of the telomeric regions and is dependent on the RAD52-mediated
recombination (Lundblad and Blackburn 1993; Lendvay et al. 1996). The human and
mouse alternative lengthening pathway (ALT) has also been proposed to involve
recombination (Bryan et al. 1995; Bryan et al. 1997; Dunham et al. 2000; Niida et
2000). Finally, as mentioned above, Drosophila melanogaster and other Dipterans,
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which lack telomerase altogether, counteract the shortening of their telomeres by
stochastically placing retrotransposons at the end of their linear chromosomes
(Biessmann et al. 1990).

Regulation of telomere maintenance
Alternative pathways of telomere maintenance are poorly understood and when
cells use these pathways, length of their telomeres can become heterogenous and
generally not very well regulated. W h e n telomerase is available, on the other hand,
telomeres stay stable through many divisions (Shampay and Blackburn 1988; Counter et
al. 1992; van Steensel and de Lange 1997). To achieve such homeostasis, activities of
replication, degradation, and D N A addition need to be tightly regulated. Understanding
of this regulation has recently flourished, especially in S. cerevisiae where multiple
factors are known to affect telomere length. Generally, factors that regulate length can
be divided into those that affect activities at the very terminus of the DNA, and those that
define the length setting of the double-stranded telomeric D N A array.

Regulation of telomere maintenance: the role of terminus factors

The best understood activity at the telomere terminus is the addition of telomeric
D N A by telomerase. As mentioned before, telomerase is a reverse transcriptase with
two essential subunits, an R N A component (TLC1 in budding yeast, hTR in humans,
m T R in mouse), and the catalytic subunit (EST2 in budding yeast, h T E R T in humans,
m T E R T in mouse). W h e n one of these essential subunits is missing (Singer and
Gottschling 1994; McEachern and Blackburn 1995; Lendvay et al. 1996),(Blasco et al.
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1997; Lingner et al. 1997; Nakamura et al. 1998; Niida et al. 1998; Fitzgerald et al. 1999;
Liu et al. 2000; Niida et al. 2000), or strongly inhibited (Hahn et al. 1999; Zhang
1999; Miller and Collins 2000), the length homeostasis is perturbed and telomeres
gradually and steadily shorten, giving rise to a phenotype which in yeast has been
coined an Ever Shorter Telomeres (est) phenotype (Lundblad and Szostak 1989).

Presence of the catalytically active telomerase is not sufficient for stable lengt

maintenance, and the recruitment of telomerase to the telomere terminus engages bo
positive and negative regulators (reviewed in Evans and Lundblad 2000)

Cdc13p seems to orchestrate access of telomerase to the terminus. Based on in

vitro binding data it is expected that Cdc13p resides on the single-stranded G-ove

(Lin and Zakian 1996; Nugent et al. 1996) and is able to interact with Estlp (Qi an
Zakian 2000), which together with Est2p, TLC1 RNA, and Est3p forms the telomerase

holoenzyme. The recruitment function of Cdc13p is further evidenced by experiments
showing that the DNA binding domain of Cdc13p (DBDCdci3) fused to Estlp (Evans and

Lundblad 1999) or Est3p (Hughes et al. 2000) rescues the est phenotype of cdc13-2e

allele, and that Cdc13-Est2p fusion bypasses the requirements for Estlp (Evans and
Lundblad 1999).
A number of other proteins positively regulate telomerase function in yeast.
Mutants in the Mre11p/Rad50p/Xrs2p complex have short telomeres (Kironmai and
Muniyappa 1997; Boulton and Jackson 1998; Nugent et al. 1998) and are in the
telomerase epistasis group since double mutants of telomerase and any of the
components of the complex do not show a more severe phenotype than mutation in
telomerase itself (Nugent et al. 1998). The complex has multiple biochemical and

cellular functions (reviewed in Haber 1998) and it is still unclear how it partici
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telomere length regulation although it has been proposed that it might prepare the

terminus for Cdc13p binding and/or telomerase action. The Mre11 complex appears to

act synergistically with Ku, deletion of which also results in short telomeres (Po
1996; Boulton and Jackson 1998; Nugent et al. 1998; Polotnianka et al. 1998). As

opposed to Mrel 1, Ku deletion also results in changes of the terminal structure o

telomere; the G-overhangs that normally are detectable only in S phase in yeast, no

persist throughout the cell cycle (Gravel et al. 1998; Polotnianka et al. 1998). Th
suggests that Ku participates in telomere protection (discussed separately below)

although it is not excluded that the two phenotypes of telomere shortening and pre
of increased single-stranded DNA are related.

Interference with two other proteins leads to telomere shortening. Teh and Tel2

were identified in genetic screen for temperature sensitive mutants resulting in a

telomere length (Lustig and Petes 1986). Tel2p turned out to be an essential protei

(Runge and Zakian 1996), which has characteristics of binding to both double-strand
and single-stranded telomeric DNA (Kota and Runge 1998; Kota and Runge 1999).

TeMp, is an ortholog of ATM (Ataxia Telangiectasia Mutated), a PI3 kinase mutated i

patients with Ataxia Telangiectasia (Greenwell et al. 1995), and its kinase activit

necessary for telomere length regulation (Mallory and Petes 2000). Medp, another PI

kinase from S.cerevisiae, that is more closely related to ATR, similarly influence
telomere length (Ritchie et al. 1999). TEL1 or MEC1 deletion leads to telomeres of
but stable length. Removal of both of the proteins leads to progressive shortening
characteristic of the est phenotype, suggesting that TeMp and Medp act in separate
pathways at telomeres. This is a similar situation to that found in S. pombe where
simultaneous mutation of both the AT ortholog RAD3 and the ATM ortholog TEL1 lead
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a progressive telomere shortening (Naito et al. 1998). Epistasis analysis in S. cerevisiae
showed that TeMp is in the same pathway as the Mre11p complex described above,

since the double mutants of teh mrel 1, teh rad50, and teh xrs2 harbor telomeres th
of the same length as they were when only a single protein of the pair was mutated

(Ritchie and Petes 2000). Moreover, TeMp phosphorylates Xrs2p in vitro (Mallory and

Petes 2000) and in vivo (Usui et al. 2001). This is analogous to the situation foun
human cells where ATM is able to phosphorylate Nbs, an equivalent, although not
obviously orthologous protein to Xrs2.

The proteins discussed above appear to positively regulate telomere length
maintenance. Some of the same proteins apparently can also negatively regulate

telomere length. In a recently identified mutant of Cdc13p (cdc13-5) (Chandra et a
2001), telomerase elongates telomeres about 1000 bp beyond the usual setting.

Additionally, the coordination between the G and C strand synthesis is lost with G
overhangs becoming unusually long in S phase. This aspect of Cdc13p function, as

previously suggested (Grandin et al. 1997), is mediated by Stnlp, a Cdc13p interact
partner, since overexpression of Stnlp suppresses all phenotypes associated with
cdc13-5. Overexpression of Stnlp also suppresses a telomere elongation defect in

mutants of DNA polymerase alpha (poll-12, poll-16, and poll-17) pointing to a pathw

of coordination of G and C strand synthesis by telomeric proteins. A similar coord

appears to exist in other organisms. In Euplotes, inhibition of DNA polymerase alph

delta results in increased length heterogeneity of the G strand and changes the le
the C strand (Fan and Price 1997). An additional telomeric protein in this pathway
yeast might be Tenlp, which interacts with both Cdc13p and Stnlp (Grandin et al.
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2001). S o m e mutations in this protein lead to telomere elongation, although the nature

of this elongation has not been yet compared with elongation of the cdc13-5 mutants

The role of helicases at telomeres is just starting to be elucidated. Pif 1 p (Sch

and Zakian 1994), a 5'-3' helicase which by chromatin immunoprecipitation localizes
telomeres, when overexpressed causes telomere shortening (Zhou et al. 2000).

Furthermore, Piflp deletion or expression of catalytically dead helicase mutants l
telomerase dependent telomere elongation. Based on the observation of telomere

length changes and biochemical activity found in Piflp, it has been suggested that
could dissociate the RNA template from the telomere thus negatively influencing
telomerase function. Another helicase, Sgslp has gained considerable attention due
its homology with helicases that are mutated in a number of human disorders that
include Bloom syndrome and Werner syndrome. Mutant sgsl has no effect on telomere

homeostasis when telomerase is present (Watt et al. 1996). However, a double deleti
of est2 and sgsl, leads to slightly faster telomere shortening than in est2 mutant

Biological meaning of this finding is unclear and currently the only telomere func

Sgslp is in a choice of the type of alternative pathways used in cells when telome

not able to maintain telomeres (Cohen and Sinclair 2001; Huang et al. 2001; Johnso
al. 2001).

Regulation of telomere maintenance: the role of proteins bound to duplex
telomeric DNA

All of the proteins discussed above, appear to function close to or at the terminus
of the DNA. Work from S.cerevisiae, S.pombe, and humans, shows that proteins that
bind along the telomere are also important for in-cis telomere length regulation.
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is an integral component of telomeric chromatin in S. cerevisiae (Conrad et al. 1990) and

it directly interacts with telomeric DNA using its two Myb-like DNA binding domain

(Konig et al. 1996). Raplp has been established as a negative regulator of telomere
length based on the facts that overexpression of the full-length protein leads to
elongation and increase in length heterogeneity (Conrad et al. 1990). Furthermore,
growth of a strain with a temperature sensitive allele of Raplp at semi-permissive
temperature led to telomere shortening, which was rescued by expression of the wt

allele (Conrad et al. 1990; Lustig et al. 1990). Further studies suggested that the
number of Raplp molecules bound to the chromosome end is counted and used as a

gauge of the length of the telomeric repeat array (Marcand et al. 1997). In these s
the C-terminal 174 amino acids of Raplp were fused to a heterologous DNA binding
domain of Gal4. By varying the number of Gal4 sites subtelomeric to an engineered
telomere, the number of Raplp molecules available for protein counting could be

altered. A correlation was seen between the number of Raplp C termini present on t

telomere and the length of that telomere. The more Raplp was tethered to the telome
the shorter the final telomere length. The C terminus of Raplp interacts with two

proteins (Rapl interacting factor 1 and 2, Rif 1 p and Rif2p) that are implicated i

telomere length regulation. Overexpression of Riflp and 2 leads to telomere shorte

and their mutation or deletion lead to telomere elongation (Wotton and Shore 1997).

Thus, like Raplp they negatively regulate telomere elongation, although the mechani

of their function is completely unknown. The Raplp C terminal domain also interact

with Sir3p and Sir4p proteins (Moretti et al. 1994), which participate in silencing

mating type loci as well as at telomeres in yeast. As opposed to deletion of Riflp

which leads to telomere elongation, removal of Sir proteins leads to moderate telo
shortening. It has been proposed that this shortening is very indirect and in the
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do not have Sir proteins, more Raplp molecules are available to interact with Rifl and
Rif2, tilting the balance towards telomere shortening (Marcand et al. 1997).

Genetic screens have identified a number of double stranded telomere binding

proteins that affect telomere length regulation in S. pombe (Cooper et al. 1997; N
et al. 1998). A strain with a deleted Tazl protein had very dramatically elongated

telomeres. Tazl is a ortholog of human TRF1 and TRF2 (see below) and like them uses
Myb domains for DNA binding. The mechanism by which Tazl regulates telomere
length is not understood.

Telomere length regulation in m a m m a l s

Telomere length regulation in mammals will be described in detail in Chapter 3

of this thesis, but the rules observed in lower eukaryotes also apply to maintenanc
telomere length in higher organisms. Although the details and molecular mechanisms

might be vastly different, both the elongating and shortening activities have to be
regulated and telomere associated proteins are best candidates for such forces.

As noted above, the overall telomerase activity in human cells is regulated at the

level of expression of the catalytic subunit (hTERT) and generally, hTERT expressin

cells have detectable telomerase activity (Kilian et al. 1997; Meyerson et al. 199

Nakamura et al. 1997). However, there is ample experimental evidence that telomeras

activity is very tightly regulated at each chromosome end. For example, tumor cells

maintain their telomeres at a stable length, while they express high telomerase act

(Counter et al. 1992; Counter et al. 1994; van Steensel and de Lange 1997). Secondl

when new telomeres are formed by elongation of a transfected short telomeric "seed"

20

the final length of a new telomere matches that of the other telomeres in the cell.

(Barnett et al. 1993; Hanish et al. 1994; Sprung et al. 1999). These findings sugge
the length of a single telomere can be monitored and adjusted.

In human cells, the double-stranded DNA binding telomere protein, TRF1 is at

least in part responsible for telomere length monitoring. When TRF1 is overexpress

a telomerase-positive cell line telomeres shorten (van Steensel and de Lange 1997).

When TRF1 is removed from telomeres by overexpression of a dominant negative allel

of TRF1, the telomeres elongate (van Steensel and de Lange 1997). In both cases the

telomere length stabilizes at a new length setting, which can be maintained for ma
population doubling (Smogorzewska et al. 2000). The level of TRF1 present on the

telomeres does not influence the telomerase activity detected in the extracts. Bas

these findings it was proposed that TRF1 acts in cis and regulates length of an in
telomere (van Steensel and de Lange 1997). According to this model, long telomeres
recruit a large amount of TRF1, which blocks telomere elongation. Due to the
shortening activities, the telomeres then gradually decrease in length until they

recruiting the inhibitory amount of TRF1. At that time, telomerase elongates the DN

ends, synthesizing more binding sites for TRF1, so that the cycle continues. This i

similar way of regulating telomere length to that of the counting mechanism that w
discussed above for Rapl (Marcand et al. 1997).
A number of other proteins clearly influence length regulation in human cells.

Tankyrase (Smith et al. 1998) and TIN2 (Kim et al. 1999) both bind to TRF1 and most

likely participate in length regulation through changing the binding of TRF1 to te

(Ye and de Lange; Smith et al. 1998; Smith and de Lange 2000). TRF2, a homologue of

TRF1 regulates telomere length independently and through a different mechanism tha
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T R F 1 . Telomere length regulation by T R F 2 and the associated factors will be discussed
in Chapter 3 of this thesis.

As described earlier, telomerase associated proteins might play a role in
telomere length regulation by affecting telomerase processing or stability. Telomeres of
cells deficient in heterogeneous nuclear ribonudeoprotein Al (hnRNP A1) are shorter
than the telomeres in wt cells (LaBranche et al. 1998), and overexpression of UP1, an
amino-terminal fragment of A1 leads to telomere elongation. Besides being associated
with the telomerase RNA, hnRNP A1 has also been reported to interact with the singlestranded telomeric DNA in vitro (Ishikawa et al. 1993; LaBranche et al. 1998; Fiset and
Chabot 2001), which led to a proposal that hnRNP might recruit telomerase to the
telomere (Fiset and Chabot 2001). Mutation in another telomerase RNA binding protein,
dyskerin, might result in increased shortening rates (Mitchell et al. 1999). Finally,
overexpression of La, which binds telomerase RNA (Ford et al. 2001) leads to telomere
shortening. These results suggest that proteins that interact with the telomerase RNA
can positively and negatively regulate telomere length. Further biochemical and
molecular studies will have to be done to decipher all of the interactions and the
mechanism of telomere length regulation by these proteins.

As in yeast, human proteins involved in DNA damage signaling might also be
involved in telomere length regulation. Although one study found no difference in
telomere length homeostasis in cells that were deficient for Ataxia Telangiectasia
Mutated (ATM), an ortholog of TEL1 (Sprung et al. 1997), primary fibroblasts from
human patients affected with Ataxia Telangiectasia showed an increased rate of
telomere shortening when cultured ex vivo (Vaziri et al. 1997). The issue of telomere
shortening rates in these cells is confounded by the fact that these cells, due to genomic
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instability, have very slow growth rates and they senesce prematurely, an event that
might be influenced both by the telomere length as well as by accumulation of DNA

damage. Peripheral T lymphocytes from patients with Ataxia telangiectasia were sho

to have accelerated telomere shortening (Metcalfe et al. 1996), but again, AT patie

are immunodefficient and the shorter telomere lengths might reflect increased turn

of stem cells supplying the peripheral leukocytes. In mice deficient for ATM, telo
length also appears to be decreased (Hande et al. 2001), suggesting that ATM might
influence telomere length. Mutations in WRN protein in human cells, like mutations

ATM, lead to increased telomere shortening rates in human primary fibroblasts cult
ex vivo (Schulz et al. 1996), but again the same caveat about growth rates applies
these experiments.
The role of Ku70, Ku80 and DNA-PKcs in telomere length regulation in

mammalian cells is controversial. SCID (severe combined immunodeficiency) mutation
in mice removes part of the DNA-PKcs protein making it non-functional in V(D)J

recombination. Comparison of telomere length in mice carrying SCID mutation with t

telomere length in wt mice shows that SCID mice have longer telomeres (Hande et al.

1999; Goytisolo et al. 2001). When one of the groups compared telomere length of wt
cells with those that had a complete null DNA-PKcs, the difference disappeared

(Goytisolo et al. 2001). This could be explained if the SCID mutation created a gai
function mutation for telomere length maintenance. It is much harder to explain
discrepancies in results of telomere length assessment in mice lacking Ku80. Even
though the two groups worked with mice from the same source, one of the groups

concluded that the KO cells had shorter telomeres than the wt cells (d'Adda di Fag

et al. 2001), while the other group found no telomere changes between the two strai
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(Samper et al. 2000). There is some data that suggest a slight shortening phenotype in

the KO cells in the results of the second group ((Samper et al. 2000), Figure 5, le
panel), although, the results would have to be very carefully quantified.

Similar discrepancy arose when these two groups looked at the role of poly(ADPribose) polymerase PARP in telomere length regulation. Again, one group has
concluded that there was a telomere shortening phenotype (d'Adda di Fagagna et al.

1999), and the other, that there were none (Samper et al. 2001). This time, the mic

both groups used were from different origin so there could be some strain differen
giving rise to different results. It must be said, though, that the results of the

claimed no difference in telomere length in mutant animals (Samper et al. 2001) we
much more convincing and supplied a much more detailed analysis of the length

phenotype in the KO animals. Also, this group has correctly concluded that there we
no end-to-end chromosome fusions arising due to telomere deprotection, and all of
fusions that were seen in the mutant animals could be accounted for by the genomic

instability observed in these animals rather then the telomere deprotection as sug
by d'Adda di Fagagna et al. (d'Adda di Fagagna et al. 1999).

Telomere protection and its regulation
The first cytological description of fusogenic potential of the broken ends came
from Barbara McClintock, who observed dicentric chromosomes forming chromatin
bridges in anaphase cells of Zea mays (McClintock 1938). While being pulled to the

opposite poles of the dividing cell, dicentric chromosomes will break, resulting i

formed ends moving to daughter cells. Two outcomes were observed. In the first one,
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the broken end formed by rupture fused with its copy after the chromosome was

replicated and because this created another dicentric chromosome the breakage-fusi
bridge cycle would continue through subsequent divisions. This occurred when the

initial break arose in the endosperm and the breakage-fusion-bridge cycle continue

through the development of that tissue. When the break occurred in the zygote, on t

other hand, the cycle would cease and sporophytic tissue that developed behaved as
there were no free ends present. In the words of McClintock, the ends were healed.

healed chromosome stayed stable even when reintroduced into in the gametophytic or

endosperm tissue. Two conclusions could be drawn from these observations. First, th

broken ends were not stable and would fuse with another broken end to form a dicen

chromosome, which, in turn, would lead to the formation of a bridge in the next div

Second, some tissues were capable of healing broken ends. McClintock did not know i

at the time, but the healing power in the zygote is most likely supplied by telomer
whose activity is very high at that developmental stage, but very low in endosperm

(Killan et al. 1998). Telomerase, when present, is able to add telomeric DNA to the

broken end. The added DNA in turn recruits all the necessary components to create a
non-fusogenic chromosome end, a telomere. This current interpretation of healing
implies that to create a proper, protected end, there is a need for telomeric DNA

as a binding site for proteins. If one of those components fails, a telomere will b
nonfunctional and can become fusogenic.
There are many examples of failure of protection resulting from the lack of

sufficient length of telomeric DNA to support proper telomere function. As noted i
section describing telomere length regulation, elimination of telomerase activity

organisms studied to date leads to a gradual but constant loss of telomeric DNA (S
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and Gottschling 1994; McEachern and Blackburn 1995; Lendvay et al. 1996),(Blasco et

al. 1997; Lingner et al. 1997; Nakamura et al. 1998; Fitzgerald et al. 1999; Liu e

2000; Niida et al. 2000). Initially, this loss is associated with no abnormal pheno
showing that presence of telomerase per se is not necessary for end protection.

Eventually telomeres become so short they are non-functional and become fusogenic.

End-to-end fusions are visible in cells derived from mice without functional

telomerase due to deletion of the mTR gene (Blasco et al. 1997), but this phenotype
develops after the telomerase deficient mice have been bred for a number of
generations allowing cell division during which the telomeres shorten. The number

generations to achieve telomere dysfunction varies from 3 to 6 (Blasco et al. 1997;

Herrera et al. 1999) and is highly dependent on the initial length of telomeres in

strain. Similarly, removal of the telomerase catalytic subunit in Arabidopsis thal

produces telomere dysfunction after a delay of 5 generations (Riha et al. 2001). Pl

cells tolerate chromosomal abnormalities allowing for a spectacular display of fus

very late generations of growth without telomerase. Nearly half of the of anaphase

terminal plants (those that do not give rise to offspring) carry at least one brid
A striking outcome of telomere dysfunction is found in S. pombe after loss of its

telomeric DNA due to growth without the catalytic subunit of telomerase or in abse

both Rad3p and TeMp. Molecular analysis of the genome of these cells revealed that

three chromosomes were circularized, thus circumventing the need for end protectio

(Naito et al. 1998; Nakamura et al. 1998). This is an example of healing of ends wi
formation of dicentric chromosomes, a pathway that apparently is available if an
organism has a small number of chromosomes. As an aside, having circular
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c h r o m o s o m e s is compatible with vegetative growth but meiosis is extremely inefficient in
such cells (Naito et al. 1998; Nakamura et al. 1998).

All of the examples above deal with a gradual loss of telomeric DNA leading to
chromosome fusions. In these cases, de-protection results from lack (or too little) of
telomeric DNA. A number of recent experiments suggest that the proteins that bind to
that DNA are ultimately the important players in protection. Based on the molecular
outcome of their removal, protective proteins can be grouped in different categories.
There are those that when removed lead to a very rapid destruction of only the C strand
of the telomere, those that when removed lead to loss of both strands of the DNA and
finally, there are those that cause deprotection but leave the telomeric DNA evidently
intact.

The first category is represented by the Cdc13 complex. Cdc13p, and its
associated factors Stnlp and Tenlp have been already discussed with regard to their
function in telomere length regulation. Their essential function at the telomere stems
from their ability to protect the end from nucleases. Mutations in all three proteins lead
to rapid and specific degradation of the C strand (Garvik et al. 1995; Grandin et al. 1997;
Grandin et al. 2001). The exact molecular nature of the protection is not yet understood,
but it is known that all three proteins can interact with each other. Cdc13p binds to the
single-stranded overhand and recruits the other two proteins, which in turn inhibit
degradation. Cdc13p itself is dispensable for protection because anchoring of Stnlp to
the overhang using the small DNA binding domain of Cdc13p is sufficient to inhibit the
putative nucleases (Pennock et al. 2001). A less dramatic deprotection resulting in C
strand degradation is seen in yeast lacking the Ku 70/80 heterodimer. In wild type cells
long overhangs are present only in S phase, but in both Yku70 and Yku80 mutants, the
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terminal structure of the D N A is altered and G-overhangs are present throughout the cell

cycle (Gravel et al. 1998), suggesting that the Ku heterodimer is necessary for pro
protection. Combining lack of Ku with lack of cdc13 exacerbates single mutant
phenotypes (Nugent et al. 1998; Polotnianka et al. 1998), thus it seems that these
proteins have distinct protective activities at the telomere.

Telomere end-binding protein (TEBP), the first telomeric protein to be isolated,
binds to the very terminus of a single-stranded overhang found in Oxytricha nova

macronuclear telomeric DNA (Gottschling and Zakian 1986). It is a heterodimer of a a
P subunits and forms an extremely stable, non-covalent complex with the DNA. The

DNA in this complex is completely resistant to Bal 31 exonuclease, establishing th

protein is able to protect the terminus in vitro. The crystal structure of the het

complexed with its ss DNA substrate (Horvath et al. 1998) shows that the very term

of the DNA is buried deeply in the cleft formed by the two proteins and thus, it is
inaccessible to any activities that might degrade or extend the overhang.
Although the exact conserved orthologs of Oxytricha's a and p subunits has been
only found in Stylonychia mytilis (Fang and Cech 1991), many species, including

humans, possess a protein that has sequence similarity to the DNA binding domain of
the a subunit. Functional information on this protein comes from S.pombe, where

deletion of Potl, the ortholog of the a subunit from Oxytricha TEBP leads to a rapi
degradation of both strands of telomeric DNA and results in circularization of all
chromosomes (Baumann and Cech 2001). As opposed to the gradual telomere

shortening that follows after removal of telomerase activity, these events are obv

within the first 5 to 10 generations of growth, showing that Potl is necessary for
protection of the DNA.
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Removal of Taz 1 from the telomeres of S.pombe under certain circumstances

(nitrogen starvation or rad22-/- background) also results in deprotection of telome
(Godhino Ferreira and Promisel Cooper 2001). Unlike the examples so far, the
telomeric DNA is not degraded but nevertheless the telomeres become fusogenic.

Fusions are clearly created due to the non-homologous end joining since they requi

the Ku proteins, suggesting that Tazl is necessary for protection from inappropriat

repair activities at the telomere. Tazl is itself a double-strand DNA binding prot

shares homology with the human TRF1 and TRF2 proteins (Cooper et al. 1997; Li et al
2000). The mechanism of end-protection by these double-stranded telomeric DNA
binding proteins will be explored further in Chapter 1 of this thesis.

It seems that even the non-canonical telomeres of D. melanogaster are protected

with the help of a protein. Heterochromatin protein 1 (HP1) is a chromosomal prote

that among other places is localized to telomeres (James et al. 1989). Although HP1

associates with transposable elements (van Steensel et al. 2001) it is interesting

localization at telomeres is independent of presence of the retrotransposons since

can also be found on terminally deleted chromosomes, which lack these elements (Fa

et al. 1998). Numerous mutants of HP1 give rise to end-to-end fusions of chromosome

(Fanti et al. 1998), showing its role in telomere protection. Currently it is a com

mystery how HP1 is able to protect the chromosome ends, especially if one notes tha

HP1 itself does not seem to have DNA binding ability (Singh et al. 1991; Powers and

Eissenberg 1993). Mutation in another Drosophila protein, UbcD leads to formation o

fusions. Although the nature of these fusions is unclear, it has been proposed that
ubiquitin-conjugating (E2) enzyme activity of UbcD might be necessary for proper
behavior of telomeres in D. melanogaster (Cenci et al. 1997).
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Currently, there is also little knowledge about h o w telomeres are protected in
human cells. Observation of low level of telomere fusions, which retain telomeric DNA,
occurring in mouse embryo fibroblasts that lack Ku70, Ku80 and DNA-PKcs (Bailey et al.
1999; Samper et al. 2000; Goytisolo et al. 2001), implicates this complex in end
protection. Although Ku has been reported to interact with both of the double strand
binding telomeric proteins TRF1 and TRF2 (Hsu et al. 2000),(Song et al. 2000), the data
are insufficient for these conclusions and Ku may also simply localize to telomeres
through its ability to interact with DNA ends (Walker et al. 2001) including DNA ends
containing telomeric DNA (Bianchi and de Lange 1999).

How the protection of telomere ends might be achieved molecularly is suggested
by the structure of Oxytricha TEBP, which shows how the very 3' end of chromosomes
can be hidden in a deep hydrophobic protein pocket (Horvath et al. 1998). A tantalizing
possibility of a second way of hiding the very end comes from a finding that telomeres in
evolutionarily distant species end with a t-loop (Griffith et al. 1999; Murti and Prescott
1999; Munoz-Jordan et al. 2001)(Figure i-4). Observation of the chromosome termini
from human and mouse cells using electron microscopy revealed that the telomere loops
back forming a large duplex lariat called the t-loop (Griffith et al. 1999). The t-loop is
stabilized by the strand-invasion of the 3' telomeric overhang into the double-stranded
telomeric DNA. Such architectural remodeling of a telomere in effect masks the very
end, thus eliminating the need for its direct protection by a TEBP-like protein. T-loops
were also found at the chromosome ends in T. brucei (Munoz-Jordan et al. 2001), as
well as at the ends of micronuclear polytene chromosomes of O. fallax (Murti and
Prescott 1999). Thus Oxytricha, and possibly other organisms might use both the t-loop
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directed protection, as well as the T E B P like protection of their termini, possibly at
different times in the cell cycle (Baumann and Cech 2001; de Lange 2001).

No matter what the basis of telomere protection, there is ample evidence that

lack of protection can have disastrous effects on the survival of the organism. Ge

when telomere function is compromised, cells grow very poorly and unless they find
alternative way of maintaining their telomeres, they undergo a terminal arrest or
few examples from recent literature illustrate this point.

A number of studies have explored what happens in the ciliate Tetrahymena

when the RNA template is mutated resulting in incorporation of altered sequences i

the telomere (Yu et al. 1990; Kirk et al. 1997). As discussed earlier, such changes
result in telomere length deregulation, presumably because changes in telomere
sequence preclude or modify the binding of telomere protein necessary for length
regulation. By the same token, some changes were severe enough to alter telomeric

protection and lead to the appearance of large cells with abnormal nuclei and in m

cases complete cessation of growth of certain strains (Yu et al. 1990). In particul
changing the telomeric sequence from GGGGTT to GGGGTTTT leads to a severe
anaphase block with appearance of the telomere associations (Kirk et al. 1997).

Although the cause of the growth arrest was misinterpreted at the time to mean tha
telomere function was necessary for correct chromosome segregation, and not for
protection of ends from fusions, the outcomes of telomere dysfunction were deadly
the organism.
Lack of telomere function in S. cerevisiae also has deleterious effects for cell

survival. All of the Ever Shorter Telomeres (est) mutants (Lundblad and Szostak 19
Lendvay et al. 1996) as well as the mutant lacking the RNA template (tld) (Singer
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Gottschling 1994) cease to grow and die when their telomeres become too short to

support proper telomere function. Cultures only survive when telomeric DNA is rest
through recombination dependent processes (Lundblad and Blackburn 1993). When

this independent process is not available in rad52 mutants (Lundblad and Blackburn
1993), or double mutants of rad50 and rad51 (Le et al. 1999), lack of telomere
maintenance is completely lethal.

The outcome of lack of telomere function in human cells will be explored in detail

in Chapter 2 of this thesis but generally the result depends on the cell type. Som

respond with permanent growth arrest, and others with apoptosis. When telomerase i
inhibited in human tumor cell lines by expression of a dominant negative allele of
telomerase (Hahn et al. 1999; Zhang et al. 1999) cells cease to grow and appear to
undergo apoptosis. This phenotype is observed after an expected lag phase during

which telomeres shorten. Since the replicative potential of cells expressing the d
negative allele of hTERT is thwarted, such cells, as expected, do not give rise to
in nude mice (Hahn et al. 1999). A more recent study using a chemical inhibitor of

telomerase led to a similar conclusion but instead of apoptosis, a cell cycle arre
characteristics of senescence was seen (K. Damm, personal communication).

A mouse strain lacking the telomerase RNA gene is a good illustration of the

consequences of telomere dysfunction at the organismal level. As discussed earlier,
telomere dysfunction in mTERC -/- animals commences only after the mice have been
bred for a number of generations. The development of chromosomal fusions, a marker

of telomere deprotection, coincides with the appearance of adverse effects that in

sterility due to abnormal spermatogenesis resulting in cell death in the testis (H

al. 2001), decreased proliferative capacity of the hematopoietic tissues (Lee et al.
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shortened life-span, and a reduced capacity to heal skin lesions or to respond to blood
cell depletion (Rudolph et al. 1999). Additionally, the rate of spontaneous tumor

formation rises in the late generations of mTERC -/- mice, suggesting that the ins

that is triggered by telomere dysfunction might contribute to tumorigenesis (Rudol
al. 1999).

H u m a n telomeric proteins

In recent years we have seen an enormous surge in our knowledge of the protein
components of mammalian telomeres. The first two human telomeric proteins, TRF1

and TRF2 and their interacting partners will be described in detail below. The pre
of these proteins on telomeres is firmly established. Ku70, Ku80, and DNA-PKcs as

noted above, have a protective function at telomeres. Recently chromatin IP analysi

has revealed that all three proteins were somewhat enriched on the telomeric DNA a

compared to bulk DNA as detected with an Alu repeat probe (d'Adda di Fagagna et al.

2001). It is unclear at this point, whether the association of Ku proteins with tel

constant or whether they bind at specific times. Human Potl, an ortholog of Potlp f
S.pombe has been described (Baumann and Cech 2001) but there is no data yet on the
localization or function of Potl in human cells. Finally, there is data to suggest
WRN and BLM proteins, both orthologs of Sgsl RecQ helicase in S. cerevisiae can be

present at telomeres. BLM has been reported to colocalize with a subfraction of the

telomeres in human cells (Yankiwski et al. 2000), although the significance of such

infrequent colocalization is unclear. WRN protein can be found mainly in the nucle

cells (Marciniak et al. 1998), but in cells that maintain their telomere length thr

alternative mechanism described before (ALT), WRN can also reside in ALT associated
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P M L (AA-PML) bodies, where it colocalizes with PML, Rad52, TRF1, and T R F 2

(Johnson et al. 2001). By analogy to Sgsl in S. cerevisiae, WRN could play a role i
telomere maintenance by the alternative pathways. The only indication that WRN

protein might also play a role in regulating length in non-ALT cells comes from the

finding that telomere shortening is accelerated in cells from Werner Syndrome pati
(Schulzetal. 1996).

TRF1 and T R F 2

TRF1 was identified in cell extracts as an activity that specifically bound to
human TTAGGG repeats (Zhong et al. 1992; Chong et al. 1995). Biochemical

characterization revealed a homodimeric protein (Bianchi et al. 1997) that uses tw
type helix turn helix motifs to bind to variably spaced sites of the sequence 5'YTAGGGTTR-3' (Bianchi 1999). TRF1 is widely expressed and due to its binding

activity, specifically localizes to telomeres at all stages of the cell cycle (Cho

1995). Electron microscopy studies of TRF1 binding to arrays of TTAGGG repeats have

shown that the protein is able to pair two duplex tracts of telomeric DNA (Griffit

1998). Such architectural activity has been proposed to aid TRF1 in telomere length

regulation. As will be discussed further in Chapter 3, TRF1 influences telomere le
vivo through regulating the elongation pathway of telomere length maintenance
(Karlseder and de Lange; van Steensel and de Lange 1997)
Three proteins interact with TRF1 at telomeres. Tankyrasel (Smith et al. 1998),
Tankyrase2 (Kaminker et al. 2001), and TIN2 (Kim et al. 1999) were discovered in
separate yeast-two-hybrid screens using TRF1 as bait. Tankyrasel, a poly (ADP-

fibose) polymerase (PARP), binds to an acidic N-terminus of TRF1 and modifies it us
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its catalytic activity. This modification alters T R F V s ability to bind to telomeric D N A in
vivo and in vitro thus indirectly influencing telomere length (Smith et al. 1998;

de Lange 2000). The biochemical role of TIN2 is less well defined but its influence
telomere length is also consistent with the regulation of TRFl's presence on the
telomere (Ye and de Lange; Kim et al. 1999).

Early human cDNA sequencing efforts uncovered a cDNA fragment encoding a

Myb domain that had striking similarities to that found in TRF1 (Bilaud et al. 1996

Cloning of the full-length cDNA revealed a protein, which due to its similarity to
and ability to bind TTAGGG repeats was named TTAGGG repeat binding factor 2

(TRF2) (Bilaud et al. 1997; Broccoli et al. 1997). As shown in Figure i-2, the high

conservation between TRF1 and TRF2 is found in the Myb domains (58%). This level of
conservation is in agreement with the fact that both proteins recognize the same

sequence in vitro (Bianchi et al.; Broccoli et al. 1997) as well as with the local
TRF2 to telomeric DNA in vivo (Broccoli et al. 1997), and Figure i-3.
The second most conserved domain in TRF1 and TRF2 is the TRF homology
domain (TRFH) (Broccoli et al. 1997; Li et al. 2000). This part of the protein is

responsible for homotypic interactions (Bianchi et al. 1997) as well as interactio

other proteins (TIN2 (Kim et al. 1999) for TRF1, and hRapl (Li et al. 2000) for TRF
Although the sequence identity between TRF1 and 2 is only 29% within TRFH, crystal

structures of these domains can be superimposed (Fairall et al. 2001). Despite this

overall architectural conservation, the structure reveals slight differences betwe

dimer interfaces of TRF1 and 2 that include changes in the length of the interacti

helices, differences in the side chain amino acids and in the hydrogen bonding patt
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Figure i-2. Schematic of domain structure of TRF1 a n d T R F 2 (adapted from Broccoli et al.,
1997; Griffith et al., 1999). Not drawn to scale. Identities are shown in black, similarities in
grey. T R F homology (TRFH) domain is used in homodimerization as well as in interactions with
other factors specific for each protein. Myb domain is used in D N A binding.
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Figure i-3. Localization of T R F 2 to telomeres of h u m a n c h r o m o s o m e s .
immunofluorescence

Indirect

with 647 antibody (raised against full length T R F 2 protein) on a

metaphase spread of HeLal.2.11 cells.
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These findings explain w h y T R F 1 and 2 fail to heterodimerize (Broccoli et al. 1997; Zhu
et al. 2000).

Electron microscopic studies directly implicate TRF2 in t-loop formation.
Baculovirus-derived TRF2 is able to induce invasion of the 3' single-stranded TTAGGG

repeats into duplex telomeric DNA, forming t-loops in vitro (Griffith et al. 1999). A single
stranded overhang of six nucleotides of a G strand (TTAGGG) is sufficient for in vitro tloop formation by TRF2 and it needs to be adjacent to the double-stranded telomeric
DNA so that the double- to single-stranded transition is composed of TTAGGG
sequence (Stansel et al. 2001). When the t-loop is formed, TRF2 can be visualized at its
base where the invasion of the single-strand overhang is thought to occur (Griffith et al.
1999; Stansel et al. 2001). Based on these findings and the earlier studies of the
biochemical activities of TRF1, a model for t-loop formation has been proposed (Griffith
et al. 1999; Stansel et al. 2001) and Figure i-4. In this model, TRF1 pairs the telomeric
sequences and TRF2 aids in the invasion by the single-stranded overhang into the
telomeric repeats. Besides creating the t-loops, telomeric proteins might also stabilize
these structures.

TRF2, like TRF1 has multiple binding partners. Rapl, an ortholog of S.
cerevisiae's Rapl (discussed earlier) has been identified in a yeast-two-hybrid screen
with TRF2 as bait. Like the yeast Raplp, hRapl is implicated in telomere length
regulation although its mode of action is not yet understood (Li et al. 2000). However,
unlike the yeast protein, hRapl does not bind to DNA directly and uses TRF2 as an
anchor. Further analysis of known telomeric proteins in S. pombe revealed that Tazl is
an ortholog of the human TRF proteins (Li et al. 2000). This suggests that the telomeric
complex in S. pombe resembles the human complex more than it does the S.
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cerevisiae's telomeric complex. It also suggests that the ancestral telomeres had both

Rapl like molecules and a TRF-like molecules, and the budding yeast lost the TRF l
component.

Immunoprecipitation with antibodies against TRF2 from human cells revealed
that a small portion of the Rad50/Mre11/Nbs repair complex associates with TRF2 in
vivo (Zhu et al. 2000). Immunofluorescence and cell cycle experiments showed that

Rad50 and Mrel 1 reside at telomeres during all stages of the cell cycle, whether a
Nbsl joins the complex only in S-phase. Genetic studies have implicated the Mrel 1

complex in homologous recombination and in telomere maintenance in yeast (reviewed
in (Haber 1998)and (de Lange and Petrini 2001)). Studies in mammalian systems have

been hindered by the lethality of the organisms lacking the complex. However, NBS1
component of the Mre11 complex, is mutated in patients with Nijmegen breakage

syndrome (NBS) (Carney et al. 1998; Varon et al. 1998) and Mre11 itself is mutated
an Ataxia-Telangiectasia-like disorder (A-TLD) (Stewart et al. 1999). NBS and ATLD

characterized by chromosomal instability, increased sensitivity to ionizing radiat

radioresistant DNA synthesis (RDS) (Carney et al. 1998; Stewart et al. 1999). These
findings implicate the Mre11 complex in detection and signaling of DNA damage

(reviewed in Petrini 1999). In agreement, the complex rapidly localizes to the site

damage (Nelms et al. 1998). Moreover, Nbs is a substrate for phosphorylation by ATM

(Gatei et al. 2000; Lim et al. 2000; Wu et al. 2000; Zhao et al. 2000) and it is nec

for the ATM dependent S phase checkpoint (Lim et al. 2000). Currently the functiona

consequences of the telomeric localization of the Mrel 1 complex are unknown altho
it has been suggested that the complex could generate the 3' G-overhangs or could
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participate in formation, stabilization and/or resolution of t-loops (Zhu et al. 2000; de
Lange and Petrini 2001)

The experimental part of this thesis concentrates on TRF2. Its function has been
explored using an ex vivo primary cell culture system, in which a number of different cell
types were used in order to gain a better understanding of the protein. First, I describe
in detail the role of TRF2 in protection of chromosome ends. Then, I show that the
removal of TRF2 from the telomeres leads to the rapid induction of senescence in
primary cells. This will be followed by description of TRF2 as an essential regulator of
telomere length, mainly, if not exclusively involved in determining the shortening rate of
telomeres. Chapter 4 describes telomere loss and growth arrest phenotypes associated
with a truncation allele of TRF2 that lacks its N-terminal basic domain, and suggests that
this domain is important for the proper function of TRF2. In Chapter 5 an additional
phenotype of loss of TRF2 function, whole genome reduplication and aberrant
centrosome duplication, as well as the finding of TRF2 at centrosomes will be discussed.
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Introduction

Telomeres confer protection onto chromosome ends. Early cytological studies

revealed that ends devoid of telomeres are spontaneously repaired by fusion with o
broken ends (McClintock 1938). Telomeric DNA seems to be a necessary component of

the protected terminus. In human somatic cells, which naturally lack, or have a ver
level of telomerase, telomeres shorten by 50-200 bp per division (Cooke and Smith

1986; Harley et al. 1990; Hastie et al. 1990). Once a certain, still ill-defined- l
setting is reached, telomeres lose their ability to protect and become fusogenic,
resulting in the formation of dicentric chromosomes (Wolman 1964; Thompson and
Holliday 1975; Benn 1976).

End-to-end fusions also arise in tumors where in many cases their appearance

has been correlated with short telomere length ((Counter et al. 1992; Saltman et a
1993), reviewed in de Lange 1995). As pointed out previously (de Lange 1995),
resolution of dicentric chromosomes can lead to loss of heterozygosity (LOH), gene
amplification and chromosomal rearrangements, events that are hallmarks of many
cancer cells. However, most human cancer cells are characterized by high level of
telomerase activity (reviewed in Shay and Bacchetti 1997), hence telomere-directed
chromosomal abnormalities might be important at the early stages of the tumor
development.
In the past four years, the mouse strain lacking the telomerase RNA (mTERC
KO) became a very fruitful model system for studying telomere dysfunction and its

consequences for tumorigenesis. Cells derived from mice null for telomerase exhibi
end-to-end fusions (Blasco et al. 1997). In mice, as in humans, telomeres become

fusogenic only after they become short, which in a mouse can take 4 to 6 generatio
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growth without telomerase (Blasco et al. 1997; Herrera et al. 1999).

It has been

proposed that lack of telomeres in the aging mice of the late generation mTERC KO
could be responsible for the increased rate of spontaneous cancers seen in these
animals (Rudolph et al. 1999). The majority of tumors in such mice originated from

highly proliferative cells that were expected to divide extensively during the anim

leading to increased attrition of their telomeres. In agreement, the tumor cells we
found to display a 3-18 fold increase in chromosome fusions (Rudolph et al. 1999).
Recent studies (Artandi et al. 2000) further substantiate the notion that lack of
leads to increased genomic instability and enhanced tumorigenesis (reviewed in
DePinho 2000).

A number of different repair pathways participate in the maintenance of general
stability of the genome (reviewed in Hoeijmakers 2001). Two of these pathways,
homologous recombination (HR) and non-homologous end joining (NHEJ) are pertinent
to the repair of double-stranded DNA breaks. Engagement of both of the pathways at
telomeres should be avoided. HR involving telomeric repeats might lead to poorly-

regulated telomere lengthening (Dunham et al. 2000). NHEJ activity at telomeres cou
lead to formation of end-to-end fusions.

The core of NHEJ pathway consists of five proteins (Ku80, Ku70, DNA-PKcs,

DNA Ligase IV [Lig4], and XRCC4) that work in concert to repair site specific break

which occur during a physiological event of V(D)J recombination in the immune syst

as well as random breaks occurring in the genome (reviewed in Critchlow and Jackson
1998). Surprisingly, lack of Ku70, Ku80 or DNA-PKcs in mouse cells leads to a mild
telomere deprotection phenotype (Bailey et al. 1999; Samper et al. 2000; Goytisolo
2001). The function of the DNA-PK complex in telomere protection seems to be
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independent of its function in N H E J , since deletion of the other two components of the
pathway- Lig4 or XRCC4, which together are thought to act in the ligation step of the
repair reaction (Lieber 1999), do not show telomere end-to-end fusions ((Ferguson et al.
2000; Gao et al. 2000), this chapter).

The molecular mechanism of protection by telomeric DNA has been proposed to

involve formation of the t-loop (Griffith et al. 1999), a large, lasso-like structure in whi
the telomeric G-overhang is tucked into the double-stranded telomeric DNA. Although
repetitive arrays like the telomeric DNA might be imagined to spontaneously form tloops, it has been shown that the telomeric proteins aid in t-loop formation and/or
stabilization. In particular, TTAGGG repeat binding factor 2 (TRF2) is capable of
generating t-loops in vitro when supplied with a substrate with duplex TTAGGG repeats
ending with the telomeric 3' single-stranded overhang (Griffith et al. 1999; Stansel et al.
2001). Electron microscopic analysis of in vitro formed t-loops revealed that TRF2 can
be visualized at the base of the t-loop where the invasion of the single strand is thought
to occur Griffith et al. 1999; Stansel et al. 2001).

TRF2 is one of two proteins that directly bind to the mammalian telomeric DNA
(Bilaud et al. 1997; Broccoli et al. 1997). It binds DNA as a homodimer using two Myb
related helix-turn-helix domains brought together by the dimerization of the TRF2
polypeptide through a TRF homology (TRFH) domain (Broccoli et al. 1997; Fairall et al.
2001). Another distinct domain of TRF2 is its N-terminus, which is highly basic (pi of 9)
(Broccoli et al. 1997). TRF2 resides at all telomeres throughout the cell cycle (Broccoli
etal. 1997).

This chapter focuses on the role of TRF2 in telomere protection. Experiments
described in this section show that loss of TRF2 from telomeres leads to telomere
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deprotection, which manifests itself in formation of end-to-end fusions, visible as

dicentric chromosomes in metaphase cells and chromosome bridges in anaphase cells.
The fusions are covalent and are formed through Ligase 4 action on chromosome ends

that most likely have lost the single-stranded G-overhangs. Breakage of end-to-end
fusions in subsequent divisions can lead to translocations, which are markers of
genomic instability. The mechanism of protection by TRF2 is suggested by the

decrease in the frequency of t-loops in cells without functional TRF2. Unregulated
dissolution of the t-loops is proposed to constitute a necessary event leading to
formation after TRF2 inhibition. Furthermore, these findings suggest that short

telomeres in senescent or tumor cells become deprotected because they fail to recr
sufficient amount of TRF2 to support t-loop formation.

Results

To study the function of TRF2 at human telomeres, a dominant negative allele of
TRF2 was expressed in a number of different cell types. The design of the dominant

negative allele was guided by the knowledge that TRF2, like TRF1 is a dimeric prote
(Bianchi et al. 1997; Broccoli et al. 1997), which preferably uses two Myb domains
efficiently bind the telomeric DNA (Bianchi et al. 1999). A protein containing the
dimerization domain but lacking the Myb domain should be able to interact with the

endogenous protein and preclude it from binding to telomeres. Additionally, a high

basic N-terminal domain of TRF2 was removed and replaced with a myc tag to facilit

discrimination between the dominant negative allele and the endogenous protein. Thu

the dominant negative allele of TRF2 used in these studies lacks the Myb domain and
the basic domain of the protein and is designated TRF2ABAM (Figure 1-1). The full
TRF2 (FLTRF2) was used as a control for many of the studies and sometimes included
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Figure 1-1. Schematic of T R F 2 alleles used in these studies.
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In some experiments,

constructs with a N-terminal F L A G or M Y C tag were used. Untagged FL T R F 2 included the
endogenous methionine as the first amino acid. Untagged deletion alleles included a
methionine in front of amino acid 45 and ended with amino acid 453 or 500, as indicated.
In N-terminally tagged FL T R F 2 , the tag w a s fused in-frame with the 2nd amino acid of
the protein, and in tagged T R F 2 A B and TRF2ABAM alleles, the tag w a s fused to amino
acid 45.

Asterisk indicates a segment of T R F 2 that is recognized by antibody 508.

Antibody 647, raised against a full length protein, recognizes all of the alleles used in this
study.
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an N-terminal tag, as indicated in the text. T h e protein lacking only the basic domain
(TRF2AB) will be discussed separately (Chapter 4) since this allele is able to localize to
telomeres and phenotypes associated with its expression are different from an inhibition
of telomeric TRF2 by dominant negative TRF2.

Two different systems were employed to overexpress TRF2 alleles (Figure 1-2).
One of them made use of retroviral vectors, which when transfected into a packaging
cell line produced replication-deficient retroviral particles that were subsequently used
for infection of human and mouse primary fibroblasts. A timeline of experiments

following retroviral infection is shown in Figure 1-2 (top). Cells were infected three times
in 5-hour intervals and the selection was started on the following day. Puromycin or
hygromycin were the most commonly used markers for infection of the TRF2 alleles.
Selection produced a pure population of expressing cells within 3 and 5 days for
puromycin and hygromycin, respectively. Expression of the alleles was confirmed by
immunofluorescence with appropriate antibodies and by western analysis.

A second system used in these studies is an inducible expression system in the
HTC75 cell line, a Tetracyclin-inducible derivative of HT1080 human fibrosarcoma cell
line previously used to study the function of TRF1 in telomere length regulation (van
Steensel and de Lange 1997). An untagged full length TRF2 or a FLAG-tagged
TRF24BAM were placed under control of a Tetracyclin-controlled promoter and were stably
transfected into the HTC75 cells. Subsequently, single cell clones were isolated and
named P clones (FLTRF2) or T clones (TRF2ABAM). A control cell line expressing no
exogenous protein was also created and named B27. As opposed to the retroviral
system described above, selection of stable clones gave rise to clonal populations of
cells, requiring analysis of a number of clones of each type. The
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-10 1 2 3 4 5 15(days)
!

1
A

1
1
1
1
h #
1
| day of expression/experiments^

induction
plating of uninduced cells

Figure 1-2. Timeline of experiments using the retroviral delivery system and the
Tetracyclin-inducible system. Alleles of TRF2 shown in Figure 1-1 were delivered using

retroviral vectors or were stably transfected and induced by removal of doxycyclin (Tetrac

derivative) from the media. Expression of all alleles was confirmed using immunofluorescenc
and western blotting.
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Tetracyclin-inducible system was set up such that removal of doxycyclin from the

medium resulted in a relief of repression and appearance of expression of the allel
For clarity, "induced" will mean that the indicated allele was expressed and "noninduced" that it was not expressed. Expression of the alleles reached its highest

within one day after induction (van Steensel et al. 1998) and this was the day tha
designated to be the first day of expression (Figure 1-1, bottom).

In order to test the effects of expression of a FLTRF2 and TRF2ABAM allele on
endogenous TRF1 and TRF2, a subclone of human Helal cells (Saltman et al. 1993),

HeLal.2.11 with particularly long telomeres of 15-40 kbp (Griffith et al. 1999), we
infected with a myc-tagged FLTRF2 and myc-tagged TRF2ABAM (Figure 1-3). One day

after infection the cells were fixed and immunostained with an antibody recognizin
myc tag (9E10), an endogenous and transduced FLTRF2 (508), and TRF1 (371).

Antibody 508 was raised against a peptide present in the basic domain and it recog

the full-length TRF2 but not TRF2ABAM or TRF2AB (van Steensel et al. 1998). FLTRF2,

when overexpressed, gave high nucleoplasm^ staining with overlaid punctate stainin

that co-localized with TRF1 (Figure 1-3, B, top panel), suggesting that some of the
expressed TRF2 localizes to telomeres. Moreover, the TRF1 staining pattern did not
change with FLTRF2 expression, indicating that presence of TRF1 on telomeres was

largely unperturbed. A diminished level of TRF1 on telomeres has been noticed in c

that expressed the FLTRF2 at a very high level (van Steensel et al. 1998), suggesti

that a very high load of telomeric TRF2, as sometimes achieved in transient transfe
experiments, might be able to displace some of the TRF1 from telomeres. TRF2ABAM,

when overexpressed, gave a diffuse nucleoplasm^ staining and efficiently removed t
endogenous TRF2 from the telomeres, visualized as loss of punctate staining of
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endogenous T R F 2 when the myc-tagged TRF2ABAM was expressed (Figure 1-3, A,
bottom panel). Telomeric TRF1 did not seem to be affected by TRF2ABAM expression
(Figure 1-3, B, bottom panel).

Expression of TRF2 ABAM in the HTC75 cells and in human primary fibroblasts led
to appearance of frequent anaphase bridges and lagging chromosomes (Figure 1-4).

Such anaphase abnormalities were very rare in any other cell line analyzed, includ

non-induced HTC75 T cell lines (van Steensel et al. 1998), IMR90 cells that did not
express any exogenous proteins (vector in Figure 1-4, A, Table 1-1), or FLTRF2
expressing cells (Table 1-1). Quantification of the frequency of anaphase bridges

HTC75 T4 cell line on the 4th day of induction revealed a very low frequency of an
bridges and lagging chromosomes (less than 0.1 events per anaphase) when
expression of TRF2ABAM was not induced. The frequency of bridges and lagging

chromosomes increased to 0.7 abnormalities per anaphase with induction of TRF2ABAM

(van Steensel et al. 1998). Similarly, IMR90 cells infected with a control virus or
FLTRF2, showed only 0.2 fusions per anaphase (Table 1-2) and the expression of the
TRF2ABAM allele induced frequent anaphase bridges (1.5 chromosome fusions per
anaphase) when scored on day 7 of selection.
Anaphase bridges can arise from abnormal chromosomes with more than one
centromere being pulled in opposite directions by the mitotic spindle. If this is
of anaphase bridges when TRF2 is inhibited, chromosome fusions in TRF2ABAM-

expressing cells should be also visible as dicentric chromosomes in metaphase spre
Indeed, when TRF2ABAM was expressed in IMR90 cells (Figure 1-5) or in HTC75 T cell
lines (Figure 1-6 and (van Steensel et al. 1998)) multiple end-to-end fusions are
They include both single chromatid arm fusions and double chromatid fusions
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o
rr

B

Figure 1-4. Anaphase bridges in TRF2ABAMexpressing IMR90 h u m a n primary fibroblasts
and H T C 7 5 fibrosarcoma cells. A. Anaphases of IMR90 cells infected with a vector control
virus carrying no exogenous T R F 2 (vector) or TRF2ABAM (TRF2ABAM) on day 7 of selection. B.
Anaphases of HTC75-T19 cell line expressing TRF2ABAM (TRF2ABAM).

Expression

of

TRF2ABAM was induced for 6 days. D N A was stained with DAPI. The arrow points to a lagging
chromosome.
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Table 1-1. Induction of fusions in anaphase and metaphase IMR90 primary fibroblasts infected
with control vector, full length TRF2, and TRF2ABAM. All alleles had a N-terminal myc tag. 50
anaphase cells were analyzed for all infections. Scoring of events was done on day 7 of selection
and was done on coded samples. Pieces and breaks were also scored in this experiment (see
Table 4-2).

Fraction of

Number of

Fusions3 per

anaphases

metaphases

Fusions per

metaphases

Viral vector

anaphase

with fusions

scored

metaphase

with fusions

pLPC

0.2

8%

98

0.06

6%

PLPC TRF2

0.3

20%

115

0.2

17%

pLPCTRF2ABAM

1.5"

78%

57

2.2

55%

a including bridges and lagging chromosomes
b0.4 lagging chromosomes per anaphase, 1.1 bridges per anaphase
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Fraction of

Table

1-2.

Induction of fusions in metaphase cells expressing no exogenous protein or

TRF2ABAM. The HTC75 T4 and T19 cells were grown under conditions resulting in repression or

induction of the dominant negative allele of TRF2, TRF2ABAM. The HTC75 B27 cell line which d
not express any exogenous protein was used as a control. Metaphase spreads were prepared
on day 4 of induction and number of fusions was assessed in 50 metaphase spreads.

Cell line

T R F 2 allele

Induction

Fraction of

Fusions per

metaphases

metaphase

with fusions

HTC75 B27

none

-

22%

0.2

HTC75 T4

-rpppABAM

-

38%

0.4

HTC75 T4

TpppABAM

+

77%

2.4

HTC75T19

TpppABAM

-

52%

0.6

-rpppABAM

+

78%

3.5

HTC75T19
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Figure 1-5. Telomere fusions in metaphases of TRF2ABAM-expressing IMR90 h u m a n
primary fibroblasts. Metaphase spreads of IMR90 cells expressing TRF2ABAM prepared on
day 7 of selection.

Chromosomes were stained with DAPI. Many likely chromatid and

chromosome end-to-end fusions are seen (arrows). The arrowhead is pointing to a likely ring
chromosome.
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vector
day of selection

-\Q

-| 5

TRF2
10

ABAM
15

23-

9.4-

6 .6-

4.4-

Figure 1-6. Telomere length analysis in IMR90 primary fibroblasts expressing TRF2ABAM.
Southern blot of telomeric restriction fragments from cells carrying no exogenous T R F 2 (vector)
or TRF2ABAM (TRF2ABAM).

Genomic D N A was isolated from cells on the indicated days of

selection, digested with Hinfl and Rsal, fractionated on a 0.7% agarose gel, and hybridized with
a T T A G G G repeat probe. The molecular weights of marker D N A s are indicated in kb.
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(chromosome fusions). However, sister chromatids were never observed to form fusions.

Quantification of the fusions in 50 metaphases of HTC75 T4 and T19 cell lines indu

to express TRF2ABAM for 4 days, and IMR90 TRF2ABAM cells on the 7th day of selectio

(Table 1-1 and 1-2) revealed a greater than 6 fold increase in fusion frequency wh
compared to cells that do not express exogenous TRF2 or express the FLTRF2 allele.

In mice lacking a telomerase RNA subunit, telomeres gradually shorten and
eventually metaphase spreads reveal the presence of chromosome end-to-end fusions
(Blasco et al. 1997). When such spreads are further analyzed by performing

fluorescence in-situ hybridization with a telomeric probe, sites of fusions show n

telomeric signal, suggesting that the fusions formed between chromosomes that have

lost telomeric DNA. To ask if end-to-end fusions induced by the presence of TRF2AB

could be due to generalized loss of the telomeric DNA, telomere length was compare
between wt IMR90 cells and IMR90 cells expressing TRF2ABAM (Figure 1-6). The

analysis revealed no differences in telomere length between these cells (but see b

for the description of telomere length in HTC75 T4 cells). Furthermore, when peptid
nucleic acid (PNA) telomeric probe was employed to perform fluorescent in-situ

hybridization (FISH) on the metaphases harboring fusions, telomeric signal was alw

found at the sites of fusion (Figure 1-7). The signal often appeared to be much br

at the site of fusion than on the adjacent sister chromatids, consistent with pres
of both telomeric repeat arrays at the fusion site.
As opposed to IMR90 cells in which Southern blot with a telomeric probe

revealed no changes in hybridization pattern when TRF2ABAM was expressed, the HTC7

T cell lines revealed a new class of DNA that was hybridizing with a telomeric pro

This new class of TTAGGG positive DNA first appeared faintly on the 4th day of ind
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Figure 1-7. T T A G G G

repeats at the sites of fusions in a metaphase of TRF2ABAM-

expressing H T C 7 5 cells. Peptide neucleic acid (PNA) fluorescence in-situ hybridization with a
telomeric probe on chromosomes of HTC75-T4 cells induced to express TRF2ABAM for 6 days.
Telomeric D N A was visualized using a fluorescently labled P N A (CCCTAAA)3 probe. D N A was
counterstained with DAPI. Arrows point to sites of fusion.
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T 4 (TRF2ABAM)
Day of induction

0

1

2

4

6

9

23-

4.4-

2.32.0 -

Figure 1 -8. Time course of changes in telomere structure with expression of TRF2ABAM in
H T C 7 5 T4 cell line. Southern blot of telomeric restriction fragments from H T C 7 5 T4 cells
induced to express TRF2ABAM

Genomic D N A was isolated from cells on the indicated days

after induction, digested with Hinfl and Rsal, and hybridized with a T T A G G G repeat probe after
fractionation on a native 0.7% agarose gel. The molecular weights of marker D N A s are
indicated in kb. The arrow points to a new high molecular weight D N A that appears after
induction of TRF2ABAM but not in control cell line (not shown). The mean length of the new
species is around 10 kb and mean length of the telomeres before induction is about 5 kb.

This experiment was performed by Bas van Steensel (van Steensel, Smogorzewska, and
de Lange, 1998).
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of TRF2ABAM (Figure 1-8 and van Steensel et al. 1998). The strength of hybridization to

this new class of telomeric DNA increased with time. However, the median size of th

new class of telomeric DNA remained stable with time and in all cell lines examine

was twice the median size of the original telomeres (van Steensel et al. 1998). Fur

molecular analysis showed that the higher molecular weight telomeric DNA represent

the fused telomeres, since that DNA was resistant to an exonucleolytic activity of
(van Steensel et al. 1998). The Southern blot visualizing the new class of TTAGGG
repeat fragments (Figure 1-8) was performed on the DNA that has been extensively

treated with proteinase K, hence, it was concluded that the fusions arose from joi
the deprotected chromosome ends at the DNA level and are not formed by a
proteinaceous connection.
Two types of joining events involving telomeric DNA might be imagined. One
would be a covalent joining of the deprotected ends where the DNA would be ligated

together, and the other would be a non-covalent, but very stable interactions at t

termini. For example, TTAGGG repeats present in the single-stranded G-overhangs of
human telomeres readily form G-G base-paired structures in vitro (for review see

Henderson 1995) and this type of interaction could be responsible for the end-to-e
fusions. To address whether the telomere fusions induced by TRF2 removal were
covalent, the fusions were analyzed under denaturing alkaline conditions.

DNA was isolated from HTC75 T4, T19, and T22 cell lines with or without

induction of TRF2ABAM (Figure 1-9). Protein free genomic DNA was isolated, digeste

with Hinfl and Rsal, and size-fractionated on native (Figure 1-9, A) or alkaline (F
B and C) agarose gels. Comparison of the pattern of TTAGGG repeat containing
restriction fragments in cells grown with or without the induction of TRF2ABAM, as
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A

cell line
induction

native
blotted
T4 T19 T22

B

denaturing

denaturing

blotted

in-gel

T4

T19

- +

-

T22

T4

+

+

T19
-

T22
+

«...

Figure 1-9. Visualization of fusions in HTC75 cells expressing TRF2ABAM under native and
denaturing conditions. Southern blot of telomeric restriction fragments from H T C 7 5 T4, T19,
and T22 cell lines resolved under native (A) and denaturing (B and C) conditions. Three
independent cell lines (T4, T19, and T22) were grown under conditions resulting in repression (-)
or induction (+) of the dominant negative allele of TRF2, TRF2ABAM. Protein-free genomic D N A
was isolated, digested with Hinfl and Rsal and fractionated on a native 0.7% agarose gel (A), or
treated with 0.05 N N a O H and fractionated on an alkaline 0.5% agarose gel (B and C).

The

native gel (A) and one half of the denaturing gel (B) were blotted onto a nylon membrane and
hybridized with the T T A G G G repeat probe. The other half of the denaturing gel (C) w a s
hybridized in-situ without blotting onto a membrane.

The molecular weights marker were

prepared by digesting a T T A G G G repeat bearing 2.6 kb pTH5 plasmid with Hindlll and self
religation of the cut plasmid. Markers are in the first lane in each gel and their size is indicated in
kb.
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expected, showed the larger class of T T A G G G repeat containing fragments when T R F 2
was inhibited (Figure 1-9, left). This new class of larger TTAGGG repeat-bearing
restriction fragments was also detectable when the DNA was fully denatured by

incubation in NaOH and fractionated on an alkaline gel (compare Figure 1-9 A and B

To verify that this treatment denatured telomeric DNA fully, a DNA ladder generate

ligating the Hindlll linearized TTAGGG repeat bearing plasmid (pTH5; de Lange et a
1990) was used as a marker. This DNA was fractionated on an alkaline gel and
hybridized in situ to a TTAGGG repeat probe without additional denaturation. As

expected this control DNA hybridized to the probe showing that it was denatured (F
1-9, C). As a further control, the genomic DNAs were analyzed in parallel by

fractionation on an alkaline gel followed by either blotting onto a membrane (invo

additional denaturation step) (Figure 1-9, B) or in-gel hybridization (not involvi

additional denaturation) (Figure 1-9, C). Since both protocols gave similar patter

intensity of hybridization signals, it is likely that the alkaline gel procedure h
denatured the genomic DNA.
These experiments demonstrated that the telomeric fusions induced by the
removal of TRF2 are formed by a covalent linkage of chromosome ends. Given the

presence of long G-overhangs at the end of all chromosomes (Makarov et al. 1997) s

ligation is unexpected. To assess the state of G-overhangs in cells expressing TRF

allele, a G-overhang assay (Makarov et al. 1997) was performed. HTC75 T4 cells wer

induced and the DNA was isolated at different days of induction. After digestion w

Rsal and Hinfl, equal amounts of DNA were hybridized in solution with a radiolable
(CCCTAA)4 probe under non denaturing conditions (50°C). The reactions were

fractionated under native conditions (Figure 1-10) and the resulting signal from t
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T 4 induced
induction °

dsTTAGGG
T
I
Hinfl, Rsal

1

2 4

6

T 4 noninduced
9

0

1

2 4

6

9

G overhang
T
=
I * = ^PfCCCTAA^
-****

>. a jj. • T4 induced
• T4 uninduced
days
Figure 1-10. T i m e c o u r s e of disappearance of G-strand o v e r h a n g signal in cell expressing
TRF2ABAM.

G-strand overhang assay (Makarov et al., 1997) performed o n genomic D N A

isolated from H T C 7 5 T 4 cells.

H T C 7 5 T 4 cells were grown under conditions resulting in

repression or induction of the dominant negative allele of T R F 2 , TRF2ABAM. D N A w a s isolated
from cells o n the indicated days after induction, digested with Hinfl and Rsal, and hybridized
without denaturing with a radiolabled ( C C C T A A ) 4 visualizing only the single-stranded telomeric
D N A (Top). Loss of G-strand overhangs w a s quantified after induction of T R F 2 A B A M in two
independent experiments performed with the T 4 clone (bottom). T h e data were derived from two
experiments similar to those s h o w n and the average value w a s plotted.

This experiment was performed by Bas van Steensel (van Steensel, Smogorzewska, and
de Lange, 1998).
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hybridization of the single-stranded probe to the G-overhang was quantified (Figure 1-

10). With induction of TRF2ABAM, G-overhang signal diminished to reach a minimum l

of about 50% of the signal in TRF2ABAM non-expressing cells. The specificity of th

was confirmed by treating the DNA with Mung Bean nuclease prior to hybridization w
the (CCCTAA)4 probe. Mung Bean nuclease removes the overhang without degrading

the double-stranded telomeric DNA, which resulted in a loss of hybridization signa
G-overhang assay, but not in a Southern blot performed on the Mung Bean nucleasetreated samples (data not shown, performed by Bas van Steensel). Furthermore, when
a (TTAGGG)4 probe was used for the hybridization, G-overhangs were not visualized
(data not shown, performed by Bas van Steensel).

Loss of the hybridization signal in the G-overhang assay on DNA from TRF2ABAM-

expressing cells could not be fully accounted for by formation of fusions, since o
20% of telomeres appeared to be fused at the time when the overhang signal was
diminished to 50% (van Steensel et al. 1998). It is impossible to discern from the
overhang assay how much of the G-overhang is lost at an individual telomere. For
instance, all of the telomeres may have lost half of the G-overhang or half of the

telomeres lost the entire overhang. However, the detection of covalent fusions sug
that at least some of the chromosomes lost all of the G-overhangs preceding their
fusion.
Under normal growth conditions the G-overhangs are thought to invade the

double-stranded telomeric repeats, forming t-loops. Disappearance of the G-overhan
upon induction of TRF2ABAM suggested that t-loop formation may be diminished when

TRF2 is absent from telomeres. This would parallel the in vitro findings, in which

was shown to aid in formation and/or stabilization of t-loops (Griffith et al. 199
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et al. 2001). To test the hypothesis that removal of T R F 2 from telomeres would lead to

dissolution of t-loops, electron microscopic analysis was performed on DNA from ce

expressing no exogenous protein, FLTRF2 and TRF2ABAM (Figure 1-11, table 1-3). For

these experiments IMR90 cells were first infected with SV40 Tag to allow continuou

division while expressing TRF2ABAM (see Chapter 2). Subsequently, a second infecti

was performed with a control vector (pLPC) or with TRF2 alleles (pLPC TRF2 and pLPC

TRF2ABAM). Nuclei were prepared from about 2x108 cells per cell type and the DNA wa
cross-linked by exposing the nuclei to 365 nm UV light in the presence of 4'aminomethyltrioxsalen (AMT). Further analysis was done by Jack Griffith using a
modification of a procedure previously used to discover t-loops at the ends of

chromosomes (Griffith et al. 1999). An example of a t-loop from IMR90 cells infecte
with a vector control is shown in Figure 1-11. Preliminary analysis showed that a
number of t-loops visible in samples obtained from TRF2ABAM-expressing cells was
diminished when compared to control or FLTRF2-expressing cells and dropped to 40%
of the control levels. In this experiment only 65% of cells used for the analysis

expressed TRF2ABAM as assessed by immunofluorescence staining. This means that the

TRF2ABAM-expressing sample contained a substantial fraction of cells that no longe

expressed the dominant negative allele of TRF2, resulting in an underestimate of th
effect of TRF2ABAM on the t-loop frequency
The above experiments suggest that removal of TRF2 from telomeres results in

the loss of at least some of the t-loops, loss of the G-overhang and a covalent fu
deprotected telomeres. To ask whether the non-homologous-end-joining (NHEJ)

pathways are responsible for formation of end-to-end fusions after inhibition of TR

mouse embryonic fibroblasts (MEFs) lacking Ligase IV (Lig4) (Frank et al. 2000) we
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Figure 1-11 A t-loop from IMR90 cells expressing SV40 large T antigen but no exogenous
T R F 2 allele. An electron micrograph of a telomeric D N A fragment isolated from IMR90 cells
expressing S V 4 0 large T antigen. Nuclei of logarithmically growing cells were prepared and
their D N A was crosslinked using 4'-aminomethyltrioxsalen (AMT). D N A was digested with Mbol
and Alul and after fractionation over a Biogel A 5 M column, fractions containing telomeric D N A
were spread for E M analysis as described in materials and methods.

Collection of cells was done with the help of Jan Karlseder. All preparation and analysis
following crosslinking including the E M analysis w a s performed by Jack Griffith,
University of North Carolina, Chapel Hill.
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Table 1-3. T-loop frequency in I M R 9 0 primary fibroblasts expressing S V 4 0 Large T antigen
infected with control vector, full length T R F 2 , and TRF2ABAM O n average 2x108 cells per
experiment were harvested and their D N A w a s crosslinked using 4'-aminomethyltrioxsalen
(AMT). D N A w a s digested with Mbol and Alul and after fractionation over a Biogel A 5 M column,
fractions containing telomeric D N A were spread for E M analysis (as descried in materials and
methods).
E M analysis w a s performend by Jack Griffith, University of North Carolina, Chapel Hill.
% cells
Viral vector

# t-loops/

Relative t-loop

expressing

Molecules

t-loops

1000

frequency per

TRF2ABAM

scored

found

molecules

experiment

pLPC(expl)

n.a

621

33

53

100

pLPCTRF2(exp1)

n.a

689

36

52

98

pLPCTRF2ABAM(exp1)

65%

717

15

21

40

p L P C (exp2)

n.a

n.d.

n.d.

n.d.

n.d.

pLPCTRF2ABAM(exp2)

50%

n.d.

n.d.

n.d.

n.d.

pLPC(exp3)

n.a

n.d.

n.d.

n.d.

n.d.

pLPCTRF2ABAM(exp3)

50%

n.d.

n.d.

n.d.

n.d.

n.a- not applicable
n.d- not determined
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used to investigate fusion formation after expression of TRF2ABAM. Lig4 has been shown
to be necessary for the NHEJ in human cells (Grawunder et al. 1998). Mice that are
devoid of Lig4 or that lack a Lig4 accessory factor (XRCC4) die during embryonic
development and cells recovered from the embryos are unable to perform NHEJ

resulting in their sensitivity to irradiation ((Barnes et al. 1998; Frank et al. 1

al. 1998; Frank et al. 2000), reviewed in Sekiguchi et al. 1999). Because MEFs lacki

Lig4 grow extremely poorly, Lig4 MEFs that also lacked p53 were used for the analy

(Frank et al. 2000). Lack of p53 rescues the organismal lethality of the Lig4 KO as

as allows for faster and continuous growth of the population, while not influencin
primary NHEJ defect of these MEFs in non-homologous end joining pathway (Ferguson

et al. 2000; Frank et al. 2000). For the analysis of fusions, Lig4+/+p53-/- and Lig4/- MEFs obtained from the same litter were infected with the pLPC control or the
TRF2ABAM-expressing virus. Chromosomal abnormalities in 30 metaphase spreads of
each type were assessed on coded samples. To aid in distinguishing between end-to-

end fusions that are formed due to TRF2ABAM expression and fusions that form betwe

broken chromosomes that are expected to be present in Lig4 null cells, PNA FISH was

performed to visualize telomeric DNA. Metaphases from Lig4+/+p53-/- cells infected
a control vector (Table 1-4) showed presence of some breaks and fragments and low
level of chromosome fusions without the telomeric DNA, but no chromosome fusions
with telomeric signal. Expression of TRF2ABAM led to appearance of the expected
telomere fusions (Figure 1-12). Such fusions were never seen when TRF2ABAM was

expressed in MEFs that were devoid of Lig4, despite the fact that these cells show

general increase in chromosomal abnormalities. Abnormalities in Lig4-/-p53-/- cells

included breaks, fragments, and chromosome fusions without telomeric signal (Figure
12 and Table 1-4) and they were all independent of TRF2ABAM expression. The only
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Figure 1-12. C h r o m o s o m a l abnormalities observed in m o u s e embryonic fibroblasts
expressing TRF2ABAM. Peptide nucleic acid (PNA) fluorescence in-situ hybridization with a
telomeric probe on chromosomes from mouse cells infected with TRF2ABAM .

Metaphase

spreads of Llg4+/+ p53-/- and Lig4-/- p53 -/- cells expressing TRF2ABAM were prepared on the
third day of selection.
colored in red.

D N A was counterstained with DAPI and chromosomes were false-

Llg4+/+ p53-/- M E F s expressing TRF2ABAM showed all abnormalities

documented in B to L. Lig4-/- p53 -/- expressing TRF2ABAM cells showed no abnormalities of
the type illustrated in I to L, and short arm chromatid fusion shown in H was seen independent
of presence or absence of TRF2ABAM (also see Table 1-2). (A) Normal chromosome

(B)

Fragments without telomeric signal (C) Fragment with telomeric signals (D) Chromosome with
telomeric signal missing from the long arms

(E) Break

(F) Long arm chromosome fusion

without telomeric signal (G) Short arm chromosome fusion without telomeric signal (H) Short
arm chromatid fusion with telomeric signal

(I) Two-chromosome ring chromosome with

telomeric signal at the fusion sites (J) Long arm chromosome fusion with telomeric signal (K)
Short arm chromosome fusion with telomeric signal

(L) Long arm chromatid fusion with

telomeric signal (arrow) and short arm chromosome fusion with telomeric signal (as in panel K).
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T a b l e 1-4. C h r o m o s o m a l abnormalities in 3 0 m e t a p h a s e s p r e a d s of primary Lig4+/+p53-/- a n d
Lig4-/-p53-/- m o u s e
pLPCTRF2ABAM

embryonic

fibroblasts infected with control vector ( p L P C p u r o ) or

Peptide nucleic acid fluorescence in-situ hybridization w a s p e r f o r m e d

on

m e t a p h a s e s p r e a d s from cells o n the 3rd d a y of selection. Abnormalities w e r e scored o n c o d e d
samples. T h e data reflect t w o separate experiments.

Genotype

Breaks

Chromatid
fusions
without
telomeric
signal

Chromatid
fusions with
telomeric
signal

Chromosome
fusions without
telomeric signal
i

Chromosome
fusions with
telomeric
signal

Chromosome
fusions with
telomeric
signal
per cell §

+

and

Expressed allele

fragments*

Lig4+/+p53-/vector

17

1

3

2

0

0

Lig4+/+p53-/'TTD'COABAM

28

1

6

4

45

1.5

Lig4-/-p53-/vector
Lig4-/-p53-/prp-pT~joABAM

59

2

2t

17

0

0

60

3

2t

3

0

0

* Including fragments with a n d without telomeric signal, a s well a s c h r o m o s o m e s with missing
telomeric signal at t w o chromatids (see e x a m p l e s Figure 1-11, panels B-E)
t All w e r e short a r m chromatid fusions (see e x a m p l e Figure 1-11 2 H )
§ A v e r a g e n u m b e r of c h r o m o s o m e s per cell: 6 4 (Lig4+/+p53-/-, vector), 64(Lig4+/+p53-/-,
TRF2ABAM), 71 (Lig4-/-p53-/-, vector), a n d 7 4 (Lig4-/-p53-/-, TRF2ABAM)
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fusion with a telomeric signal at the site of fusion in Lig4-/-p537- M E F s was of the
chromatid type (Figure 12-H) and only at the short arm of the mouse chromosome.

Formation of this type of fusion was also independent of TRF2ABAM expression, beca

examples of such fusions were seen in all cells examined, even when they were infe

with a vector control (Table 1-4). Taken together, the main conclusion of this exp
is that ligase 4 and hence non-homologus end joining, is necessary for the fusion
formation after inhibition of TRF2.
As shown above, end-to-end fusions formed after expression of the dominant

negative TRF2 allele can be visualized as anaphase bridges, representing dicentric

chromosomes being pulled apart to opposite spindle poles. Resolution of such bridg
may give rise to broken chromosomes, giving rise to chromosome translocations. To
ask whether lack of TRF2 presence on telomeres can cause genomic instability,

multiplex fluorescence in situ hybridization (M-FISH) was employed in collaboratio
Dr. Anna Jauch at Institute fur Humangenetik in Heidelberg (Speicher et al. 1996;

al. 1998). This technique relies on hybridization of metaphase spreads with a set o
fluorescent probes representing individual chromosomes. Each chromosome is

recognized by computer-assisted decoding of its unique hybridization color, enabli
detection of translocated chromosome segments. M-FISH analysis performed on 35
metaphase spreads of normal human primary fibroblasts revealed two breaks in the
centromere region of chromosome 10 and 2 [del(10p) and del(2p), see Table 1-5] but
translocations. In contrast, cells expressing TRF2ABAM showed a high number of
chromosome translocations (Table 1-5). Many of them were end-to-end chromosome
fusions (also known as telomere associations) (Figure 1-13, C, indicated by the
asterisk). However, other translocations that involved terminal fragments and not
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Figure 1-13.

H

Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts

expressing TRF2ABAM.

Multiplex fluorescence in situ hybridization (M-FISH) on metaphase

spreads of cells expressing TRF2ABAM. Spreads were prepared on day 6 of selection, after 12hour colcemid treatment. A. and B. Examples of full metaphase spreads. C. Examples of
translocation (top row),

likely telomere associations (indicated by *), and other chromosomal

abnormalities
(Experiments done in collaboration with Heidi Holtgreve-Grez and A n n a Jauch (Institute
fur Humangenetik, Heidelberg, Germany)
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Table 1-5. Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts infected with

control vector (pLPC puro), full length TRF2 (FL TRF2) or the dominant negative allele of T
(pLPCTRF2ABAM), as assessed by M-FISH. Metaphase spreads were prepared on day 6 of

selection after a 12 hour colcemid treatment. Chromatid fusions are not scored by this met
All alleles were untagged.
(Experiments done in collaboration with Heidi Holtgreve-Grez, Anna Jauch (Institute fur
Humangenetik, Heidelberg, Germany)

Number of
Viral vector

Metaphases scored

pLPC puro

35

del(10p), del(2p)

PLPC TRF2

10

t(2;7)

pLPCTRF2ABAM

44

translocations
t(2;5), t(8;22), t(2;8), t(20;21), t(20;21),

Cumulative abnormalities*

telomere associations1
t(16;22), t(7;18), t(12;12), t(7;11), t(10;16),
t(5;6),t(12;17)
deletions and fraaments
del(2)x2, +1q, +1p, del(X)x3, del(5p), del (5q),
del(11p), del(11q),fra(1p)
other abnormalities
dup12, chrg(12)§
* excluding numerical changes, which w a s seen in all samples, most likely due to imperfect
spreading
flikely an end-to end fusion-cytogenetically referred to as telomeric association (tas)
§chrg= c h r o m o s o m e gap
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complete chromosomes were also seen (Figure 1-12, A, B, and C, top row). The
existence of such translocations suggest that removal of TRF2 can lead to genomic

instability even in the otherwise normal human fibroblasts. Chromosomal abnormaliti

are generally underdetected by M-FISH, since chromatid fusions are not scored (unle

they give rise to true translocations) and terminal deletions that should be forme

translocations involving telomeric DNA are not well visualized, given that they re
loss and not gain of the chromosome DNA.

Discussion

This chapter provided evidence that the maintenance of protection at human

telomeres is highly dependent on TRF2, one of the two TTAGGG binding factors presen
in all mammalian cells tested to date. Removal of TRF2 from telomeres by
overexpression of the dominant negative (TRF2ABAM) allele leads to telomere
deprotection which can be deduced from the presence of end-to-end fusions in
metaphase and in anaphase cells.
The striking finding that telomeric DNA is present at sites of fusions when TRF2

is removed, shows that the telomeric DNA itself is insufficient to provide protect

chromosome ends and that it must act in concert with TRF2 and possibly other prote
to confer protection. A strong requirement for the TTAGGG repeats has been noted

during the de novo telomere formation in human cells (Hanish et al. 1994). In other
experiments, addition of non-TTAGGG repeats by a mutant telomerase resulted in

telomere dysfunction leading to the formation of end-to-end fusions (Guiducci et a

2001) and the decline in growth potential of cells harboring mutated telomeric seq

(Guiducci et al. 2001; Kim et al. 2001). Based on the results presented in this chap

is likely that the acquisition of TRF2 by the transfected telomere seed allows for
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Figure 1-14. M o d e l of c h r o m o s o m a l events following inhibition of T R F 2 . T w o alternative
pathways from t-looped state to deprotected and fusogenic state are s h o w n . (Left) Expression
of T R F 2 A B A M

leads to dissolution of t-loops. G-overhangs b e c o m e deprotected and degraded.

(Right) Expression of T R F 2 A B A M

leads to lack of re-establishment of t-loops on c h r o m o s o m e

e n d s that w e r e replicated by leading strand synthesis. For example, T R F 2 could b e necessary
for the formation of G-overhangs.

Both pathways converge w h e n the telomeres lacking the G-

overhang are repaired by the non homologous end joining ( N H E J ) pathway employing ligase 4
in the covalent ligation of D N A strands. Breakage of a dicentric c h r o m o s o m e formed by the
end-to-end fusion leads to formation of a translocation and a deletion.
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development of the fully functional new telomere. Conversely, inability of the nonTTAGGG repeats synthesized by the mutated telomerase to recruit TRF2, can be now
proposed to lead to telomere deprotection seen in these cells.

The mechanism of how TRF2 and telomeric DNA collaborate to ensure the

protected state has been proposed to involve formation of the t-loop (Griffith et a

In preliminary experiments described here, t-loop formation was significantly redu
cells that express TRF2ABAM, but normal when cells expressed a full length TRF2

(FLTRF2). In light of this finding, two different scenarios for telomere fusions ca

envisioned (Figure 1-14). In one scenario, expression of TRF2ABAM could lead to the
dissolution of t-loops. T-loop opening would then make the G-overhang susceptible

degradation (Figure 1-14, left) resulting in the formation of a suitable substrate

ligation by the NHEJ pathway. Alternatively, cells expressing TRF2ABAM could be un

to re-establish t-loops on chromosome ends after replication. For example, TRF2 co
be necessary for the formation of G-overhangs after replication by leading strand

synthesis. Such a role for TRF2 would not be unexpected since it interacts with the

Mrel 1 complex, which has been proposed to act in the formation of the overhang (de

Lange and Petrini 2001). As in the first scenario, a telomere remaining devoid of a
overhang would then be a substrate for the NHEJ.
The above proposals are not mutually exclusive; however, a recent study by

Bailey and colleagues (Bailey et al. 2001) substantiates parts of the second propos
these studies end-to-end fusions in HTC75 cells expressing TRF2ABAM were analyzed
using chromosome orientation-FISH (CO-FISH), a technique to differentiate between

chromatids formed by leading and lagging DNA synthesis. The conclusion reached from

these studies was that all of the chromatid fusions seen in the HTC75 T lines were
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to fusion of two chromatids synthesized using leading strand synthesis ("leading to
leading" chromatid fusions).

Based on these studies, one might assume that TRF2 is responsible for
protection of only half of the chromatids- those that are formed by the leading strand
synthesis. Such interpretation would not be prudent at this point since there are many
caveats to these experiments. The dominant negative effect of the TRF2ABAM construct
might never be complete in these experiments. The fact that the dominant negative
effect is often not complete is stressed by the fact that many of the metaphases of the
TRF2ABAM-expressing cells did not show any abnormalities, while others showed as many
as 30 aberrations (van Steensel et al. 1998). There might be also variability of the
dominant negative effect within each cell so that some telomeric TRF2 might be resistant
to stripping by the dominant negative allele. In this case only the most vulnerable sites
might reveal themselves in forms of fusions. Chromatids that were replicated by the
leading strand synthesis might represent such vulnerable sites. Finally, one example
(Figure 1-5 top panel, three-chromosome fusion on the right of the picture) possibly
demonstrates that a leading to lagging chromosome fusion could occur. The caveat here
is that without the CO-FISH on this very spread one will never know if one of these
fusions represent a true lagging-to leading chromatid fusion.

In general, further studies of how t-loops are resolved and re-established during
the cell cycle, and how and when the G-overhang is formed on the chromatids replicated
by the leading strand synthesis, will aid in an understanding of the details of telomere
protection by TRF2. Study of the cells that lack any TRF2 will also be needed to confirm
and further develop the details presented in this chapter. The dominant negative
approach of TRF2 inhibition has added to the knowledge about the mechanism of
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Table 1-5. Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts infected with

control vector (pLPC puro), full length TRF2 (FL TRF2) or the dominant negative allele of TR
(pLPCTRF2ABAM), as assessed by M-FISH. Metaphase spreads were prepared on day 6 of

selection after a 12 hour colcemid treatment. Chromatid fusions are not scored by this metho
All alleles were untagged.
(Experiments done in collaboration with Heidi Holtgreve-Grez, Anna Jauch (Institute fur
Humangenetik, Heidelberg, Germany)

Number of
Cumulative abnormalities*

Viral vector

Metaphases scored

pLPC puro

35

del(10p), del(2p)

PLPC TRF2

10

t(2;7)

pLPCTRF2ABAM

44

translocations
t(2;5), t(8;22), t(2;8), t(20;21), t(20;21),
telomere associations1
t(16;22), t(7;18), t(12;12), t(7;11), t(10;16),
t(5;6),t(12;17)
deletions and fraaments
del(2)x2, +1q, +1p, del(X)x3, del(5p), del (5q),
del(11p), del(11q), fra(1p)
other abnormalities
dup12, chrg(12)§

excluding numerical changes, which w a s seen in all samples, most likely due to imperfect
spreading
flikely an end-to end fusion-cytogenetically referred to as telomeric association (tas)
§chrg= c h r o m o s o m e g a p
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complete chromosomes were also seen (Figure 1-12, A, B, and C, top row). The
existence of such translocations suggest that removal of TRF2 can lead to genomic

instability even in the otherwise normal human fibroblasts. Chromosomal abnormaliti

are generally underdetected by M-FISH, since chromatid fusions are not scored (unl

they give rise to true translocations) and terminal deletions that should be forme

translocations involving telomeric DNA are not well visualized, given that they re
loss and not gain of the chromosome DNA.

Discussion

This chapter provided evidence that the maintenance of protection at human

telomeres is highly dependent on TRF2, one of the two TTAGGG binding factors presen
in all mammalian cells tested to date. Removal of TRF2 from telomeres by
overexpression of the dominant negative (TRF2ABAM) allele leads to telomere
deprotection which can be deduced from the presence of end-to-end fusions in
metaphase and in anaphase cells.

The striking finding that telomeric DNA is present at sites of fusions when TRF2

is removed, shows that the telomeric DNA itself is insufficient to provide protect

chromosome ends and that it must act in concert with TRF2 and possibly other prote
to confer protection. A strong requirement for the TTAGGG repeats has been noted

during the de novo telomere formation in human cells (Hanish et al. 1994). In other
experiments, addition of non-TTAGGG repeats by a mutant telomerase resulted in

telomere dysfunction leading to the formation of end-to-end fusions (Guiducci et a

2001) and the decline in growth potential of cells harboring mutated telomeric seq

(Guiducci et al. 2001; Kim et al. 2001). Based on the results presented in this chap

is likely that the acquisition of TRF2 by the transfected telomere seed allows for
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Figure 1-14. M o d e l of c h r o m o s o m a l events following inhibition of T R F 2 . T w o alternative
pathways from t-looped state to deprotected and fusogenic state are shown. (Left) Expression
of TRF2ABAM leads to dissolution of t-loops. G-overhangs b e c o m e deprotected and degraded.
(Right) Expression of TRF2ABAM

leads to lack of re-establishment of t-loops on c h r o m o s o m e

ends that were replicated by leading strand synthesis. For example, T R F 2 could be necessary
for the formation of G-overhangs.

Both pathways converge w h e n the telomeres lacking the G-

overhang are repaired by the non homologous end joining (NHEJ) pathway employing ligase 4
in the covalent ligation of D N A strands. Breakage of a dicentric c h r o m o s o m e formed by the
end-to-end fusion leads to formation of a translocation and a deletion.
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development of the fully functional n e w telomere.

Conversely, inability of the non-

TTAGGG repeats synthesized by the mutated telomerase to recruit TRF2, can be now
proposed to lead to telomere deprotection seen in these cells.

The mechanism of how TRF2 and telomeric DNA collaborate to ensure the

protected state has been proposed to involve formation of the t-loop (Griffith et al. 1999).
In preliminary experiments described here, t-loop formation was significantly reduced in
cells that express TRF2ABAM, but normal when cells expressed a full length TRF2
(FLTRF2). In light of this finding, two different scenarios for telomere fusions can be
envisioned (Figure 1-14). In one scenario, expression of TRF2ABAM could lead to the
dissolution of t-loops. T-loop opening would then make the G-overhang susceptible to
degradation (Figure 1-14, left) resulting in the formation of a suitable substrate for
ligation by the NHEJ pathway. Alternatively, cells expressing TRF2ABAM could be unable
to re-establish t-loops on chromosome ends after replication. For example, TRF2 could
be necessary for the formation of G-overhangs after replication by leading strand
synthesis. Such a role for TRF2 would not be unexpected since it interacts with the
Mrel 1 complex, which has been proposed to act in the formation of the overhang (de
Lange and Petrini 2001). As in the first scenario, a telomere remaining devoid of an
overhang would then be a substrate for the NHEJ.

The above proposals are not mutually exclusive; however, a recent study by
Bailey and colleagues (Bailey et al. 2001) substantiates parts of the second proposal. In
these studies end-to-end fusions in HTC75 cells expressing TRF2ABAM were analyzed
using chromosome orientation-FISH (CO-FISH), a technique to differentiate between
chromatids formed by leading and lagging DNA synthesis. The conclusion reached from
these studies was that all of the chromatid fusions seen in the HTC75 T lines were due
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to fusion of two chromatids synthesized using leading strand synthesis ("leading to
leading" chromatid fusions).

Based on these studies, one might assume that TRF2 is responsible for
protection of only half of the chromatids- those that are formed by the leading strand
synthesis. Such interpretation would not be prudent at this point since there are many
caveats to these experiments. The dominant negative effect of the TRF2ABAM construct
might never be complete in these experiments. The fact that the dominant negative
effect is often not complete is stressed by the fact that many of the metaphases of the
TRF2A8AM-expressing cells did not show any abnormalities, while others showed as many
as 30 aberrations (van Steensel et al. 1998). There might be also variability of the
dominant negative effect within each cell so that some telomeric TRF2 might be resistant
to stripping by the dominant negative allele. In this case only the most vulnerable sites
might reveal themselves in forms of fusions. Chromatids that were replicated by the
leading strand synthesis might represent such vulnerable sites. Finally, one example
(Figure 1-5 top panel, three-chromosome fusion on the right of the picture) possibly
demonstrates that a leading to lagging chromosome fusion could occur. The caveat here
is that without the CO-FISH on this very spread one will never know if one of these
fusions represent a true lagging-to leading chromatid fusion.

In general, further studies of how t-loops are resolved and re-established during
the cell cycle, and how and when the G-overhang is formed on the chromatids replicated
by the leading strand synthesis, will aid in an understanding of the details of telomere
protection by TRF2. Study of the cells that lack any TRF2 will also be needed to confirm
and further develop the details presented in this chapter. The dominant negative
approach of TRF2 inhibition has added to the knowledge about the mechanism of
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telomere protection; however, this approach depended on the overexpression of

TRF2ABAM. It is formally possible that the phenotype is caused by the dominant neg

allele not only removing TRF2 from telomeres but also non-specifically titrating o
proteins. To control for effect of overexpression, a FLTRF2 was overexpressed and

overexpressing cells were noted not to have phenotypes associated with deprotectio
however, FLTRF2 when overexpressed might suppress some of the phenotypes by

increased telomeric localization. Two approaches might be useful in addressing thi

problem. First of all, using the information from the crystal structure of the TRF

domain, a dominant negative allele containing a much smaller portion of the molecu

might be created, decreasing its ability to titrate other proteins. Secondly, a mo

of TRF2 will be very informative. Based on the phenotypes observed after expressio

the dominant negative allele of TRF2, it is likely that the mouse deficient in TRF
not be able to develop, thus the KO needs to be of the conditional type.
Another point that needs to be addressed is the discrepancy in fusion types

visualized in studies in HTC75 T cell lines (Bailey et al. 2001) and studies prese
this chapter. Chromosome fusions (those in which two sister chromatids of one
chromosome are joined with two sister chromatids of a second chromosomes, (see

Figure 1-15) were often observed and are shown in Figures 1-5, 1-12, and 1-13. Eve

the HTC75 T lines, such fusions were clearly visualized (van Steensel et al. 1998).

However, Bailey et al. (Bailey et al. 2001) have noted that they only observed chr

fusions (Figure 1-15), but never chromosome fusions. Chromosome fusions can form in

two ways; both arms can fuse in S or G2 stage of the cell cycle, or a single chroma
fusion, which was not broken during metaphase to anaphase transition can be
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M

Figure 1-15.

G1

Types of fusions following inhibition of T R F 2

M

A. Chromatid fusion, B.

Chromosome fusion, C. Schematic of events leading to formation of a chromosome fusion
through a replication of a chromatid fusion, which was not severed during the metaphase to
anaphase transition (M-A).
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duplicated in a subsequent S phase (Figure 1-15). C h r o m o s o m e fusions formed through
the second process should have been visualized in the studies of Bailey et al. The
reason why they were not observed probably stems from the fact that the experiments in
that study were done soon after expression of the TRF2ABAM (day 5). Also, the procedure
used in that study, included contact inhibition of the cells during the first days of
expression and release from this inhibition followed by collection of cells after 24 hours
of growth (personal communication). Therefore, only fusion events in the first cell cycle
after inhibition of TRF2 were being studied. Inhibition of TRF2 leads to covalent joining
of telomeric DNA, since, as shown, the fused DNA is resistant to alkaline conditions.
The lack of telomeric fusions in TRF2ABAM-expressing MEFs lacking NHEJ activity
revealed a requirement for this pathway in the end-to-end fusion formation. Ligase IV, in
particular, was required for formation of fusions after inhibition of TRF2. The
requirement for DNA-PK was not assessed since the results would be confounded by
the fact that all three components of DNA-PK themselves play some, although small,

role in telomere protection (Bailey et al. 1999; Samper et al. 2000; Goytisolo et al. 2001).
Participation of the NHEJ pathway in the repair of deprotected chromosomes validates a
long-standing presumption that unprotected telomeres can behave like double stranded
breaks. Such a conclusion has also been reached in S. pombe (Godhino Ferreira and
Promisel Cooper 2001). Nitrogen starvation of cells lacking Tazl, or a combination of
tazl- and rad22- leads to telomere deprotection in this yeast. Telomeres can be shown
to fuse to each other and fusion is dependent on the NHEJ since it does not occur when
Ku70 or Lig4 are mutated (Godhino Ferreira and Promisel Cooper 2001).

This repair of telomeres through NHEJ pathway is not a desired event. M-FISH
analysis of metaphase spreads from cells expressing TRF2ABAM, not only confirmed
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presence of c h r o m o s o m e end-to-end fusions, but also s h o w e d that abnormalities
resulting from such fusions may persist as translocations. Translocations, as
demonstrated in these experiments can even occur in a setting of wild type primary
human fibroblasts, which generally are very sensitive to damage (Di Leonardo et al.
1994), Chapter 2. This experiment shows that telomere deprotection can induce
genomic instability in human cells.

The findings presented in this chapter might also shed light on what defines a
critically short telomere, a telomere that is too short to function. Critically short
telomeres are usually described in the setting of somatic cells at the end of their

replicative life-span, or tumor cells that have not (yet) reactivated telomerase. Cells tha
have critically short telomeres harbor dicentric chromosomes (reviewed in de Lange
1995). Hence, some of the telomeres in the population had reached a length that could
no longer support proper protection. Since the protected state is proposed to be a tlooped state and TRF2 is thought to aid in formation and/or stabilization of t-loops, the
critical length would be the length of the DNA that can no longer recruit sufficient TRF2
to form a proper t-loop. Several experiments could be performed to check the validity of
this hypothesis. First of all, senescent human primary fibroblasts should have a
decreased frequency of t-loops. Similarly, tumors with critically short telomeres and
frequent telomere fusions may also be expected to have fewer t-loops, but tumors that
have reactivated telomerase and show no sign of deprotection should have normal
levels of t-loops, even if such tumors still harbor very short telomeres. Finally, adding

TRF2 to cells with critically short telomeres might aid in their protection by facilitating
loops formation even on very short telomeres.
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Other proteins, besides T R F 2 might also participate in telomere protection in
human cells. One candidate is Potl, a single-strand TTAGGG DNA binding protein
recently identified in the human database (Baumann and Cech 2001). Lack of Potl in
pombe leads to rapid degradation of both strands of telomeric DNA. It will be very

interesting to compare results after removal of human Potl from telomeres with the
outcome of removal of telomeric TRF2 described in this chapter.

84

C h a p t e r

TRF2AB*M

induces
ana

senescence
the

Rb

2

through

pathways

the

p53

Introduction

The first description of the limited replicative capacity of human fibroblasts has
been reported 40 years ago by Hayflick and Moorhead (Hayflick and Moorhead 1961),
and the point at which human fibroblasts cease to divide when cultured in vitro is
referred to as the Hayflick limit or senescence (from Latin senescere- to grow old). The
limited life-span of human fibroblasts is a consequence of the accumulated number of

cell divisions and not the calendar time spent in culture (Dell'Orco et al. 1973; Goldstein
and Singal 1974), suggesting that the counting of cell divisions by a mitotic clock is
responsible for the scheduling of senescence entry.

It has been proposed that in vivo, senescent cells might be contributing to a
number of age-related diseases (Stanulis-Praeger 1987; Dimri et al. 1995) however, the
best evolutionary reason for the existence of a limit to the number of divisions of human
cells is its tumor suppressive potential (reviewed in de Lange 1998). Most of the known
tumor cells are immortal, suggesting that senescence represents one of the obstacles
that need to be overcome during tumorigenesis.

The indication that telomeres might determine the timing of entry into
senescence came from the findings that telomeres shorten in most human somatic cells
(Harley et al. 1990; Hastie et al. 1990). It has been proposed that lack of telomere
maintenance stems from the deficiency in telomerase activity in cells (Cooke and Smith
1986). Indeed, telomerase activity is repressed in most normal human tissues (Kim et al.
1994). Activity can be found only in ovaries and testis (Wright et al. 1996), where it
assures immortality of the germline, and highly proliferative tissues including
hematopoietic cells (Broccoli et al. 1995; Counter et al. 1995).
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However, the formal proof that telomere shortening leads to senescence was

provided by experiments in which the catalytic subunit of telomerase was expressed
telomerase-negative primary human cells (Bodnar et al. 1998; Vaziri and Benchimol
1998). Telomerase-expressing cells exhibited elongated telomeres and divided well

beyond the scheduled senescence timepoint. Importantly, although not surprisingly,
ectopic expression of telomerase did not change the karyotype, the growth

requirements, or the cell cycle checkpoint responses of the cells (Morales et al. 1

The above experiments have established the causal relationship between

telomere shortening and senescence. However, it is not understood, what exactly is

trigger for senescence. Lack of telomere maintenance leads to attrition of telomer

until they reach a certain length setting, commonly referred to as the "critical t

length". At that stage, telomeres lose their ability to protect the chromosome end
become fusogenic, resulting in the formation of dicentric chromosomes as observed
senescent cells (Thompson and Holliday 1975; Benn 1976). It is unclear what is the

length of the "critically short" telomeres. It is difficult to imagine how loss of
kbp from a telomere of 10 kbp could lead to such a critical difference in telomere

function. The high median telomere length in senescent cells might suggest that it
the telomere length alone that determines the senescence entry. Alternatively, it

possible that some of the telomeres in each senescent cell are much shorter than t

median size, and that those telomeres are responsible for the signaling into senes

The main effectors of the senescence entry seem to be the p53 and Rb

pathways (reviewed in (Shay et al. 1991) and (Sedivy 1998)). Expression of SV40 Tag

which neutralizes the activity of p53 and Rb (reviewed in Pipas and Levine 2001) or
simultaneous expression of HPV16 E6 and E7 (Shay et al. 1991) suppresses
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senescence and allows for additional divisions (see Figure 2-1 for a schematic).
However, the cells do not become automatically immortal since they have not stabilized
their telomeres. After about 20 to 30 divisions (Ide et al. 1984; Neufeld et al. 1987; Shay
and Wright 1989) they enter a state of crisis, in which there is no net gain in cell growth
resulting from equal rates of cell division and cell death.

Viral oncogenes, although useful in the initial dissection of the requirements for
the induction of senescence are not perfect for such studies since they have pleiotropic
effects. Mouse cells are also not ideal to study senescence since their replicative lifespan in culture is not determined by telomere length (reviewed in Sherr and DePinho
2000). A knockout approach in human cells has been used to assess the role of p21, an
inhibitor of cyclin-dependent kinases (Brown et al. 1997), resulting in the proposal that
p21 is one of the main effectors of the senescence program. However, it is not excluded
that other genes were also altered during the long culture period required for this
experiment. A more defined system is needed to study the pathways that lead to
senescence induction in human primary fibroblasts.

Inhibition of TRF2, one of the two proteins able to directly bind to human
telomeres, leads to dissolution of t-loops, loss of the G-overhangs and eventually repair
of the deprotected ends resulting in formation of end-to-end fusions (See Chapter 1). In
many cells, inhibition of TRF2 leads to induction of apoptosis (Karlseder et al. 1999).
Cells can undergo apoptosis even before they enter the first S phase after TRF2ABAM is
expressed. This points out that the signal resulting in cell apoptosis appears to come
from the deprotected telomeres and not from the secondary damage that ensues after
the inhibition (e.g. dicentrics ruptured in mitosis). Apoptosis is mediated by

87

H P V 1 6 E 6 p53175H
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Figure 2-1. Schematic of experimental strategies to inhibit p53 and Rb pathways. p53
and Rb can be simultaneously inactivated using SV40 Tag antigen (reviewed in [Pipas and
Levine,2001]) or they can be individually inactivated by H P V 1 6 E6 and E7 proteins (reviewed in
[zur Hausen, 2000]). p53 can also be inhibited by overexpression of a dominant negative allele
of p53 (Serrano et al., 1997).
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the A T M kinase and p53 since cells that are deficient in either of these proteins fail to
undergo programmed cell death.

Human primary fibroblasts are another exception to the apoptotic response. To
further study the cellular outcomes of inhibition of TRF2 in primary human fibroblasts
that naturally undergo a telomere-directed senescence, retroviral infection was used to
deliver TRF2ABAM, the dominant negative allele of TRF2. Removal of TRF2 from
telomeres in primary human fibroblasts resulted in rapid induction of a permanent growth
arrest with characteristics of senescence. Strikingly, simultaneous elimination of the p53
and Rb pathways by expression of SV40 Tag bypassed the arrest. These findings
suggest that critically short telomeres existing in pre-senescent human primary cells are
unable to recruit sufficient TRF2 to achieve proper protection, which results in signaling
into arrest through the DNA damage checkpoint pathways.

Results

As shown in the previous chapter, removal of TRF2 from telomeres by
overexpression of a dominant negative TRF2 allele (TRF2ABAM) leads to telomere
deprotection. To study the influence of inhibition of TRF2 on the growth of human
primary fibroblasts, IMR90 cells were infected with a TRF2ABAM retrovirus, a control virus
carrying no exogenous protein, or a FLTRF2 virus. All experiments followed the timeline
presented in Figure 1-2 (Chapter 1) and all the TRF2 alleles were untagged. In growth
studies, in which the cells were plated at the same density on day 4 of selection and
counted on day 5 and every-other day until day 15 of selection, TRF2ABAM-expressing
cells always fared much worse than the control counterparts (Figure 2-2, A).
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Figure 2-2. Effects of expression of T R F 2 a n d TRF2ABAM o n growth of h u m a n primary
fibroblasts. A. Representative growth curve of cells expressing no exogenous protein (vector),
F L T R F 2 (FLTRF2) or TRF2ABAM (TRF2ABAM). At later time points, T R F 2 expressing cells grow
as fast as vector control cells. O n the 4th day of selection, cells were plated in duplicate at
3x104 cells per well in a six-well plate. O n the indicated days cells from 2 wells were washed,
trypsinized and counted in duplicate using a Coulter counter.

B. % of cells in S-phase as

measured by 1 hour bromo-deoxyuridine (BrdU) incorporation on day 5, 10 and 15. All
numbers are normalized to the level of BrdU incorporation in vector control cells using the
formula: (fraction of BrdU-positive cells in TRF2ABAM-expressing cells/ fraction of BrdU-positive
cells in vector control cells) x 1 0 0 % .

For example if 3 0 % of cells infected with vector control

were positive for BrdU and 1 5 % of TRF2ABAM-expressing cells were positive, the plotted number
would b e 5 0 % . Average values and S D s derived from 5 experiments for vector and TRF2ABAM,
and 4 experiments for T R F 2 are shown.
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Within 10 days of the growth assays, the control cells gained 4.4 population doublings

(PDs), FLTRF2-expressing cells gained 3.9 PDs, but TRF2ABAM-expressing cells gained

only 1.5 PDs. When the growth curve was continued for an extended time, the FLTRF2expressing cells reached the growth rates of the control cells. However, TRF2ABAMexpressing cells continued to be very sparse. Growth assays were also performed in

HS68 and WI38 cells with similar results. Between day 5 and 11 of selection contro
68 cells gained 3.4 PDs, FLTRF2-expressing HS68 cells, 3.7 PDs and TRF2ABAM-

expressing HS68 cells only 1.9 PDs. During the same period, control WI38 cells gai
1.8 PDs, FLTRF2-expressing WI38 cells, 2.1 PDs and TRF2ABAM-expressing WI38 cells
only 0.7 PDs.
Lack of gain in number of population doublings can be due to rapid division

followed by death of the produced cells, or alternatively can be due to the cessati

cellular division. To differentiate between these two possibilities, a BrdU incorp

assay was performed to assess the number of actively cycling cells. Cells on day 4

and 14 of selection were plated in equal numbers and incorporation of BrdU into the
newly synthesized DNA was assessed during a 1-hour interval on the following day.
rapid decline in percentage of cells in S phase in the TRF2ABAM population was

documented when compared to control or FLTRF2-expressing cells (Figure 2-2, B). In
experiments, the % of S phase cells among TRF2ABAM-expressing cells on day 15
averaged only 17% (+/- 7%) of the control cells found in S phase. The declining

numbers of cells in S phase specifically among TRF2ABAM-expressing cells led to th

conclusion that TRF2 inhibition causes cell cycle arrest. Similar results were obt
other primary cell lines including WI38, and BJ hTERT fibroblasts (Table 2-1).
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Table 2-1. Effects of expression of T R F 2 and TRF2ABAM on growth of h u m a n primary fibroblasts.
Relative % of cells in S-phase as measured by 1 hour bromo-deoxyuridine (BrdU) incorporation
on day 5, 10 and 15. All numbers are normalized to the level of BrdU incorporation in vector
control cells as explained in Figure 2-2.
Relative % of cells in S-phase
Celli line
Wi38

W I 3 8 T ag

BJ h T E R T

T R F 2 allele

Day 5*

Day10§

Day 15

FL TRF2
TpppABAM

104

104

117

21

5

2

FL TRF2

120

124

105

TpppABAM

102

100

70

FL TRF2

93

97

n.d

TpppABAM

17

23

n.d

*BrdU in BJ hTERT cells was assessed on day 4
§ BrdU in BJ h T E R T cells w a s assessed on day 9
n.d- not determined
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T h e morphology of TRF2ABAM-expressing cells w a s also suggestive of a growth
arrest. With time, cells became enlarged and flat, and often harbored multilobed nuclei
(Figure 2-3). These cells were strikingly similar to primary IMR90 fibroblasts at the end
of their natural replicative life-span. Positive staining for p-galactosidase at pH6 (so
called senescence associated p-galactosidase activity SA-p-gal) has been described to
be one of the markers of senescent cells (Dimri et al. 1995). The SA-p-gal staining
intensity of TRF2ABAM-expressing cells was high, although not as intense as in senescent
cells stained under the same conditions (Figure 2-3,). In contrast, FLTRF2-expressing

cells or control cells did not exhibit staining for SA-p-gal. However, all cells were positi
when control staining was performed at pH 4, which revealed the lysosomal activity of Pgalactosidase.

To define the cell cycle phase of the arrest, a Fluorescence Activated Cell
Sorting (FACS) analysis was performed on day 15 of the selection and revealed that
cells were accumulating in broad 2n and 4n peaks when stained with propidium iodide
(Figure 2-4). This pattern of growth arrest has also been seen in senescent cells.

Because of the striking similarities between the phenotype of senescent cells and
cells expressing TRF2ABAM, their protein expression profiles were compared. This
analysis has also included IMR90 cells treated with y-rays. It has been reported that
primary human cells irradiated with y rays, a treatment leading to formation of double
stranded breaks (DSB), undergo a permanent growth arrest that resembles senescence
(Di Leonardo et al. 1994). To directly compare results of irradiation and expression of
TRF2ABAM, the irradiated cells were maintained for 15 days after treatment. The three
conditions, expression of TRF2ABAM, senescence and irradiation, resulted in a very similar
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vector

FLTRF2

Figure 2-3. Cell morphology and SA-p-activity in control, TRF2, TRF2ABAM infected IMR90
cells and IMR90 cells undergoing replicative senescence. Cells infected with T R F 2 alleles
were plated at low density and stained for p-galactosidase activity on day 16 of selection. Note
the differences in cell size and staining. At pH 4, which assesses the lysosomal activity, and
acts as a control, all cells showed very intense level of staining.
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Figure 2-4. Effects of expression of T R F 2 and TRF2ABAM on cell cycle profile in h u m a n
primary fibroblasts- comparison with senescent and irradiated cells. F A C S analysis of
control, TRF2, TRF2ABAM, senescent fibroblasts, and fibroblasts treated with 10 Gy IR. A.
Control, TRF2, TRF2ABAM cells were analyzed on day 15 of selection, senescent cells were
analysed when the cells completely ceased dividing B. The irradiated cells were maintained for
1,5, or 15 days with feeding before analysis. 50000 events were collected per sample and the
data are presented without gating. C. S a m e cells as in A. and B. except 10000 events above
"4n" were collected. Note different scales that were used to normalize for different cell numbers
in M1 and M 2 regions. An approximate % of 2n cells is given.
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pattern of protein expression, including increased levels of p53 and its transcriptional

target p21, accumulation of p16 and a switch from the hyper- to hypo-phosphorylate

state of Rb (Figure 2-5). The Rb protein was almost not detectable in the senescent

cells and after irradiation, and it was greatly reduced in TRF2ABAM-expressing cell

Consistent with consequence of the cell cycle arrest, cyclin A (Figure 2-5) and cy
(Figure 4-8) levels were very low.

In order to test the role of the p53 and Rb pathways in the induction of
senescence by TRF2ABAM, viral oncoproteins were used (see Figure 2-1). Young
fibroblasts were first infected with SV40 Tag or with pBabeNeo control virus and
subsequently with control, TRF2, or TRF2ABAM carrying viruses. Comparison of BrdU
labeling in these cells showed that the cell cycle arrest induced by TRF2ABAM was
eliminated in IMR90 cells expressing SV40 Tag (IMR90-SV40Tag) (Figure 2-6, B). On

day 15 of selection, the fraction of cells in S phase in TRF2ABAM-expressing cells
close to that in control cells (88% [+/- 9]). However, the growth curves of these

revealed that the population of TRF2ABAM-expressing SV40 Tag cells did not grow as
as the control populations also expressing the SV40 T antigen (Figure 2-6, C). At
10 of the growth assay, the control cells gained 4.9 PDs, FLTRF2-expressing cells
gained 5.1 PDs, and TRF2ABAM-expressing cells gained 3.7 PDs. Since cells lacking

SV40 Tag but expressing TRF2ABAM only gained 1.5 PDs, SV40 Tag clearly has a strong
suppressive effect on TRF2ABAM-induced arrest.
The morphology of the TRF2ABAM-expressing IMR90-SV40T cells was non-

senescent (Figure 2-7), they did not stain for SA-p-galactosidase, and the only di

between these and control Tag cells was the presence of many refractile cells deta

from the plate (Figure 2-7). Such cells are presumed to be unable to divide, expla
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Figure 2-5. Effects of expression of TRF2 and TRF2ABAM on protein profiles in human
primary fibroblasts- comparison with senescent and irradiated cells. Western blot
analysis of cell cycle regulatory proteins in control, TRF2, TRF2ABAM, senescent fibroblasts, and
cells treated with 10 G y IR from a 137Cs source. Control, TRF2, TRF2ABAM cells were collected
on day 15 of selection, senescent cells were collected when the cells completely ceased
dividing and the irradiated cells were left in tissue culture for 15 days with feeding before
preparation of a lysate. Lysates from the five cell types represented the same number of cells.
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Figure 2-6. Effects of expression of TRF2 and TRF2ABAM on growth of human primary
fibroblasts that also e x p r e s s S V 4 0 T a g . A . Western blot showing expression of S V 4 0 Tag
and of T R F 2 alleles in y o u n g I M R 9 0 cells infected with p B a b e S V 4 0 Tag or a p B a b e N e o
control. E n d o g e n o u s T R F 2 is not detectable under these conditions. T h e I M R 9 0 S V 4 0 Tag
cells w e r e used for experiments s h o w n in panels B a n d C . B . Relative % of cells in S-phase a s
m e a s u r e d by 1 hour B r d U incorporation o n d a y 5, 1 0 a n d 15. All n u m b e r s are normalized to the
level of B r d U incorporation in vector control cells a s explained in Figure 2-2. M e a n values a n d
and S D s derived from 3 experiments are s h o w n .

C . Representative growth curve of cells

expressing n o e x o g e n o u s protein (vector), F L T R F 2 ( F L T R F 2 ) or T R F 2 A B A M (TRF2ABAM). O n the
4th d a y of selection, cells w e r e plated in duplicate at 3x104 cells per well in a six-well plate. O n
the indicated d a y s cells from 2 wells w e r e w a s h e d , trypsinized a n d counted in duplicate using a
Coulter counter.
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vector
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Figure 2-7. Comparison of cellular morphology of cells with or without SV40 large T
antigen, expressing no exogenous protein or TRF2ABAM

Micrographs showing cell

morphology on day 13 of selection. Young IMR90 were first infected with SV40 Tag or a Neo
marker alone and were confirmed to express the large T antigen by immunofluorescence and
western blotting (see Figure 2-5). Subsequently these cells were infected with a vector control
or a TRF2ABAM carrying virus. O n the 4th day of selection, cells were plated at 3x104 cells per
well in a six-well plate for the growth curve shown in Figure 2-5. Photographs were taken on
day 13 of selection. Note that in SV40 Tag cells expressing TRF2ABAM, the cell density is
similar to S V 4 0 T antigen cells infected with a vector control but the latter culture has many
floating cells that are round and refractile .
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the discrepancy between the hindered population growth and the normal levels of the
BrdU labeling in TRF2ABAM-expressing cells.

To further analyze the requirements for p53 and Rb in the induction of
senescence by TRF2ABAM, these pathways were separately inhibited by expression of
HPV16E6 or HPV16E7 respectively. The expression of E7 was verified by
immunoblotting (Figure 2-8, A). Since the available antibodies against E6 do not seem
to recognize the protein in western blots, loss of p53 protein acted as a surrogate marker
for the presence of E6 (Figure 2-8, A). As expected from the results of the Tag
experiments, simultaneous expression of E6 and E7 abrogated the arrest caused by the
TRF2 inhibition in primary human cells (Figure 2-8, B), but separate repression of the
p53 and the Rb pathways led only to a limited suppression of the growth arrest.
Additionally, expression of p53175H, a dominant negative allele of p53 (Serrano et al.
1997) could not overcome the arrest (Figure 2-8, B), even though it was expressed at
very high levels. These experiments suggested that signaling through either one of the
pathways is sufficient to induce and maintain the arrest after TRF2 inhibition.

Signaling from the unprotected telomere to growth arrest might be expected to
involve the PI-3 kinases that have been implicated in DNA damage signaling. Based on
the previous experiments, in which the induction of apoptosis by telomere deprotection
depended on the ATM gene product (Karlseder et al. 1999), it was pertinent to test
whether the arrest induced by TRF2ABAM expression also required the ATM kinase. Three
different primary fibroblast lines from patients affected with Ataxia Telangiectasia and
one control line from a heterozygous parent of one of the affected patients were
analyzed for the ability to undergo growth arrest after inhibition of TRF2. The ATM
status of the cell lines was confirmed by immunoblot analysis with an antibody directed
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Figure 2-8. Effects of expression of TRF2ABAM on growth of human primary fibroblasts
that co-express H P V 1 6 E 6 , H P V 1 6 E 7 , H P V 1 6 E 6 a n d E 7 , p53175H, or p B a b e N e o . A.
Western blot confirming presence or absence of H P V 1 6 E 7 or p53 in cells that were infected
with viruses carrying H P V 1 6 E6, H P V 1 6 E 7 , both H P V 1 6 E 6 and H P V 1 6 E 7 , or p 5 3 D N
(p53175H).

Lack of p 5 3 acts as a surrogate marker of expression of H P V 1 6 E6. B. Relative %

of cells in S-phase as measured by 1 hour BrdU incorporation on day 5, 10 and 15 of selection
after infection with TRF2ABAM. All numbers are normalized to the level of BrdU incorporation in
vector cells as explained in Figure 2-2.
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against the A T M kinase (Figure 2-9, A). The A T status did not influence the percentage

of cells that were in S phase (Figure 2-9, B) nor the morphology of the cells after

expression of TRF2ABAM, suggesting that the ATM kinase is dispensable for the indu

of the arrest but not excluding the possibility that ATM, when present, can be inv
signaling from unprotected telomeres in primary fibroblasts.

One possibility is that ATM signals to p53 and that in its absence inhibition of

TRF2 induces senescence via the Rb pathway. The prediction would be that p53 is not

upregulated in AT cells expressing TRF2ABAM. However, western blot analysis showed

increased levels of p53 in TRF2ABAM-expressing AT cells (Figure 2-9, C). This indi

that ATM is not solely responsible for p53 activation in this setting. Furthermore

suppression of Rb in AT cells by expression of HPV16E7 (Figure 2-10, A) led to only

minimal suppression of the growth arrest caused by TRF2ABAM expression (Figure 2-1
B). However, parallel experiments in which HPV16E7 was expressed in cells that
already expressed p53175H (dominant negative allele of p53 (Serrano et al. 1997))

led to a minimal suppression of the growth arrest caused by TRF2ABAM expression. T

might indicate that inhibition of the endogenous p53 with p53175H and HPV16E6 prot

are not equivalent, and makes the lack of full suppression of growth arrest caused
TRF2abam expressjon jn AT cells expressing HPV16E7 hard to interpret.

Telomere directed senescence does not seem to occur in mouse cells (reviewed

in Sherr and DePinho 2000); however, telomere dysfunction can have deleterious effe
as shown by studies using the mTERC KO mice (Lee et al. 1998; Rudolph et al. 1999;
Hemann et al. 2001) or inhibition of TRF2 in MEFs (Karlseder et al. 1999). In both

settings, cells undergo apoptosis, appearance of which can be temporarily inhibited

(Chin etal. 1999; Hemann etal. 2001), or completely suppressed (Karlseder et al. 199
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Figure 2-9. Effects of expression of T R F 2 A B A M o n g r o w t h of h u m a n primary fibroblasts
that e x p r e s s or lack e n d o g e n o u s A T M protein.

A . Western blot confirming presence or

a b s e n c e of A T M in primary fibroblasts obtained from individuals affected with Ataxia
Telengiectasia ( A G 0 4 4 0 5 , A G 0 2 4 9 6 , A G 0 3 0 5 8 A ) , fibroblasts from heterozygous mother of the
individual w h o donated the A G O 3 0 5 8 A cells ( A G 0 3 0 5 7 ) or wt primary fibroblasts (IMR90). B .
Relative % of cells in S-phase a s measured by 5 hour B r d U incorporation o n d a y 5, 1 0 a n d 1 5
of selection after infection with TRF2ABAM-

All n u m b e r s are normalized to the level of B r d U

incorporation in vector cells a s explained in Figure 2-2. C . Western blots in the A G 0 2 4 9 6 cells
after expression of T R F 2 alleles o n d a y 1 5 of selection. Note that the loading is in different
order than in previous westerns. Also, the loading is not equal (best visualized o n cyclin D
western). Lysates m a d e from ~ 5 7 0 0 F L TRF2-expressing cells, ~ 1 7 5 0 0 control cells, ~ 1 0 0 0 0
TRF2ABAM-expressing cells, a n d ~ 1 0 0 0 0 TRF2AB-expressing cells w e r e loaded.
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Figure 2-10 Effects of expression of TRF2ABAM on growth of h u m a n primary fibroblasts
that lack A T M and express H P V E7 or Neo control A. Western blot confirming presence or
absence of H P V 1 6 E 7 in two A T cell lines (AG02496 and AG04405). Loading control is a crossreacting band observed with the antibody against E7 antibody. B. Relative % of cells in Sphase as measured by 5 hour BrdU incorporation on day 5, 10 and 15 of selection after
infection with TRF2ABAM. All numbers are normalized to the level of BrdU incorporation in vector
cells as explained in Figure 2-2.

104

O L171-4 p53+/+Iig4+/+
O 219-11 p53-/- Iig4+/+
a 219-19 p53-/-Iig4-/-

days of selection

Figure 2-11. Effects of expression of TRF2ABAM on growth of wt primary MEFs and MEFs
deficient in p 5 3 protein.

Relative %

of cells in S-phase as measured by 1 hour BrdU

incorporation on day 5, 10 and 15 of selection after infection with TRF2ABAM. All numbers are
normalized to the level of BrdU incorporation in vector cells as explained in Figure 2-2.
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by the lack of p53 protein. T o determine if primary M E F s , like h u m a n cells, undergo
growth arrest after inhibition of TRF2, they were infected with a control virus or TRF2ABAM
virus. Indeed, the primary MEFs arrested very efficiently after inhibition of TRF2 (Figure
2-11). The arrest was dependent on p53 protein because MEFs deficient in p53 did not
undergo arrest (Figure 2-11) despite having clear markers of telomere dysfunction (see
Figure 1-12). These data suggest that lack of TRF2 on telomeres is sensed by the DNA
damage checkpoint, and that lack of p53 alone suppresses the TRF2ABAM-induced arrest
in mouse cells.

Discussion

The data presented in this chapter show that the presence of TRF2 on telomeres
is required for continuous growth of human primary fibroblasts. This finding parallels the
conclusion that inhibition of TRF2 is incompatible with cell survival and leads to
apoptosis in certain cells (Karlseder et al. 1999). Senescence can be viewed as a
different terminal phenotype assuring that cells with chromosomes that are not properly
protected, no longer divide.

Telomeres devoid of TRF2 become deprotected and it was surmised that the
state of being deprotected results from the inability of the telomere to fold into a t-loop
(see Chapter 1). An unfolded telomere on a chromosomal level leads to telomere fusion
through the NHEJ pathway, which suggests that it is recognized as a double stranded
break (DSB). Here it is shown that chromosome ends that are without TRF2, and
thought to be in a non t-looped state, can activate checkpoint pathways resulting in
growth arrest. The striking similarity of the phenotypes and pathways required for the
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Figure 2-12. A model of parallels between events leading to growth arrest in replicative
senescence and after inhibition of T R F 2 in h u m a n primary fibroblasts. Inhibition of T R F 2
(right) leads to t-loop opening and signaling to p53 and Rb pathways resulting in growth arrest.
Telomere shortening due to the "end replication problem" (left) eventually is proposed to lead to
loss of sufficient T R F 2 from the telomere, resulting in opening of t-loops and downstream
events that activate p53 and R b pathways bringing about the arrest.
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arrest induced by inhibition of T R F 2 and naturally occurring senescence suggests the

possibility that the inability of short telomeres in pre-senescent cells to fold into a t-l
leads to activation of the senescence program (Figure 2-12). If this hypothesis is
correct, senescent cells should have greatly diminished levels of t-loops, a prediction
that is currently being tested

The similarity of protein expression in cells at the end of their replicative life-span
and cells expressing TRF2ABAM led to the conclusion that the same pathways are
activated in both states. In testing the necessity for signaling through the p53 and Rb
pathways, it was found that expression of TRF2ABAM in the presence of the SV40 Tag
overcomes senescence but that the population seems to enter a state similar to crisis.
An analogy can be drawn between inhibition of TRF2 in the presence of Tag and lifespan extension of wt primary fibroblasts in which both p53 and Rb are inhibited by
expression of Tag, or simultaneous expression of HPV16E6 and E7 proteins. In such
cells, the signal to halt proliferation is presumably disregarded, resulting in suppression
of senescence and continued growth despite considerable telomere dysfunction,
evidenced by frequent dicentrics and other chromosomal abnormalities present in these
cells (Ray et al. 1992). After 20-30 population doublings of additional growth, such
cultures enter crisis, a state in which cell numbers do not increase because cell division
is offset by cell death. The cause of crisis is unclear and may stem from loss of
essential subtelomeric genes that are normally protected by telomeres. The crisis-like
state induced by TRF2ABAM in SV40Tag expressing cells occurs without loss of telomeric
DNA, making it unlikely that subtelomeric genes were lost. Perhaps, a more plausible
explanation for crisis is the cumulative genome damage caused by cells that divide with
unstable chromosomes.
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There are m a n y remaining questions about the induction of senescence. A very
important question is what the upstream signals are that activate the p53 pathway.
ATM, even though clearly involved in signaling from DSB (Rotman and Shiloh 1998), is
not essential for the induction or the maintenance of the arrest after inhibition of TRF2.

This is in agreement with findings that fibroblasts from patients afflicted with A-T underg
replicative senescence (Vaziri et al. 1997). p53 is also induced in senescent A-T cells,
suggesting that other pathways are also responsible for signaling to p53. Similarly, in a
mouse model of A-T, gamma irradiation leads to a partial G1 cell cycle arrest (Xu and
Baltimore 1996), which is completely removed when p53 is also mutated (Xu et al.
1998).

Two other PI-3 kinases, ATR and DNA-PK are candidates for the signaling from
damaged DNA, and thus potential candidates for the sensors of unprotected telomere.
ATR is able to phosphorylate p53 in vitro and in vivo (Lakin et al. 1999; Tibbetts et al.
1999) and its inhibition leads to hypersensitivity to damaging agents (Cliby et al. 1998).
DNA-PK also phosphorylates p53 in vitro (Lees-Miller et al. 1990; Shieh et al. 1997);
however, recent analysis of DNA-PKcs deficient mice suggests that DNA-PK is not
essential for signaling after general genome damage (Jhappan et al. 2000). It will be
important to test the requirements for ATR and DNA-PK in induction of arrest after the
inhibition of TRF2.

p53 can also be regulated by p14ARF (Kamijo et al. 1997; Stott et al. 1998). Semi
quantitative RT-PCR has shown increased levels of p14ARF message in senescent cells,
and overexpression of the protein can result in growth arrest of human primary
fibroblasts (Dimri et al. 2000). It remains to be determined if TRF2 inhibition also can
result in increased levels of p14ARF.
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R b hypophosphorylation in replicative senescence and after inhibition of T R F 2
seems to result from p16 upregulation. When present, p16 inhibits the Cdk4 and Cdk6cyclin D complexes, leading to inhibition of Rb phosphorylation; however, events leading
to increase in p16 expression are much less well defined than events leading to p53
stabilization. With ongoing divisions, p16 mRNA as well as p16 protein accumulate in
human fibroblasts (Hara et al. 1996). This accumulation seems to be at least partially
dependent on the increase in the transcriptional factor Ets1 (Ohtani et al. 2001),
although other pathways of p16 regulation are also expected to operate in human cells,
based on the finding that mouse cells deficient in Bmi-1, a transcriptional repressor
belonging to the Polycomb group, p16 levels are increased (Jacobs et al. 1999).

Again, at this point it is not known how p16 is induced in cells in which TRF2 was
inhibited. It might be informative to use some of the mouse KO and overexpression
model systems to confirm the involvement of the discussed proteins in growth response
to telomere deprotection.

It is also of interest to point out that growth arrest in human primary fibroblasts
can be induced by DSBs resulting from irradiation ((Di Leonardo et al. 1994) and Figure
2-5), as well as by an inappropriate mitogenic stimulus originating from expression of
oncogenic Ras (Serrano et al. 1997; Zhu et al. 1998). Under these conditions, the

pattern of protein expression is very similar to the pattern of expression after inhibition
TRF2, suggesting a common pathway that is engaged in implementation and/or
maintenance of the arrest.

One of the important questions in the senescence field pertains to the signal that
induces the growth arrest when telomeres reach the critical length. Some suggest that
progressive telomere shortening might change expression of genes that would
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eventually lead to growth arrest (Baur et al. 2001); however, as of yet, no candidate
genes were found to be localized in the subtelomeric regions of human cells. Others
propose that there is a telomere specific checkpoint that examines the telomere status
and dictates the arrest. Finally, the critically short telomere might signal as a double
stranded break inducing common DNA damage response pathways. The data
presented in this chapter support the last model of how senescence signals into arrest.
Additionally, based on the data presented in Chapter 1, it can be further proposed, that
the signal to these pathways is brought on by the unfolding of the t-loop as a
consequence of insufficient TRF2 being recruited to the critically short telomere or
telomeres.
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Introduction

Human cells that lack telomerase generally do not maintain telomere length.

They can activate a poorly understood alternative lengthening pathway (ALT) (Bryan
al. 1995), which has been proposed to rely on homologous recombination (Dunham et

al. 2000). However, activation of ALT is a very rare event even in tumor cells, and

human primary cells lacking telomerase do not maintain their telomeres, which resu

loss of 50 to 200 bp of telomeric DNA from each telomere per division (Cooke and S

1986; Harley et al. 1990; Hastie et al. 1990). Shortening originates from the inabi

the DNA polymerases to fully replicate some of the termini, but also from nucleoly

activities that may participate in the formation of the G-overhangs. Eventually, l

telomere maintenance leads to deprotection of telomeres (discussed in Chapter 1) a
senescence (discussed in Chapter 2).
Expression of hTERT, a catalytic subunit of telomerase restores telomerase

activity as well as stabilizes telomere length in most primary cells tested to dat
et al. 1998; Vaziri and Benchimol 1998). This is in agreement with findings that
telomerase activity in human cells is regulated at the level of expression of the
subunit (hTERT) and hTERT expressing cells usually have detectable telomerase
activity (Kilian et al. 1997; Meyerson et al. 1997; Nakamura et al. 1997). Tissues
express hTERT at a very low level but have no discernable telomerase activity in

extracts have been proposed to produce a telomerase variant that is able to act as
dominant negative allele poisoning the wt activity (Colgin et al. 2000).
Although existence of the functional telomerase enzyme in the cell is often a
requirement for telomere maintenance, its presence does not automatically lead to
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telomere elongation. A number of findings suggest that telomere length is regulated in

cis at each telomere. Despite high telomerase activity in the germline (Mantell an

Greider 1994; Prowse and Greider 1995; Wright et al. 1996), telomere length is spec

specific. (Kipling and Cooke 1990, Zhu et al. 1998). While expressing high telomera

activity, many tumor cell lines maintain their telomeres at a stable length (Count
1992; Counter et al. 1994; van Steensel and de Lange 1997). Finally, new telomeres

that are synthesized after transfection of telomeric DNA (so called "telomeric see

the cultured cells are elongated to match the length of the other telomeres in tho

(Barnett et al. 1993; Hanish et al. 1994; Sprung et al. 1999). To achieve such contr
length of each telomere has to be monitored and regulated separately.
Telomere length control studies in human cells have shown that the TTAGGG
binding factor 1 (TRF1) is a negative regulator of telomerase-directed elongation
(Karlseder and de Lange; van Steensel and de Lange 1997). Removal of TRF1 from

telomeres by overexpression of a dominant negative allele of TRF1 in cells that al
express telomerase leads to telomere elongation (van Steensel and de Lange 1997).

Overexpression of TRF1 in the same cell line causes telomeres to shorten (van Stee
and de Lange 1997). Under conditions of inhibition or overexpression of TRF1, the

telomere length stabilizes at a new length setting, which can be maintained for ma
population doublings (Smogorzewska et al. 2000). Based on these findings it was

proposed that TRF1 acts in cis and regulates length of each individual telomere (v
Steensel and de Lange 1997). According to the model, a large amount of TRF1 is
recruited to long telomeres. This blocks telomerase from adding more repeats and
telomeres gradually shorten. When they reach a length at which they no longer can
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recruit enough T R F 1 to cause inhibition, telomerase again is able to add more repeats.
Through multiple cycles of such changes, telomeres achieve length equilibrium.

To establish that TRF1 affects telomere length through regulating the telomerase
pathway, TRF1 or its dominant negative allele were introduced into primary human cells.

Because these cells lack telomerase, their telomeres naturally shorten with cell divisions.
This characteristic shortening rate did not change when any of the TRF1 alleles were
added and confirmed that TRF1 acts through modulating the telomerase pathway
(Karlseder and de Lange, unpublished).

TRF1 is regulated by one of its interacting proteins. Tankyrasel, a poly (ADPribose) polymerase (PARP), binds to an acidic N-terminus of TRF1 and modifies it using

its catalytic activity (Smith et al. 1998). Upon this modification TRF1 loses its affinity f
the telomeric DNA, which can be demonstrated both in vitro and in vivo (Smith et al.
1998; Smith and de Lange 2000). In agreement with its ability to inhibit TRF1,
expression of tankyrase leads to telomere elongation (Smith and de Lange 2000), and
the effect requires the PARP activity of tankyrase since an allele lacking the PARP
domain does not affect telomere length. Taken together, these experiments suggest
that tankyrase acts through TRF1 to modulate telomere length. However, the ultimate
experiment showing that tankyrase acts only through regulating TRF1 by creation of a
TRF1 allele that cannot be modified by tankyrase has not been done yet.

TRF1 has a second binding partner, TIN2 (Kim et al. 1999), which also
participates in telomere length regulation (Kim et al. 1999). Expression of a number of
truncation alleles of this protein leads to telomere elongation that is dependent on
telomerase. Since TIN2 exists in a complex with TRF1 (Kim et al. 1999) and tankyrase
(Ye and de Lange, unpublished), it is likely that the proteins act in the same pathway.
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This chapter defines TRF2, the second T T A G G G repeat binding factor, as a

regulator of telomere length. Overexpresion of TRF2 leads to telomere shortening i
telomerase positive but also in telomerase negative cells showing that TRF2 can

influence the shortening activities at the telomere. At this point, it is impossibl
discern whether TRF2 can also influence the telomerase pathway, but the fact that
interacts with Rapl, which when overexpressed causes mild telomere elongation,
suggests that TRF2 might endow the telomere with both the positive regulators of
shortening and negative regulators of elongation.

Results

One of the indications that both TRF1 and TRF2 might influence telomere length
comes from the observations that long telomeres seem to accumulate much more TRF1

and TRF2 than short telomeres. Immunofluorescent staining of telomeric proteins wa
performed in HeLal.2.11, a HeLa subclone with very long telomeres (15-40kbp), and

Helall, a subclone with considerably shorter telomeres (3-6.5 kbp) (Saltman et al.

(Figure 3-1). Telomere staining of TRF2 was generally less visible than staining o
TRF1, and staining with aTRF2 antibodies always resulted in a higher nucleoplasm^
signal than staining with aTRF1 antibodies. Although quantification of the signal
feasible, the punctate pattern of staining against both proteins was reproducibly

more prominent in HeLal.2.11 than HeLall (Figure 3-1, B, pictures were taken at th

same exposure time and are reproduced without any adjustments). Many cells in HeLa
population had almost no punctate staining visible above the overall nucleoplasms
staining. These results indicate that the length of the telomere tract influences

accumulation of telomeric proteins at the chromosome termini. However, this appare

differential presence of TRF1 and TRF2 on short and long telomeres does not seem to
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correlate with the expression levels of these proteins since TRF1

levels were

comparable in Helal.2.11 and HeLall cells, and levels of TRF2 in Helal.2.11 were s

lower than in HeLall (Figure 3-1, A). It needs to be noted that another study foun

fold difference in the TRF1 levels between HeLa cells with short and long telomere

much smaller difference for TRF2 (Okabe et al 2000). This group has also calculated
that the number of molecules of TRF1 present in the cell per each kb of TTAGGG

repeats is higher in cells with shorter telomeres than with longer telomeres. This
correlation was weaker for TRF2 (Okabe et al 2000).

To gain understanding of how TRF2 influences telomere length, a previously

established Tetracyclin-inducible expression system was used ((van Steensel and de
Lange 1997), and see Chapter 1 for a more detailed description). An untagged full
length TRF2 was placed under the control of a Tetracyclin-controlled promoter and

stably transfected into the HTC75 cells, a derivative of HT1080 human fibrosarcoma

line characterized by high telomerase activity and stable telomere length (van Ste
and de Lange 1997). A number of clonal lines were established by Bas van Steensel

and were called P lines. In short term experiments induction of TRF2 had no effect

growth ((van Steensel et al. 1998), Chapters 1 and 2). To study the influence of TR
on telomere dynamics, cells induced and non-induced for expression of TRF2 were
grown in parallel for 124 population doublings (PDs). Telomere length was assessed

periodically by Southern blot hybridization with a telomeric probe. Out of the fou

cell lines examined, one (P4) showed erratic changes in telomere length that did n

correlate with presence or absence of TRF2. This cell line was not studied further.

Three other cell lines (P7, P12, and P33), when grown without induction, maintaine

their telomeres at a stable length. TRF2 induction in these cells produced a compl
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Figure 3-1. Immunofluorescent analysis of TRF1 and T R F 2 staining in cells with long and
short telomeres. A. Western blot showing expression of TRF1 and T R F 2 in buffer C extracts
from two HeLa cell lines with different telomere lengths. TRF1 was detected with antibody 371;
T R F 2 was detected with antibody 647. Cyclin D is used as a loading control. In the first two
lanes, loading w a s based on cell numbers and the second two lanes were normalized based on
protein amounts (30 \ig). B. Indirect immunofluorescence staining for TRF1 and T R F 2 in two
HeLa cell lines with the indicated telomere lengths. All samples were processed identically and
in parallel and images are presented without any adjustment. For each combination of cell line
and antibody, nuclei are presented at two magnifications. D N A was stained with DAPI.
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pattern of telomere length changes, which generally was comprised of an initial period of

telomere shortening, followed by telomere re-growth (Figure 3-2). In the P7 cell li

initially telomeres shortened at 82 bp per PD (calculated from telomere lengths be

PDO and PD28). Unexpectedly, this trend of shortening halted around PD 48 and withi

the next 30 PDs telomeres regained their original length, which appeared to be sta

maintained until the end of the experiment. Similar changes in telomere length wer

observed in P33 cell line, in which the initial shortening (47 bp/PD, calculated fo
PD 40) was followed by elongation, which started around PD72 and was not completed

by the end of the experiment. P12 cell line also showed initial telomere shortenin
bp/PD, calculated from telomere lengths at PDO and PD8), but telomeres started

elongating soon after that and reached a length setting that was longer than the o

length setting in this cell line. Such telomere behavior was very different from t
observed in TRF1 studies where TRF1 overexpression led to telomere shortening and

eventual stabilization of telomere length at the lower setting (van Steensel and d
1997). However, these complex telomere changes were consistently seen in three
different cell lines, which led to a conclusion that TRF2 was the causative agent
unexpected changes.
Changes in telomere dynamics seen in the above experiments could be

explained if the initial high expression of the exogenous TRF2 subsided with time.

initial telomere shortening determined by TRF2 would then also stop, leading to te

elongation. In order to test this hypothesis TRF2 levels were analyzed at differen

points during the experiment (Figure 3-3). Western blots have shown very high leve

TRF2 at the start of the experiment in all three lines. With time, the levels decre

dramatically with no, or very little exogenous TRF2 being produced at the end of t

119

P7
induced
PD 8

48

non-induced

76 124

8

124
r81 kDa

T R F 2 -in* • '
-46 kDa

P33
induced non-induced
PD 8

124

8

124
-81 kDa

TRF2 « —
-46 kDa

B

non-induced, PD2

P12
Induced
non-induced
PD 8 48 76 124 8 124
"81 kDa
TRF2 -P"»
"46 kDa

induced, PD2

induced, PD 12

P12

P12

o.
X
UJ
0 " I ' ' I ' ' I ' ' I ' ' I ' ' I ' ' I ' ' I ' 7Y2 4 6 8 10 12 14 16
48
population doublings after induction

Figure 3-3. T R F 2 expression in P7, P12 and P33 H T C 7 5 cells at various times during
growth. A. Immunoblot analysis of T R F 2 levels in P7, P12 and P33 cells grown under induced
and non-induced conditions. Buffer C extracts were prepared at indicated population doublings
(PDs), and T R F 2 was detected with antibody 508. Endogenous T R F 2 is below detection limit
under these conditions. B. Immunofluorescence with antibody 508 in non-induced and induced
P12 cells at PD2, and induced P12 cells at PD12. Note that at P D 12 the level of expression is
invisioble in two cells, very low in other two, and high in one. C. % expressing P12 cells at
different PDs. All expressing cells were counted, so that 3 out of the 5 cells in right panel of B.
would be counted as being positive for expression.
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experiment (Figure 3-3 A).

As documented by immunofluorescence, this decline in

expression was due to a decrease in numbers of cells that expressed exogenous TRF2
as well as decrease in levels of TRF2 in the expressing cells (Figure 3-3 B). The
changes in expression roughly coincided with the switch from the shortening to

elongation states. P12 line exhibited this switch at a very early time point (befo

28). Loss of expression in this cell line also occurred very early and by PD 48 no
the cells in the population expressed TRF2 as determined by IF (Figure 3-3, C).
Exogenous TRF2 in the P7 cell line, on the other hand, expressed robustly at PD 48
telomeres were still shortening at that time. However, at PD 76, only 20% of cells
expressing TRF2 in that cell line and telomeres in the population were already

elongating. Overall, this correlation further stresses that telomere changes in th

cell line were being influenced by TRF2. However, it is curious that whereas TRF1 c
be stably maintained for 300 PDs (Smogorzewska et al. 2000), TRF2 expression was

being extinguished during these experiments. This finding might suggest that prese
of TRF2, or the short telomere state that is achieved when TRF2 is being
overexpressed, or the combination of both is detrimental for the cell. While the

deleterious nature of TRF2 overexpression could not be fully addressed in this sys

because of the asynchrony of TRF2 loss, it has been noted that the morphology of ce

in the population, which was about to lose TRF2 expression, differed from uninduce
cells, and many cells appeared to have multilobulated nuclei (Figure 3-4).
To further understand the events that led to the initial telomere shortening in

HTC75 cells, the ability of TRF2 to influence telomerase activity and expression of
telomerase subunits was examined. Telomeric repeat amplification protocol (TRAP)

assay was performed on extracts from HTC75 cells induced or not induced to express
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P 1 2 non-induced, P D 1 4

P 1 2 induced, P D 1 4
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Figure 3-4. Cell morphology of P12 H T C 7 5 cells at P D 14.

DAPI staining of P12 H T C 7 5

cells uninduced or induced to express TRF2. Note the presence of multilobulated nuclei and
DAPI positive material joining two interphase cells (indicated as * in the lower panel) in cells
expressing TRF2.
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Figure 3-5. Effects of expression of TRF2, TRF2ABAM and TRF2AB on telomerase activity.
Telomeric repeat amplification protocol (TRAP) assay in HTC75 grown in the presence or
absence of doxycyclin (- and + induction respectively). 0.5 ug total protein of buffer C extract as
assayed by Bradford assay (BioRad) w a s used per reaction. R N a s e digestions were done in
parallel to the untreated reactions by addition of 0.2 ,ug DNase-free R N A s e . Buffer C w a s used
instead of extract in the "no extract" control (last lane on the right).
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full length T R F 2 and the two truncation alleles (TRF2ABAM and TRF2AB). T o assure that
only telomerase activity was being assayed, RNAse was included in parallel reactions.
Additionally, one reaction was performed without any extract to control for any
contamination during the polymerase chain reaction. Telomerase activity appeared to
be comparable in all cells examined (Figure 3-5). This parallels findings that TRF1 or
any of the truncation alleles of TRF1 also did not change the in vitro telomerase activity,
showing that neither TRF1 nor TRF2 modulate the global activity of telomerase, but are
more likely to act in cis at each telomere. Furthermore, expression of TRF2 did not
influence expression of the telomerase subunits, hTERT or hTR, as shown using the
RNAse protection assay on total RNA from HTC75 P lines induced or not induced to
express TRF2 (Figure 3-6).

The many parallels between telomere behavior upon overexpression of TRF1
and TRF2 might suggest that the two proteins act in concert to modulate the telomerase
pathway of telomere length maintenance. However, there remains a possibility that
TRF2, unlike TRF1, influences the shortening activities at the telomere. In an attempt to
address this issue, TRF2 was induced in the HTC75 cell lines previously infected with a
dominant negative allele of hTERT (hTERTD710A) (Hahn et al. 1999). Expression of
hTERTD710A in three HTC75 cell lines examined (P7, P12, P33) inhibited, although not
fully abolished the endogenous telomerase activity (Figure 3-7). Nevertheless, telomere
shortening expected after inhibition of telomerase was seen in all three cell lines (Figure

3-8, A, indicated as "- induction" in the blots, black squares in the graphs). Parallel

induction of TRF2 in these cells led to an increased rate of telomere shortening (Figure

3-8, A, indicated as "+ induction" in the blots, red diamonds in the graphs). One

interpretation of this finding would be that TRF2 is capable of influencing the shortening
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Figure 3-6. Effects of induction of T R F 2 on expression levels of h T E R T and h T R R N A .
RNase protection assay on total R N A in B27, P12, P7, P33 H T C 7 5 cells grown in the presence
or absence of doxycyclin (- and + induction respectively) for 9 days, p-actin served as a control.
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Figure 3-7. Effects of expression of the dominant negative h T E R T in P7, P12, P33 H T C 7 5
cells on telomerase activity. Telomeric repeat amplification protocol (TRAP) assay in noninduced P7, P12, and

P33 H T C 7 5 expressing the dominant negative h T E R T allele

(hTERTD710A> (Hahn et al., 1999). The TRAPeze telomerase detection kit (Intergen) was used
for this assay. Activity was in a linear range. A signifies heat treatment which was done in
parallel to the untreated reactions by incubation of the extract at 85°C for 10 minutes prior to
telomerase extension. C is a positive control, and the "no extract" lane contains product of
reaction performed with lysis buffer supplied with the kit instead of the extract. S-IC is an
internal control during a P C R step
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Figure 3-8. Telomere dynamics analysis in HTC75 cells co-expressing the dominant
negative hTERT( D N h T E R T ) and TRF2.

A. Southern blot of telomeric restriction fragments

from P7, P12, and P33 H T C 7 5 cells carrying D N h T E R T (hTERTD71°A) grown in the presence or
absence of doxycyclin, resulting in repression (-) or induction (+) of TRF2.
weights of marker D N A s are indicated in kb.

The molecular

Length changes were quantified and plotted as

median telomere length (Y axis) against population doublings (PDs) (X axis). B. Immunoblot
analysis of T R F 2 levels in P7, P12, and P33 H T C 7 5 cells carrying D N h T E R T grown under
induced and non-induced conditions. T R F 2 was detected with antibody 647.
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activities at the telomere. According to this interpretation, an increased rate of telomere
shortening in the cell lines expressing both hTERTD710A and TRF2 results from the
additive effect of inhibition of telomerase pathway by hTERTD710A and stimulation of the
shortening pathway by TRF2. Although this interpretation is attractive, the
overexpressed TRF2 in these experiments might have still been able to modulate the
residual activity of telomerase at the shortening telomeres. Therefore, to further study
the effects of TRF2 on the shortening rate, TRF2 was expressed in human primary
fibroblasts, which naturally lack any telomerase activity.

IMR90, primary lung fibroblasts were infected with an untagged full length TRF2
allele and telomere length was observed in short term experiments. Already by the 5th
day of selection telomere shortening was evident in cells expressing TRF2 but not in
cells expressing vector control (Figure 3-9, left panel). A long-term expression of TRF2
in IMR90 cells that also expressed a SV40 Tag led to a steady decrease in telomere
length, and the rate of shortening remained increased throughout the experiment when
compared to rate of shortening in cells expressing vector control (Figure 3-9, right
panel). Moreover, TRF2 expression was not lost from the FLTRF2 infected cells during
this experiment. Similar results were obtained in long-term expression of TRF2 in
IMR90 cells that did not express SV40 Tag (Karlseder and de Lange, unpublished). In
those studies, quantification of telomere shortening revealed that telomeres shortened at
a rate of 110 bp/PD in cells infected with a control vector or any of the TRF1 alleles, but
at a rate of 165-180 bp/PD in cells expressing TRF2 (Karlseder and de Lange). These
results unequivocally demonstrate that although TRF2 is a negative regulator of
telomere length maintenance, it does so primarily through positively regulating telomere
shortening.
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Figure 3-9. T e l o m e r e length analysis in I M R 9 0 primary fibroblasts infected with control
virus or with F L T R F 2 . Southern blot of telomeric restriction fragments from cells carrying n o
exogenous T R F 2 (vector) or T R F 2 (TRF2). O n the left, a short term experiment is s h o w n in wt
I M R 9 0 cells. O n the right, a longer term experiment is s h o w n in I M R 9 0 expressing Tag. Similar
results are obtained in long term experiments w h e n T ag is absent (Jan Karlseder and Titia d e
Lange, unpublished). G e n o m i c D N A w a s isolated from cells on the indicated days of selection,
digested with Hinfl and Rsal, and hybridized with a T T A G G G repeat probe. T h e molecular
weights of marker D N A s are indicated in kb.
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However, these findings do not exclude the possibility that besides being a positive

regulator of telomere shortening, TRF2 might also influence the telomerase pathway

Addressing this question is difficult given current experimental methods. In an at
show that the telomerase pathway of telomere length regulation can be affected by

TRF2, TRF2ABAM, the dominant negative allele of TRF2, was expressed in the BJ prima
cells expressing hTERT (Bodnar et al. 1998). As shown in Chapter 2, expression of

TRF2ABAM leads to growth arrest even in telomerase positive lines. To circumvent t
arrest, SV40 Tag was also expressed in hTERT BJ cells. The expectation was that

removal of TRF2 from the telomeres under conditions permitting cell growth would a

telomerase to elongate the exposed telomere ends. Indeed, the telomeres appeared to
be slightly longer in cells expressing TRF2ABAM (Figure3-10, top panel lane 6 and

However, the pattern of this elongation was reminiscent of the appearance of end-t

fusions after inhibition of TRF2 (see Chapter 1). To test if this apparent telomer

elongation in TRF2ABAM-expressing cells is due to fusion formation, the genomic DN

extracted from these cells was fractionated on an agarose gel and without denatura

hybridized in situ to a (CCCTAA)4 probe. Under these conditions only the telomeres
G-overhangs are detected and DNA of fused telomeres should not be revealed. As

shown in Figure 3-10, lower left panel, telomeres from vector control cells and ce

expressing TRF2ABAM appeared to be of similar length when hybridization was perfor
under native conditions. When the same gel was denatured, the higher molecular
weight telomeric DNA reappeared in TRF2ABAM-expressing cells. These results showed

that the apparent increase in telomere length in TRF2ABAM-expressing cells seen in

Figure 3-10 was due to fusion formation and not true telomerase-mediated elongatio
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Figure 3-10. T e l o m e r e length analysis in B J h T E R T fibroblasts infected with control virus
or TRF2ABAM.

A.

Southern blot of telomeric restriction fragments from cells carrying no

exogenous T R F 2 (vector) or TRF2ABAM (TRF2ABAM). G e n o m i c D N A w a s isolated from cells o n
the indicated days of selection, digested with Hinfl and Rsal, and hybridized with a T T A G G G
repeat probe. T h e molecular weights of marker D N A s are indicated in kb. T h e arrow points to
a higher molecular weight telomeric D N A present only in lanes 6 and 7.

B. In gel hybridization

of telomeric restriction fragments with a n end-labeled telomeric probe under non-denaturing
conditions (left) and denaturing conditions (right). Under the non-denaturing conditions only the
D N A which has G overhangs is revealed, and under denaturing conditions, all telomeric D N A is
visualized.

Arrow points to a higher molecular weight telomeric D N A visualized only under

denaturing conditions.
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This suggests that a telomere devoid of T R F 2 cannot be elongated by telomerase but it
still does not exclude that TRF2 affects the telomerase-pathway.

Discussion
This chapter has identified TRF2 as a regulator of telomere length. The ability of TRF2
to cause telomere shortening in human cells lacking telomerase led to the conclusion
that TRF2 can positively regulate the rate of telomere shortening. The mechanism of
such regulation was not addressed in these experiments and a number of possibilities
can be proposed. TRF2 could influence the shortening rate by affecting the replication
through the terminus. For example, the last primer on the lagging strand could be
placed farther from the tip when more TRF2 was present on the telomere. Secondly,
TRF2 might be able to regulate nucleases involved in telomere shortening. Expressing
more TRF2 might place more of the nuclease activity on telomeres leading to faster
shortening. TRF2 might physically be able to interact with a nuclease or might positively
regulate it. However, if TRF2 were to physically be in a complex with such a nuclease,
this proposal assumes that there would be an excess of nucleases in the cell that could
be brought to the telomeres by the overexpressed TRF2. Another possibility pertinent to
regulation of the putative telomeric nuclease is to propose that TRF2 interacts with an
inhibitor of shortening and that expression of TRF2 in the nucleoplasm titrates away this
activity from telomeres, leading to the decreased presence of this inhibitor on the
telomeres, increased nuclease activity and telomere shortening. These proposals are
testable especially in light of a putative nuclease, the Mre11 complex localizing to
telomeres (Zhu et al. 2000, Lombard and Guarente 2000).

TRF2 expression in primary human cells led to persistent and continuous
telomere shortening. Eventually cells senesced (Karlseder and de Lange, unpublished)
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and although the dynamics of senescence with overexpressed T R F 2 will not be
discussed here, these findings shed light on the reasons why telomerase positive

HTC75 cells induced to express TRF2 might have lost expression of the allele (Figu

2 and Figure 3-3). It seems that the telomerase activity present in the HTC75 cell
unable to compensate for the loss of telomeres caused by the shortening activities
stimulated by the overexpression of TRF2. Evidently, the shortening activities are
dominant in this setting. With time telomeres become critically short and probably

become non functional. Although presence of fusions was not noted m the P lines whe
the telomeres were short, such an event could have been missed because of the

asynchrony of the telomere shortening and emergence of cells that have lest express

However, the HTC75 P cell lines were noted to have an altered morphology at the tim
when cells had short telomeres. The multilobulated nuclei of cells could have

represented events of cells trying to undergo anaphase with a large number of fusio

aborting such event and returning to a G1 like state resulting in a dumbbell shape
or a phenotype that has been described as a "cut" phenotype in yeast. If the HTC75

cells were unable to select for the non-expressing cells when their telomeres were
short, the population probably would have ceased to grow.

The findings presented here stress the differences in how TRF1 and TRF2

regulate telomere length. Although the two proteins are pa.-alogs and are able to i

with the same DNA sequence, they act in two different pathways to regulate telomere
length. This ability of TRF1 and TRF2 to impinge on different pathways must s'ium
their capacity to interact with different partners. As pointed out earlier, two of

binding proteins- tankyrasel and TIN2 are also involved in telomere length regulati
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will be interesting to see what are the other functions of TRF1, since studies to date
suggest that the complex is devoted exclusively to telomere length regulation.

So far, TRF2 has not been shown to have the ability to regulate telomere

elongation. It would be surprising if TRF2 did not have such capacity since Rapl, w
seems to exists in a 1:1 complex with TRF2 (Zhu et al. 2000) behaves as a negative

regulator of telomere elongation (Li et al. 2000). A protein that anchors a regulat
telomere elongation should be itself functioning as such. However, if TRF2 can
influence the telomerase pathway it would do so in cis at each telomere.

Overexpression of any of the alleles had no influence on the telomerase activity a
assayed by TRAP assay. Expression of a full length TRF2 also did not affect the
presence of hTERT or hTR RNA messages.
Although expression of the dominant negative allele of TRF2 in telomerase

positive cells failed to show that TRF2 acts as a regulator of telomere elongation

suggest that a telomere devoid of TRF2 is inert with regards to its interaction wi
telomerase. Without TRF2, the chromosome end might no longer be seen as a
telomere. Such an end does not get degraded and it does not seem to get elongated.

now behaves like a break (see Chapter 1) and as such it might be initially protect
then repaired by the NHEJ pathway. This also suggests that the presence of TRF2 is
necessary for the proper elongation of the telomere.
Parenthetically, it is useful to note that IMR90 Tag control infected cells show a

prominent band that is likely to represent telomere fusions (Figure 3-9, right pan

vector). This band is not observed in cells that also express TRF2, consistent with
ability of TRF2 to protect telomeres from the NHEJ pathway (Chapter 1).
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Introduction

Besides being present at the telomeres, TTAGGG repeats are found at interstitial
sites in many species (Meyne et al. 1990). In human cells, there are a number of

interstitial sites containing telomeric repeats (Ijdo et al. 1991; Azzalin et al. 1997). The
origin of all of them is not yet known; however, at least one of them, consisting of a long
stretch of degenerate TTAGGG repeats in head to head orientation, most likely arose
from fusion of ancestral ape chromosomes (Ijdo et al. 1991). It has been proposed that

the interstitial sites can be the sites of recombination, breakage, and fragility (Hastie a
Allshire 1989). Supporting such a proposal, a number of studies in hamster cells have

correlated the presence of interstitial sites with instability (Slijepcevic et al. 1997; Da
al. 1998). In human cells, interstitial repeats participate in rearrangements including
jumping translocations, (Park et al. 1992; Jewett et al. 1998) and might represent fragile
sites (Boutouil et al. 1996), although it is not understood what the requirements are for
an interstitial site to become recombinogenic.

A recent study focused on a more defined interstitial site engineered in a way
that allows for efficient scoring of rearrangements at that site (Kilburn et al. 2001). A
stretch of 800 bp TTAGGG repeats were placed within an intron of the adenosine
phosphoribosyltransferase gene (APRT). Interstitial placement of the TTAGGG repeats
did not influence homologous recombination at this site; however, local rearrangements
involving the interstitial telomeric sequence increased 30 fold. The rearrangements
included deletions, insertions and translocations (Kilburn et al. 2001).

The study described above has defined the interstitial 800 bp of telomeric DNA
as destabilizing element in human chromosomes. However, it did not give insight in to
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the mechanism underlying the destabilizing behavior. One possibility is that T T A G G G
repeat DNA is able to form structures that somehow are destabilizing when present

interstitial sites. A second possibility can now be proposed based on the finding t
both TTAGGG binding proteins, TRF1 and TRF2, are found to bind interstitial
(TTAGGG)n sites (Smogorzewska et al. 2000). BHK-21, a Syrian hamster cell line and

CHO-K1, a Chineses hamster cell line, but not AHL-1, an Armenian hamster cell line,

contain very large blocks of pericentromeric satellite sequences that contain TTAG
and related repeats (Meyne et al. 1990; Ashley and Ward 1993). Indirect
immunofluorescence against the basic domain of human TRF2 showed that the

endogenous hamster TRF2 was binding at the interstitial sites (Smogorzewska et al.

2000). TRF1 is much less conserved between the species (Broccoli et al. 1997; Smith
and de Lange 1997), and antibodies against human or mouse TRF1 do not cross-react
with the hamster TRF1; however, a transfected human TRF1 was also able to bind to

the Syrian and Chinese hamster interstitial sites (Smogorzewska et al. 2000, Krutil

al. 2001). It is possible that an interstitial site bound by a telomeric protein mi

inappropriately processed to give a break. This proposal can now be directly teste

examining the frequency of rearrangements in cells expressing different alleles of
and TRF2 (also see discussion).

One of the striking differences between TRF1 and TRF2 are their N terminal
domains. The acidic domain in TRF1 is functionally important, as suggested by its
interaction with tankyrase. So far no protein has been found to interact with the
domain of TRF2. The only known direct interaction of TRF2 is with Rapl and it maps

the TRF homology domain of TRF2. It is not yet known if the Mrel 1 complex interact

directly with TRF2 or whether the interaction occurs via Rapl. This chapter explore
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function of the basic domain of T R F 2 by studying the truncation allele of TRF2, TRF2AB.
It is shown that TRF2AB localizes to telomeres very efficiently where it replaces
endogenous TRF2 but not TRF1 from the telomeres. Expression of TRF2AB leads to
rapid telomere loss that is distinct from the telomere shortening in the presence
increased levels of TRF2 (see Chapter 3). Large portions of telomeric DNA seem to

lost from single chromatids. The loss of telomeric DNA is also visible on telomere
and seems to be caused by loss of the duplex DNA and not a specific strand of the
telomeric DNA. Besides the telomere length phenotype, cells expressing TRF2AB are
found to have chromatid gaps and breaks, which leads to the appearance of
chromosome pieces in anaphase cells and micronuclei in interphase cells. Primary
human cells undergo a senescent-like growth arrest when they express TRF2AB. This

growth arrest is very similar to the arrest seen with TRF2ABAM-expressing cells al

the kinetics of the arrest are somewhat slower. TRF2AB-induced arrest, just like th

arrest following expression of TRF2ABAM or replicative senescence can be abrogated
expression of the SV40 Tag. It is not clear at this point what the primary source

arrest is, although the prevalence of telomeres lacking any telomeric signal sugge

that chromosomes become deprotected. Additionally, the presence of breaks might al
lead to signaling into growth arrest.

Results

The function of the basic domain of TRF2 was indirectly studied by expression of

an allele lacking this domain (TRF2AB) in a number of different cell lines. The ef
TRF2AB on the endogenous TRF1 and TRF2 was shown by expression of the tagged

TRF2AB allele in HeLal.2.11, a subclone of HeLa cells that is characterized by ver

telomeres. Immunofluorescent staining against the tagged protein revealed that whe
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overexpressed, TRF2AB gives high nucleoplasm^ signal with overlaid punctate staining

(Figure 4-1 A and B). The punctate pattern of TRF2AB staining colocalized with tha
TRF1 (Figure 4-1 B) showing that, like in vitro (Broccoli et al. 1997, van Breugel
de Lange T., unpublished, Stansel R, Griffith J. D., unpublished), TRF2AB was able

bind to telomeric DNA in vivo. TRF2AB expression did not seem to affect the presen
TRF1 on telomeres. However, fluorescent staining against the basic domain of the

endogenous protein with antibody 508 in cells expressing TRF2AB, showed no punctat

pattern, suggesting that the endogenous TRF2 was being replaced at the telomeres b
the overexpressed TRF2AB allele. Similar finding of a decreased amount of the
endogenous TRF2 on telomeres were obtained in chromatin immunoprecipitation
experiments performed on cells expressing TRF2AB (Loayza D. and de Lange T,
unpublished results).
In an attempt to characterize the phenotype of cells expressing the TRF2AB allele,

fluorescent in situ hybridization (FISH) with a peptide nucleic acid (PNA) telomer

was performed on cells infected with a vector control or the non-tagged TRF2AB all

BJ human primary fibroblasts expressing hTERT were particularly suitable for these
studies, since their telomeres are very long (median around 15 kbp) and rather
homogenous in length. These cells were also expressing SV40 Tag; however, its

expression did not influence any of the phenotypes presented here. Telomere signals

visualized by PNA FISH on metaphase spreads of cells infected with a vector contro
day 6 after selection were usually very high, and as expected, telomeric staining

sister chromatids was typically equal in intensity (Figure 4-2, top). Parallel exp

performed with cells expressing TRF2AB revealed an overall less bright telomere st

139

a-myc

aTRF2(508)

DAPI

a-myc

aTRF1(371)

DAPI

mycTRF2AB

B

mycTRF2AB

Figure 4-1. Effects of expression of myc tagged TRF2AB on endogenous TRF1 and 2
protein localization to telomeres. Indirect immunofluorescence of HeLa 1.2.11 cells infected
with myc tagged TRF2AB. Analysis was performed one day after infection on non-selected
cells. Staining with an antibody against a myc tag (9E10) reveals infected cells. T R F 2 is
visualized with antibody 508 (A), and TRF1 with antibody 371 (B).

Antibody 508 w a s raised

against a peptide ( G R R A S R S S G R A R R G R H E P G L G G P A E A G ) present in the basic domain of
T R F 2 and it recognizes FLTRF2 but does not recognize TRF2AB. D N A was counterstained with
DAPI.
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Figure 4-2 Telomeric staining in BJ h T E R T SV40 T ag cells expressing TRF2AB. Peptide
nucleic acid (PNA) fluorescence in-situ hybridization with a telomeric probe on spreads of BJ
h T E R T Tag cells infected with vector control (vector) or with TRF2AB (TRF2AB). Spreads were
prepared on the 6th day of selection. D N A was counterstained with DAPI. Overall the telomeric
signal in TRF2AB expressing cells was weaker (not shown here due to enhancement of the
signal for the reproduction purposes). As shown at the lower right (arrows), many chromatids in
the TRF2AB expressing cells had very low or had no telomeric signal. Scoring 20 metaphases
of vector cells revealed 9 single chromatids with no telomeric signal.
expressing TRF2AB, 102 chromatids had no telomeric signal.
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In 21 spreads of cells

(data not shown, but see telomere blots below). Furthermore, many chromatids lacked

any telomeric signal (Figure 4-2, bottom). In 21 spreads of cells expressing TRF2AB

chromatids had no telomeric signal which corresponds to an 11 fold increase of suc

events over control cells in which 20 metaphases revealed only 9 single chromatids

no telomeric signal. Further analysis revealed that telomere signals on many chrom

of TRF2AB-expressing cells were substantially lower from the signals on the surrou
chromosomes. Curiously, often only one of the sister chromatids showed no signal.
When two chromatids had very low signal, they frequently were on the opposite arms
(Figure 4-2, top chromosome on the right). It is not clear yet if the distribution
signals represents a stochastic event or whether telomeres of specific chromatids
being lost (see discussion). Results of overall diminution of telomere signal and
some of the chromatid signals were first observed when TRF2AB was expressed in
mouse cells (Wang R. and de Lange T., unpublished).
Non-chromosomal telomeric signals were not seen on the spreads that revealed

chromosomes without the telomeric signal, suggesting that the events of telomere D
diminution were most likely not due to sudden separation of the telomere from the

chromosome but rather a degradative process. However, telomere length changes afte
induction of TRF2AB were very different from the gradual telomere shortening that

observed in cells expressing FLTRF2. Southern blot telomere length analysis of the
cells used in the experiments described above revealed that as opposed to slow and

constant telomere shortening seen in FLTRF2-expressing cells (Figure 4-3, also see

Chapter 3), TRF2AB-expressing cells showed overall loss of the signal intensity. T

telomeric hybridization signal also became more heterogenous with appearance of so

signal in the lower molecular weight range. Loss of hybridization did not depend o
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Figure 4-3. Telomere length analysis in B J h T E R T S V 4 0 Tag, BJhTERT, and
fibroblasts infected with control virus, FLTRF2, and TRF2AB

HS68

Southern blot of telomeric

restriction fragments from cells carrying no exogenous T R F 2 (vector), FLTRF2 (FLTRF2), and
TRF2AB (TRF2AB). Genomic D N A was isolated from cells on the indicated days of selection,
digested with Hinfl and Rsal, fractionated on a 0.7% agarose gel, and hybridized with a
T T A G G G repeat probe. Lane #1 of the gel shown in C. was overloded, the rest of lanes had
equal loading as confirmed by ethidium bromide staining. The molecular weights of marker
D N A s are indicated in kb. A. Telomere length analysis of BJhTERT SV40 Tag cells. Note the
loss of the signal intensity and the increase in the heterogeneity of telomeric signal in TRF2AB
expressing cells at day 8 and 10. By day 29, most of the population of TRF2AB cells have lost
expression of the allele. The signal loss was not quantified in this experiment. Loss of intensity
did not depend on presence of h T E R T similar results were obtained with wt primary BJ cells
(see fig 4-4).

B. Telomere length analysis of BJhTERT cells. The signal in each lane was

integrated, normalized to signal in lane #1 and is presented below each lane. The number was
calculated as (signal in lane x/signal in lane 1)x100%. C. Telomere length analysis in H S 6 8
cells. Because the first lane was overloaded, lane #2 was used to normalize the signal in all
other lanes.
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presence of h T E R T or SV40 Tag because similar results were obtained with wt primary

BJ cells (see Figure 4-4) as well as with BJhTERT cells not expressing SV40 Tag. Th

effect of telomere signal loss was also noted in HS68 primary human fibroblasts (F

4-3, C), although the effect was much harder to visualize on the blots of these ce
their starting telomere length was considerably shorter and appeared more
heterogenous on standard telomere blots. TRF2AB-expressing HS68 cells on day 13 of
the selection have lost about 35 % of the telomeric signal (Figure 4-3, C)

Findings of decreased hybridization intensity in cells expressing TRF2AB
corroborate that chromosomes lose telomeric signal when TRF2AB is overexpressed.

Interestingly, this loss appears to occur very fast, possibly within the first few
after TRF2AB expression. When PNA FISH was performed on the metaphase spreads of

the non-selected population of BJ hTERT cells on the third day of TRF2AB expressio
many cells showed decreased telomere staining and some chromatids already showed

no telomeric signals. Also, Southern blots with DNA from cells on day 4 of selectio
already showed the decreased hybridization and increased heterogeneity of the

telomere signal (Figure 4-3, C). It is possible that any additional decrease in te
length might have been due to replication of the already shortened telomeres.
Overexpression of TRF2AB was deleterious to the cells because by day 29 most

BJhTERT SV40 Tag cells lost expression of the allele (see Figure 4-8 for the descr
of the growth phenotype). After TRF2AB expression was lost, telomere length of the
population returned to normal length (Figure 4-3, day 29).
To ask if one of the telomeric strands was preferentially degraded in TRF2ABexpressing cells, an in-gel G-overhang assay was performed on DNA collected from

primary BJ cells (this time not expressing SV40Tag or hTERT) expressing control ve
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FLTRF2, TRF2AB and TRF2ABAM. To visualize only G -overhang containing telomeres,
the gel was hybridized under non-denaturating condition with a (CCCTAA)4 probe

(Figure 4-4, native). Subsequently, the gel was denatured and hybridized with the s
probe to visualize all telomeric DNA (Figure 4-4, denatured). Although the TRF2AB-

expressing cells showed the expected loss and smearing down of the telomeric signa

the ratio of the G-overhang signal to total telomere signal did not appear to chan

suggesting that the G-overhangs in TRF2AB-expressing cells were unaltered. Similar
experiments using a (TTAGGG)4 probe, which recognizes the C strand telomeric DNA

led to a conclusion that no single-stranded C strand telomeric DNA was produced du

the degradation process induced by the TRF2AB expression (Figure 4-5). These findi

were further corroborated by experiments in which telomeric DNA from the same line
was run under alkaline conditions to separate the two strands of telomeric DNA.

Hybridization with the (CCCTAA)4 or the (TTAGGG)4 probe resulted in the same patte

of hybridization, indicating that both of the telomeric strands were being degrade
similar extent (Figure 4-6).
Telomere length data obtained from FISH analysis and from telomere blots have

suggested that some of the chromosome ends might have completely lost their telome
DNA. This conclusion cannot be made with full confidence since due to limits of

detection, lack of FISH signal might not represent complete telomere loss. However,
chromosomes that lack telomeres should become fusogenic. Examination of anaphase
cells of IMR90 cells induced to express TRF2AB indeed showed an increased level of

fusion formation (Figure 4-7, top, Table 4-1). On the seventh day of the selection

were 0.6 fusions per anaphase in TRF2AB-expressing cells compared to 0.2 fusions p
anaphase in control, and 0.3 fusions per anaphase in FLTRF2-expressing cells. As
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Figure 4-4. Telomere length analysis in primary BJ fibroblasts infected with control virus,
FLTRF2, TRF2AB, and TRF2ABAM. In gel hybridization of telomeric restriction fragments with an
end-labeled (CCCTAA)4 telomeric probe under non-denaturing conditions (left) and denaturing
conditions (right). Genomic D N A was isolated from cells carrying no exogenous T R F 2 (vector),
FLTRF2 (FLTRF2), TRF2AB (TRF2AB), and TRF2ABAM (TRF2ABAM ) on the indicated days of
selection, digested with Mbol and Alul and fractionated on a 0.7% agarose gel. Equal loading
was confirmed by ethidium bromide staining. The gel was first hybridized under non-denaturing
conditions (native). Subsequently, the same gel was denatured and hybridized with the same
probe (denaturing).

The molecular weights of marker D N A s are indicated in kb.
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Figure 4-5. Telomere length analysis in primary BJ fibroblasts infected with control virus,
FLTRF2, TRF2AB, and TRF2ABAM. In gel hybridization of telomeric restriction fragments with an
end-labeled (TTAGGG)4 telomeric probe under non-denaturing conditions (left) and denaturing
conditions (right). Genomic D N A was isolated from cells carrying no exogenous T R F 2 (vector),
FLTRF2 (FLTRF2), TRF2AB (TRF2AB), and TRF2ABAM (TRF2ABAM ) on the indicated days of
selection, digested with Mbol and Alul and fractionated on a 0.7% agarose gel. Equal loading
was confirmed by ethidium bromide staining. The gel was first hybridized under non-denaturing
conditions (native). Subsequently, the same gel was denatured and hybridized with the same
probe (denaturing).

The molecular weights of marker D N A s are indicated in kb.
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Figure 4-6. Comparison between the C and the G strand length in B J h T E R T S V 4 0 Tag
fibroblasts infected with control virus, FLTRF2, and TRF2AB. Southern blot of telomeric
restriction fragments fractionated under denaturing conditions. Genomic D N A was isolated from
cells on the indicated days of selection, digested with Mbol and Alul, fractionated on a 0.7%
alkaline agarose gel, blotted onto a nylon membrane and
probe and subsequently with a

(TTAGGG)4 probe.

hybridized first with a (CCCTAA)4

Equal loading was not confirmed due to

the alkaline conditions of the electrophoresis. The molecular weights marker were prepared by
digesting a T T A G G G repeat bearing 2.6 kb pTH5 plasmid with Hindlll and self religation of the
cut plasmid. Their size is indicated in kb .
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B

Figure 4-7. Chromosomal abnormalities in TRF2AB expressing cells. A.

Anaphase of

IMR90 cells infected with TRF2AB, stained with DAPI on day 7 of selection. Arrow points to two
pieces of DAPI positive material between the two future daughter cells. Two anaphase bridges
are also visible. B.

Partial metaphase spreads (top) and single chromosomes (bottom) of

IMR90 cells expressing TRF2AB showing chromatid breaks and gaps (arrow heads) and a
possible fusion most likely formed after a chromatid break (asterisk). Chromosomes were
stained with DAPI.
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Table 4-1. N o induction of fusions in metaphase and anaphase H T C 7 5 cells expressing TRF2AB.
HTC75 S13 cells were grown under conditions resulting in repression or induction of the Nterminal truncation of TRF2, TRF2AB HTC75 B27 cell line, which does not express any
exogenous protein, was used as a control. Metaphase spreads were prepared on day 4 of
induction and number of fusions was assessed in 50 metaphase spreads.

Fusions
Cell line

T R F 2 allele

Induction

H T C 7 5 B27

none

-

HTC75S13

TRF2AB

-

<0.1

0.1

HTC75 S13

TRF2ab

+

<0.1

0.2
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per anaphase

per metaphase

0.2

described in Chapter 1, 1.5 fusions per anaphase were seen in TRF2ABAM"expressing
cells. There were also more fusions visible on metaphase spreads of TRF2ABexpressing cells than in control, or FLTRF2-expressing cells; however, FLTRF2 also

considerably higher numbers of fusions than control cells (Table4-2, see discussion

Contrary to finding of fusions in primary cells, examination of anaphase HTC75 cel

induced to express TRF2AB did not show increased fusion formation on the 4th day of

induction ((van Steensel et al. 1998), Table 4-2). However, the 4th day might be to
early to see fusions (also see discussion).

Another abnormality was noted in anaphases of TRF2AB-expressing cells.
Besides the fusions discussed above, small DAPI-positive pieces were seen between

the cells. This has been seen in the HTC75 TRF2AB-expressing cells (van Steensel et
1998), as well as in primary cells infected with TRF2AB (Figure 4-7,A). 20 small
chromosome pieces were seen when 100 anaphases of TRF2AB-expressing IMR90 cells

were scored (Table 4-1). 2 pieces per 100 anaphases were seen in cells infected wi

all other TRF2 alleles examined. The presence of pieces in anaphase cells correlat
with their presence in metaphase spreads (Table 4-2). Additionally, metaphases
revealed the presence of chromosome breaks (Figure 4-7, B and Table 4-1). Breaks

were of the chromatid type and they would be able to give rise to fusions. One such

fusion has been observed in cells expressing TRF2AB (Figure 4-7 B, bottom right pa
A different way of assessing chromosome breakage is to look for its products.
Pieces seen in the anaphase cells might represent broken fragments that contained

centromere and were left behind by the spindle when the cell was dividing. In telo

such fragments may get incorporated into one of the newly formed nuclei. Alternati
they may reform their own nuclear envelope and persist next to a main nucleus as a
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Table 4-2. Induction of abnormalities in metaphase and anaphase IMR90 cells expressing no
exogenous protein, FLTRF2, TRF2AB, TRF2ABAM.

IMR90 cells infected with a vector control

(pLPC), FLTRF2 (pLPCTRF2), TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM) on day 7 of
selection were scored on coded samples for the presence of abnormalities in metaphase and
anaphase cells. All alleles were myc-tagged. Numbers in parentheses specify the fraction of
metaphases or anaphases that had the indicated abnormality.

Abnormalities per 100 metaphases5

Abnormalities per 50 anaphases

Cell line

Fusions

Breaks

Pieces

Fusions*

Pieces

pLPC

6 (6%)

6 (6%)

0

9 (8%)

1 (2%)

pLPCTRF2

18(17%)

28(16%)

6 (6%)

14(20%)

1 (2%)

pLPCTRF2AB

38 (28%)

41 (26%)

14(11%)

33 (50%)

10(18%)

pLPCTRF2ABAM

219(55%)

18(15%)

4 (2%)

75 (78%)

1 (2%)

§ 108 metaphases were scored for pLPC control, 115 for pLPCTRF2, 113 for pLPCTRF2AB, 57 for
pLPCTRF2ABAM.
* including bridges and lagging chromosomes
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micronucleus. Primary BJ cells have very low level of micronuclei. Only 3 % of control
cells had a micronucleus (Table 4-3). This number stayed low when FLTRF2 was
expressed (2%) but increased to 33% when TRF2AB was expressed. Micronuclei were
also frequent in TRF2ABAM-expressing cells although not as prominent as in cells
expressing TRF2AB. Micronuclei formed in TRF2ABAM might be due to the breakage of
anaphase bridges that are formed frequently in these cells.

Experiments described above indicate that TRF2AB expression led to dramatic
changes in the genome. Telomere degradation and chromosome breakage were

observed when TRF2AB was expressed in a variety of cells. Therefore it is not surp
that primary cells expressing TRF2AB grow poorly. IMR90 cells expressing TRF2AB
behaved similarly to TRF2ABAM-expressing cells in all growth assays (discussed in

Chapter 2); however, the growth arrest was never complete in the population. TRF2A

expressing cells grew very slowly, although slightly better than TRF2ABAM-expressi
(Figure 4-8, A). BrdU incorporation on day 15 in cells expressing TRF2AB was only

of incorporation in control cells. This number was again significantly higher than
TRF2ABAM-expressing cells. The morphology of the arresting cells in the TRF2AB-

expressing population at day 15 was very similar to TRF2ABAM-expressing cells, wit
becoming large and flat and becoming positive for the senescence-associated p-

galactosidase activity (SA P-gal). However, the degree of the morphological change,

well as the intensity of the SA p-gal staining was again decreased when compared to

TRF2ABAM-expressing cells. The protein expression profile on day 15 has confirmed t

above findings. Although p53 and p16 were induced to the same level as in TRF2ABAMexpressing cells, TRF2AB-expressing cells showed some Rb hyperphosphorylation, as

well as some cyclin A expression, suggesting that some of the cells in the populat
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Table 4-3. Micronuclei in primary BJ cells expressing no exogenous protein, FLTRF2, TRF2AB,
TRF2abam

pnmary BJ1 cells were infected with a vector control (pLPC), FLTRF2 (pLPCTRF2),

TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM).

O n day 6 of selection, DAPI stained

anaphase nuclei were scored. Most of the events comprised of a single micronucleus abutting
the interphase nucleus.

Cell line % cells with micronuclei
pLPC

3%

pLPC T R F 2

2%

pLPCTRF2AB

33%
'o

pLPCTRF2ABAM

17%

*300 interphase cells were scored for pLPC, pLPCTRF2, and pLPCTRF2ABAM, 602 interphase
cells were scored for pLPCTRF2AB.
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Figure 4-8. Effects of expression of TRF2AB on growth characteristics, protein expression
profile and S A p-gal staining of young IMR90 cells- comparison with cells expressing
TRF2ABAM (also see chapter 2).

A. Representative growth curve of vector control, TRF2,

TRF2AB or TRF2ABAM expressing IMR90 cells. O n the 4th day of selection, cells were plated in
duplicate at 3x104 cells per well in a six-well plate. O n the indicated days cells from 2 wells
were washed, trypsinized and counted in duplicate using a Coulter counter. B. % of cells in Sphase as measured by 1 hour bromo-deoxyuridine (BrdU) incorporation on day 5, 10 and 15.
All numbers are normalized to the level of BrdU incorporation in vector control cells as
explained in Figure 2-2. C. Western blot analysis of cell cycle regulatory proteins in control,
TRF2, TRF2AB, and TRF2ABAM expressing cells. Cells were collected on day 14 of selection. D.
Senescence associated 6-galactosidase activity. Cells infected with T R F 2 alleles were plated at
low density and stained for p-galactosidase activity at pH 6 on day 14 of selection.

E.

Representative growth curve of IMR90 cells expressing SV40 large T antigen and vector
control, TRF2, TRF2AB or TRF2ABAM

F. % of IMR90 cells expressing SV40 large T antigen

and T R F 2 alleles in S-phase as measured by 1 hour BrdU incorporation on day 5,10 and 15.
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were actively cycling. To determine if the SV40 Tag is able to rescue cells from the

TRF2AB-induced growth arrest, TRF2AB was expressed in cells already expressing SV40

Tag. Just like in TRF2ABAM-expressing cells, the BrdU levels were restored to level
control cells, but the growth curves showed that the TRF2AB-expressing populations
grew poorly.

Discussion

This chapter has explored the function of the basic domain of TRF2 by studying
the phenotypes associated with expression of the N-terminal truncation of TRF2,

TRF2AB. By binding to telomeres, the TRF2AB allele appears to displace the full-len

protein (Figure 4-1). This is in agreement with the finding that in vitro TRF2AB h
slightly higher affinity for telomeric repeats than FLTRF2 (van Breugel and Titia

Lange, unpublished data). In vitro TRF2AB forms higher-order oligomers to a greater

extent than the TRF2 (van Breugel and Titia de Lange, unpublished data), which migh

increase the affinity for DNA by bringing more myb domains in the vicinity of mult
binding sites on the telomeric DNA.

One of the phenotypes observed after expression of TRF2AB is loss, or a
significant reduction of telomere signal from many chromosome ends. Often only one

the sister chromatids on a mitotic chromosome had a decreased signal. Such a findin
suggests that many of the events leading to appearance of shorter telomeres had to
occur in S or G2 phase immediately preceding mitosis. One of the many possible
scenarios of how TRF2AB expression could lead to telomere loss on one chromatid is
shown in Figure 4-9 (left column). It is proposed here that the presence of TRF2AB

creates a nick in one strand of the DNA. The site of the nick suggested in the mode

not important for this discussion and could occur on any of the two strands, and at
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Figure 4-9 Model of telomere loss and break formation upon induction of TRF2AB.
Presence of TFRF2AB creates a nick (at any place in the loop not necessarily where indicated in
the schematic). The nick is processed during the S phase and creates a shortened telomere on
one chromatid and a normal telomere on the opposite chromatid. The telomeric D N A that has
been severed gets degraded. Similarly, if a t-loop is made by an invasion of the overhang into
the interstitial site, a break forms on one chromatid, but not on the other. Formation of t-loops
involving the interstitial T T A G G G sites are not necessary for this model. TFRF2AB through
binding at the interstitial sites might bring the necessary factors for the fragmentation to occur.
Also, multiple nicks might be formed due to TFRF2AB expression, leading to a faster
degradation of the telomere.
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site. T h e nick is processed into a break during D N A replication and eventually the
telomere piece that has been formed is degraded. How TRF2AB would lead to the
creation of a nick is not specified in the model, but one possibility is that the basic
domain interacts with an inhibitor of a nuclease present at telomeres. At some point in
the cell cycle such a nuclease might be needed for the resolution of the t-loop. Lack of a
basic domain would repress the inhibition leading to increased activity of the nuclease.
The biochemical activity of the nuclease would specify whether a nick, a break, or a
complete degradation of one or both strands would be expected. It is proposed here
that the nuclease makes a nick, since such a proposal would be in agreement with the
frequent finding of decreased telomeric DNA only at one of the sister chromatids.
However, other reasons for the presence of decreased signals on only one of the
chromatids can be proposed. It is possible, for example, that one of the chromatids is
more susceptible to the TRF2AB-induced loss. This might not be unlikely, since one of
the chromatids is made by a leading strand synthesis, and the other by lagging strand
synthesis. Chromosome orientation-FISH (CO-FISH) experiments, which allow for
discrimination between the two types of chromatid, will be informative in this regard. The
experiment needs to be performed at a very early timepoint after infection with TRF2AB to
aid in visualization of the events occurring in the first cell cycle after expression of
TRF2AB. Disappearance of the signal from both of the sister chromatids, an event that
was often seen in TRF2AB-expressing cells, could have been due to simultaneous loss of
a substantial length of telomeric DNA from both chromatids, or replication of a
chromosome that has lost the telomeric DNA in a previous division.

Loss of telomeric DNA was also documented on Southern blots visualizing
telomeric DNA from cells expressing TRF2AB (Figure 4-3 and 4-4). However, the signal
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never fully disappeared in any of the experiments performed. This could be due to the

growth arrest that ensues after TRF2AB is expressed. Telomeres of non-cycling cell
might not participate in the degradation events. Nonetheless, even when cells
expressing the SV40 T antigen were used for the study, (Figure 4-3) the telomeres
completely disappeared. Instead telomere length returned to normal. This was most

likely due to constant cell death (compare growth curve in Figure 4-8 E to BrdU la

in Figure 4-8 F), and due to selection against the TRF2AB allele. Another possibili

comes from the proposal that telomeres can be lost from only one chromatid. If thi

the case, it would take a very long time of constant division without the loss of T
expression, to homogenize telomeres to the low length. In combination with obvious

deleterious effects of TRF2AB the expression, reaching such state would be impossib

A related question pertains to the behavior of the HTC75 S cell lines that express

TRF2AB. Expression of TRF2AB led to appearance of breaks in these cells (see below)
however, loss of telomeric DNA was not prominent (van Steensel et al. 1998). The

telomere blots revealed a mere hint of loss of hybridization intensity, and the lo
much less pronounced than in any other cell line studied. It is possible that the
combination of the already short telomeres present in these clones and the rapid

induction of the growth arrest after TRF2AB expression, precluded identification of

telomere signal changes. Increased heterogeneity of the signal might also be missed
because telomeres in the HTC75 cells already were represented by a heterogenous
smear under electrophoresis conditions used in the experiments.

Besides the loss of telomeric DNA, metaphase spreads of cells expressing
TRF2AB also revealed the presence of chromatid breaks. Although the origin of such

breaks is unknown at this point, a model that parallels the telomere loss model aft
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TRF2AB expression is presented in Figure 4-9 (right hand side).

It is proposed that

TRF2AB localizes to the interstitial TTAGGG sites and that a t-loop is made by invasion of
the G-overhang into the interstitial TTAGGG repeats. Subsequent events, identical to
the ones presented for the telomere loss would lead to a formation of a chromatid break.

This is also an attractive model for how interstitial (TTAGGG)n sites might be able
to induce chromosomal breakage, visualized in many studies presented in the
introduction. TRF2 is proposed to bind to the interstitial telomeric DNA repeats and an
inappropriate formation of the t-loops and subsequent processing is proposed to lead to
break formation. Binding of endogenous TRF2 to interstitial sites has been noted in a
number of hamster cell lines, which are characterized by presence of blocks of telomeric
DNA sequences at internal sites (Smogorzewska et al. 2000). The influence of telomeric
proteins on break induction at interstitial sites can now be tested using the system
described in the introduction, where a block of 800 bp of telomeric DNA has been
inserted into the APRT locus in the hamster. Based on the proposal presented here
expression of TRF2 should result in increased rates of rearrangements involving the
engineered interstitial sites. Expression of the TRF2AB, due to its increased affinity for

the telomeric DNA should result in even better binding to the interstitial sites giving ris
to a greater number of rearrangements.

The chromatid breaks seen in the cells expressing TRF2AB, when repaired,
should lead to formation of fusions. As seen in Figure 4-7, one of such events has been
observed. In this case, a broken end seemed to fuse with another broken end or
possibly a chromosome end, presumably after that end lost telomeric DNA. However,
not enough fusions of this type were seen on metaphase spreads to explain the levels of
anaphase bridges noted in cells expressing TRF2AB. Fusions might have also been
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formed between c h r o m o s o m e s that lost their telomeres. Fusions resulting from joining
of broken ends or chromosomes devoid of telomeres should not have telomeric DNA at
the site of fusion. Whether fusions induced by TRF2AB do, or do not have telomeric DNA
remains to be determined.

In some of the experiments presented in this chapter, cell overexpressing
FLTRF2 behaved in a similar way to TRF2AB-expressing cells. For example, formation of
breaks and fusions was significantly higher in FLTRF2-expressing cells than in control
cells (Table 4-1), although not as high as in TRF2AB-expressing cells. This behavior of
cells infected with FLTRF2 could be explained in many ways. First, the alleles in this
experiment were tagged at their N termini. For a full-length protein a tag would occur
next to the basic domain. If the tag interfered with the correct functioning of the full
length protein, a TRF2AB-like phenotype would be expected. Secondly, some TRF2AB
and possibly TRF2ABAM protein degradation products might be present in cells expressing
FLTRF2. Presence of degradation products of FLTRF2 was observed on western blots
of short-term experiments. Since TRF2AB has a higher affinity for DNA, even if it is not
present at very high level, it might be able to compete out the overexpressed TRF2. It is
possible that with time the cells that had substantial levels of TRF2AB were lost. The
finding that the growth of TRF2 expressing cells is a little slower at the beginning of the
experiments substantiates this interpretation (Figure 4-8, A). With time, the FLTRF2expressing cells grew at the same rates as control cells. Finally, FLTRF2 might have
been titrating away the protein that normally binds to the telomeric TRF2, and in
particular to the basic domain of TRF2. As a result, there would be less of that protein
present to telomeres leading to the partial telomere dysfunction.
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T h e growth arrest of h u m a n primary cells expressing TRF2AB is very reminiscent
of the growth arrest induced by the dominant negative TRF2 (TRF2ABAM). Based on the
protein expression profile and the ability of the SV40 Tag to abrogate the arrest, it seems
that the signaling through the same pathways caused the arrest. It is interesting to
speculate about the cause of the arrest. Telomere loss is so pronounced in the cells
expressing TRF2AB, that many, if not all cells in the population might have lost a few of
their telomeres. Such event would lead to activation of the pathways that are naturally
activated during senescence, leading to the permanent growth arrest. It is also possible
that induction of breaks might lead to the growth arrest. This interpretation is supported
by the findings that the HTC75 expressing TRF2AB, arrest and exhibit chromosome
breakage but do not exhibit substantial telomere loss. However, as discussed above,
the inability to visualize telomere shortening in these cells, does not preclude that some
telomeres did get very short, leading to growth arrest

Based on the experiments presented here, the basic domain appears to be a
vital regulatory domain of TRF2. It will be important to identify proteins interacting with
the basic domain. Such proteins are predicted to be negative regulators of degradation.
Further studies of such proteins have a potential of elucidating the degradative
processes at the telomere.
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Introduction

A complicated network of proteins acting in concert to activate the cdk2

complexes regulates entry into S phase of the cell cycle (reviewed in Bartek and L
2001). The CyclinE-Cdk2 complex integrates signals emanating from Rb-E2F and the
Myc pathways, and is the main effector of these pathways leading to stimulation of
synthesis. To avoid DNA synthesis when DNA is damaged, multiple pathways are

employed to keep Cdk2 in a non-active state. These pathways include the degradation

of cyclin D1 releasing p21 to inhibit Cdk2 (Agami and Bernards 2000), degradation o

Cdc25A phosphatase leading to persistence of inhibitory phosphates on Cdk2 (Mailan

et al. 2000), and activation of p53 (reviewed in Vogelstein et al. 2000) leading to

transcriptional activation of p21 resulting in a more permanent inhibition of S ph
entry.
Centrosomes are the microtubule organizing centers of animal cells and they,
like DNA, replicate once and only once per cell cycle. The cycle of centrosomal

duplication is in fact coordinated with DNA replication, and the centrosomal dupli
also driven by the Cdk2 complexes (reviewed in Winey 1999), although controversy

exists whether Cyclin A or E is the necessary cyclin partner of Cdk2. Other kinases

including the Polo-like, Aurora-related, and NIMA-related kinases, are important fo

proper duplication and/or function of the centrosomes (reviewed in Mayor et al. 199
An inability to control centrosome numbers has been found to be a characteristic
of many tumor cells (reviewed in Duensing and Munger 2001). It appears that

centrosomal reduplication is associated with inappropriate function of many protei
including p53 (Fukasawa et al. 1996), BRCA1 (Xu et al. 1999), STK15 (Zhou et al.
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1998), and Skp2 (Nakayama et al. 2000). Based on the very high number of different

proteins that are found at the centrosome (see Table 1, (Duensing and Munger 2001))
the centrosome appears to be a site where many signals could be integrated during
growth.

A recent study has localized one of the telomeric proteins tankyrase, a TRF1

interacting factor, to mitotic centrosomes of human cells (Smith and de Lange 1999)

Tankyrase co-localizes with NuMA (nuclear/mitotic apparatus protein), which resides

the periphery of mitotic centrosomes. The function of tankyrase at human centrosom

is unknown; however, based on its poly(ADP-ribose) polymerase activity, it has been
proposed that tankyrase might regulate other centrosomal proteins.

This chapter presents two unexpected observations of genome and centrosome

reduplication occurring after expression of jRF2ABAM or TRF2AB, and of centrosomal
localization of TRF2.

Results

While examining metaphase spreads of primary human fibroblasts expressing
TRF2ABAM and TRF2AB (See Chapter 1 and 4), it was noted that some metaphases
harbored an increased number of chromosomes. Although it was often impossible to
determine the exact number of chromosomes on most metaphases, if it appeared that
there were more than 70 chromosomes on a spread, it was considered to represent
genome reduplication. According to this criterion -37% of metaphases of cells
expressing jRF2ABAM and -23% of metaphases of cells expressing TRF2AB showed

genome reduplication (Table 5-1). In contrast, only -3% of control cells expressin
exogenous protein showed reduplication of the genome. FLTRF2-expressing cells
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Table 5-1 Genomic reduplication in young cells expressing no exogenous protein, FLTRF2,
TRF2AB, TRF2ABAM. Primary IMR90 cells were infected with a vector control (pLPC), FLTRF2
(pLPCTRF2), TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM). Al! alleles were myc-tagged.
O n the day 7 of selection, metaphases were prepared after 90 min colcemid treatment and those
that had more than 80 chromosomes were scored as reduplicated.

Cell line % of metaphase spreads with reduplication"
pLPC

3%

PLPCTRF2

16%

pLPCTRF2AB

2 37
%o

pLPCTRF2ABAM

37%

* 98 metaphases were scored for pLPC control, 115 for pLPCTRF2, 113 for pLPCTRF2AB, 57 for
pLPCTRF2ABAM.
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showed an intermediate level of reduplication (-16%); however, this allele of T R F 2 was
N-terminally tagged, which could have created a partial TRF2AB allele (for a more
thorough discussion of why FLTRF2 might show some TRF2AB phenotypes, please see
the discussion to Chapter 4). The striking finding was that the reduplicated
chromosomes most often occurred in pairs, an arrangement also known in cytogenetic
literature as a diplochromosome (Figure 5-1). To assure that they were true
diplochromosomes and not prematurely separated sister chromatids, chromosomes
were observed under high magnification. Many spreads showed diplochromosomes

with clearly delineated four chromatids. Some, but not all metaphases that revealed
diplochromosomes also exhibited end-to-end fusions (Figure 5-1).
In one experiment, metaphases of TRF2ABAM and TRF2AB-expressing cells

showed premature chromosome division (PCD) (Figure 5-2), which is characterized by

dissolution of cohesion between sister chromatids not only along the arms but also
centromere while cells are still in metaphase. Normally, the separation of sister

chromatids occurs at the metaphase to anaphase transition, thus visualization of t
event in metaphase spreads is abnormal. Among 44 metaphases of TRF2ABAMexpressing cells, 87 chromosomes displayed PCDs, and among 10 metaphases of
TRF2AB-expressing cells, 14 chromosomes displayed PCDs. Premature chromosome

division was so far only visualized in one experiment in which metaphases were arr

for 12 hours by colcemid treatment. No premature chromosome division was visualize

in control cells (35 metaphases examined) or FLTRF2-expressing cells (10 metaphase
examined) prepared under identical conditions. In other experiments in which
metaphases were examined, no attention was being paid to the occurrence of PCDs.
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Figure 5-1. G e n o m e reduplication visualized on metaphases of TRF2ABAM and TRF2AB
expressing IMR90 h u m a n

primary fibroblasts.

Metaphase spreads of IMR90 cells

expressing TRF2ABAM and TRF2AB were prepared on day 7 of selection. Chromosomes were
stained with DAPI. The two top metaphase spreads show a reduplication which occurred in the
division proceeding the metaphase shown. Reduplication shown in the bottom spread might
have occurred in the preceding or an earlier division since many of the duplicated
chromosomes do not show the diplochromosome arrangement. Please note that many end-toend fusions are visible in the spreads (also see Figure 1-12 C).

168

X

If tt

^

<

;>f

1

>'

2

3

rfV*S if j« rfUl
6

)

7

8

4
*» « * t* 1 *
9

• • # • #'* *% tfV <**<*
13

14

19

Figure 5-2.

20

8l *«v

#* i*%

11

12

10
• • 4*

15

M **

5

16
•« * *
21

.

i - «» **»

17

18

«l 41

22

X

Y

Premature c h r o m o s o m e division (PCD) in metaphase spreads of IMR90

fibroblasts expressing TRF2ABAM. Multiplex fluorescence in situ hybridization (M-FISH) on
metaphase spreads of cells expressing TRF2ABAM.

Spreads were prepared on day 6 of

selection, after 12-hour colcemid treatment. Chromosomes 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13,
14, 16, 17, 21, and X show premature chromosome division

(Experiments done in collaboration with Heidi Holtgreve-Grez and Anna Jauch (Institute
fur Humangenetik, Heidelberg, Germany)
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D N A replication and duplication of the centrosomes are highly synchronized and occur in
S phase of cell cycle. The presence of metaphase spreads with twice the genetic
information should be mirrored by the presence of interphase cells with more than
centrosomes, unless DNA replication and the centrosomal cycle were uncoupled.
Indeed, many TRF2ABAM-expressing interphase cells, when stained with an antibody

directed against y-tubulin, a protein only found in the pericentriolar region of t
centrosomes, showed three or more centrosomes (Figure 5-3). They were often found

in clusters of four, suggesting two rounds of duplication, although some cells carr
more than 6 centrosomes. Quantification of centrosome numbers in interphase cells
showed that expression of TRF2ABAM allele led to 3 to 5 fold increase in anaphase
with 2 or more centrosomes (Table 5-2). TRF2AB allele expression in IMR90 primary
fibroblasts had less influence on centrosome numbers at an early timepoint after

infection (day 5 of selection), but showed a fourfold increase in % of anaphase cel

2 or more centrosomes at day 14 of selection (Table 5-2). In WI38 cells, the backgr

of interphase cells with 2 or more centrosomes was higher than in IMR90 cells, reac

9% of all interphase cells. This number was possibly higher than in the IMR90 cells

because WI38 cells were cultured for a longer time before the infections thus they

closer to entry into senescence (see below). Nevertheless, there was an almost 3 fo

increase in the % of cells with more than 3 centrosomes when jRF2ABAM was expressed

Expression of TRF2ABAM and TRF2AB was shown to lead to growth arrest with

characteristics of senescence (Chapter 2 and 4). Population very close to a senesc
state have been previously observed to have polyploid cells (Saksela and Moorhead
1963; Thompson and Holliday 1975). To examine the number of centrosomes in
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Figure 5-3. Centrosomal reduplication in IMR90 h u m a n primary fibroblasts expressing
TRF2ABAM. Indirect immunofluorescence against y-tubulin (shown in green) in primary human
cells infected with TRF2ABAM- D N A was counterstained with DAPI.
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Table 5-2 Centrosomal reduplication in young cells expressing no exogenous protein, FLTRF2,
TRF2AB, TRF2ABAM, and in senescent cells. Primary IMR90, WI38, and HS68 cells were infected
with myc-tagged vector control (pLPC), FLTRF2 (pLPCTRF2), TRF2AB (pLPCTRF2AB), or
TRF2abam (P|_PCTRF2ABAM). On the indicated days of selection, cells were methanol fixed,
indirect immunofluorescence against y-tubulin was performed, and number of centrosomes was
counted.

Cells
Young IMR90

7

% of cells with more than two
centrosomes *
3(310)

PLPC TRF2

7

4 (335)

pLPCTRF2AB

7

8 (303)

pLPCTRF2ABAM

7

15(303)

pLPC

14

5(100)

PLPC TRF2

14

5(100)

pLPCTRF2AB

14

23(100)

pLPCTRF2ABAM

14

16(100)

allele
pLPC

Day of
selection

27(100)

Senescent IMR90(~p43)

none

HS68

pLPC

5

3 (200)

PLPC TRF2

5

4(201)

pLPCTRF2AB

5

5 (200)

pLPCTRF2ABAM

5

14(203)

pLPC

5

9(201)

PLPC TRF2

5

12(201)

pLPCTRF2AB

5

16(203)

pLPCTRF2ABAM

5

25 (200)

WI38

*ln paranthesis number of cells scored is indicated
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passage 43 (p43) IMR90 cells, which reached senescence a week or two earlier,
centrosomes were visualized using anti y-tubulin. 27% of cells had three or more

centrosomes suggesting that centrosomal reduplication is one more characteristic o
senescent cells.

In the experiments were numbers of centrosomes in each cell were quantified,
TRF2 was often used to co-stain the nuclei that were being stained with y-tubulin

check for the expression of the TRF2 alleles. It was surprising to find that endoge

TRF2 in the control cells besides forming a familiar punctate pattern in the nucleu

localized to centrosomes. Two separate antibodies raised against TRF2, rabbit antib

647 and a goat antibody to TRF2 (Imgenex), recognized centrosomes both in mitosis a
well as in interphase cells (Figure 5-4). Staining of centrosomal TRF2 was much

dimmer in interphase cells, although it was still above background staining. Dimmer
staining in anaphase cells was noted for other centrosomal components.
TRF2 staining in immunofluorescent studies surrounded centrin, which gave the

expected double-dot staining of two centrioles per centrosome (Figure 5-4, top pane

Staining of y-tubulin and TRF2 generally overlapped; however, staining of y-tubuli

mitotic cells was often broader and seemed to extend onto the microtubules emanati
from the centrosomes. Overall, the most overlap was found between TRF2 and
pericentrin, a known component of a centrosome (Figure 5-4, third row).
Previous studies have localized tankyrase at centrosomes of metaphase and
early anaphase cells, but not in late anaphase, telophase or interphase cells. To

compare localization of TRF2 and tankyrase, HeLal.2.11 were stained with antibodie
recognizing the two proteins. Generally, tankyrase appeared to surround TRF2 in

metaphase, leading to clear delineation of different compartments. Such exclusion w
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DAPI

Y-tubulin

of

TRF2

to

centrosomes

in

HeLal.2.11

cells.

immuofluorescence with antibodies raised against TRF2 (goat a TRF2 and rabbit a TRF2
#647), and with mouse a centrin, mouse a pericentrin , or mouse a y-tubulin. HeLal.2.11 were
fixed in methanol and costained with the indicated antibodies. FITC-conjugated a rabbit or
FITC-conjugated a goat and TRITC a mouse secondary antibodies were used to visualize the
primary antibodies. DNA was counterstained ith DAPI. Cells in metaphase and interphase are
shown as indicated on the left.
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Indirect

especially visible in early anaphase cells (Figure 5-5). Consistent with previous results,

tankyrase staining was not present in some anaphase cells (Figure 5-5) or interpha
cells.

Often in colocalization studies a concern arises that the proteins appear to

colocalize because the signal of one of the proteins is so strong that it is seen i

adjacent channels (often called bleed-through). The finding that the TRF2 signal di

colocalize with the tankyrase signal suggests that the signals were specific for e
protein. However, to formally prove that there was no bleed-through, a control

experiment was performed. Cells were stained separately with antibodies recognizin
TRF2, tankyrase, Y-tubulin, and centrin. Subsequently, pictures were taken in all

channels. The control channels that should have exhibited no staining stayed blank
expected (Figure 5-6), which led to the conclusion that the signal of TRF2 on
centrosomes was specific.

Discussion

Reduplication of the genome is a prevented event when all checkpoints are

active in the cell. It is surprising that expression of JRF2ABAM and TRF2AB in huma

primary fibroblasts led to a frequent occurrence of apparent reduplication that wa

visualized on metaphase spreads and deduced from the presence of increased numbers
of centrosomes in interphase cells. As shown in Chapter 2 and 4, expression of
TRF2ABAM and TRF2AB alleles leads to growth arrest, a result of activation of p53
pathways. Results described here, suggest that the growth arrest is preceded or
accompanied by deregulation of the cell cycle.
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Figure 5-5. Localization of TRF2 and tankyrase to centrosomes in HeLal.2.11 cells.
Indirect immuofluorescence with rabbit a TRF2 (#647) and mouse a tankyrase. HeLal.2.11
w e r e fixed in methanol a n d costained with the indicated. FITC-conjugated a rabbit a n d T R I T C
a m o u s e s e c o n d a r y antibodies w e r e u s e d to visualize the primary antibodies.

DNA was

counterstained ith D A P I . Cells at different stages of mitosis are s h o w n a s indicated o n the left.
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Figure 5-6.

Staining of centrosomes with 647, tankyrase, y-tubulin, and centrin in

HeLal.2.11 cells. Indirect immuofluorescence with rabbit a T R F 2 (647), mouse a tankyrase,
mouse a y-tubulin, and mouse a centrin.
separately with the indicated antibody.

HeLal.2.11 were fixed in methanol and stained

FITC-conjugated a rabbit

and TRITC a mouse

secondary antibodies were used to visualize the primary antibodies. Green and red channels
were both exposed for 0.2 s with 1 0 0 % gain as a control for the bleed-through of the signal into
the other channel.
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Frequent arrangement of duplicated chromosomes in diplochromosomes implies

that the events leading to the reduplication occurred in the same cell cycle (Figu

The reasons for reduplication of the genome are unclear at this point. As described
the introduction, expression of p53 should preclude any DNA or centrosomal
reduplication. However, presence of an increased numbers of centrosomes in
senescent cells might indicate that telomere dysfunction somehow triggers the

reduplication in spite of high p53 expression. Expression of jRF2ABAM and TRF2AB a

gives rise to telomere dysfunction and because the events are fairly synchronized,

reduplication can be visualized to occur within one cell cycle. It remains to be ex

cells that are undergoing reduplication, and presumably characterized by high Cycli
Cdk2 activity, also have high p53 levels.
The events leading to reduplication might be suggested by a finding of premature
chromosome division on metaphases of TRF2ABAM and TRF2AB-expressing cells

observed in one experiment (Figure 5-2). Normally, cohesion between sister chromat
is established during S phase of the cell cycle and persists until prophase of the
phase along the chromosomal arms, or until the metaphase to anaphase transition in
centromeric region. Observation of premature separation of centromere regions
suggests that the cohesion has prematurely failed. These results were obtained by
observing metaphase spreads that were prepared by arresting cells for 12 hours in

colcemid. It could be argued that the centromere separation was an artifact of this
prolonged colcemid treatment; however, the control and FLTRF2-expressing cells did

not show this phenotype. This argues that presence of TRF2ABAM and TRF2AB, although

not necessarily directly, might predispose cells to premature centromere division.

a cell were to return to a G1 like state without undergoing anaphase and were allo
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cell with
dysfunctional telomeres"

Figure 5-7. Model of reduplication of the g e n o m e following telomere dysfunction (see text
for details).
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undergo another round of D N A

synthesis, the next metaphase would

show

diplochromosomes.

Presence of PCDs and diplochromosomes in metaphase cells might not be

causally linked; however, they both suggest failure of the cohesion apparatus at so
point in the cell cycle. Recent evidence suggests that a successful anaphase and

cytokinesis require a proper dissolution of cohesion (Stratmann and Lehner 1996; H
et al. 2001). Expression of the non-cleavable SCC1, a component of the cohesion

complex, which is cleaved at the onset of anaphase to relieve sister chromatid cohe

results in inappropriate dissociation between progression of cytokinesis and progr

of cyclin-driven cell cycle. This is documented by observation that cells expressin

non-cleavable SCC1 frequently exit mitosis and enter interphase without undergoing
anaphase. These events result in formation of polyploid cells, some of them

characterized by the presence of diplochromosomes (Hauf et al. 2001). It is interest
to speculate that the diplochromosome formation in cells that failed cohesion and

expressing mutant forms of TRF2 might be related. It is possible that without prop

telomere function, cohesion cannot be properly regulated. Further study of influenc
telomere status on establishment and dissolution of cohesion will be necessary to
understand the connection if there is any.
Another question is whether the reduplicated centrosomes are functional in
making multiple spindles during subsequent anaphase. Anaphases with tri-polar

spindles were not observed in the populations expressing TRF2ABAM and TRF2AB, which
suggests that cells with reduplicated centrosomes were already arrested, or that

centrosomes once reduplicated stayed together allowing for normal spindle formatio

is known that even cells without functional p53, which have multiple centrosomes, a
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able to form normal bipolar spindles most of the time (Ring et al. 1982; Fukasawa et al.
1996).

The observation of the presence of TRF2 on centrosomes is also unexpected. It

must be stressed that although reduplication of the genome and centrosomal localiz

of TRF2 are discussed in the same chapter, the two occurrences are not yet shown to
be related in any way.

Currently, it is not clear what function telomeric proteins could have at

centrosomes. Another telomeric protein, tankyrase, also localizes to centrosomes an

its function is also unknown. The most pressing question about the presence of TRF
centrosomes is whether TRF2ABAM and TRF2AB localize to centrosomes. It would be

surprising if the Myb domain was necessary for the localization, since after a lon

it is currently clear that there is no nucleic acid at the centrosome (Marshall and
Rosenbaum 2000). It is at this point also unknown, if JRF2ABAM removes the
endogenous TRF2 from centrosomes. It is very hard to observe overexpressed TRF2

on centrosomes using immunofluorescence staining. A better approach will be to loo
Rapl, a TRF2 binding partner, is present at centrosomes when different alleles are

expressed. To avoid a titration effect; however, TRF2 will have to be engineered to

deficient for the Rapl interaction domain. Also, the presence of all other telomeri

proteins on centrosomes needs to be explored. With the finding of TRF2 and Tankyra

at centrosomes it is possible that the whole telomeric complex is also present the
The presence of TRF2 on centrosomes might be important for meiosis. In many

species telomeres form the so-called bouquet by juxtaposing their telomeres agains

meiotic centrosome (reviewed in Scherthan 2001). There is some evidence that such a

arrangement aids in the alignment of homologous chromosomes prior to recombination
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In S.pombe, Tazl, an ortholog of T R F proteins in mammalian cells, is responsible for the
association of telomeres with a spindle pole body (SPB), a yeast equivalent of the

centrosome. Lack of Tazl leads to dissolution of the association between the SPB a

the telomere, leading to failed alignment and unsuccessful meiosis (Nimmo et al. 19

It will be interesting to learn how Tazl is anchored to the SPB. Such knowledge mi
shed light on how TRF2 localizes to centrosomes.
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C o n c l u d i n g

R e m a r k s

This thesis has concentrated on exploring the function of T R F 2 in human cells.
TRF2 was cloned by Dominique Broccoli and myself based on homology to the Myb
domain of TRF1, the first human telomeric protein. Functional analysis has pointed
that despite high homology in the Myb domain as well as in the TRFH domain, TRF1
and TRF2 have completely divergent roles at telomeres.

As described in detail in the introduction, the main function of the telomere in al

species is to protect the chromosome end from being recognized as a double-strande
break. Although the mechanisms might not be fully understood yet, it is now clear

TRF2 is able to supply this protective function to human telomeres. Deprotection af

removal of TRF2 was observed in multiple human and mouse cell lines including a tu

cell line (HTC75), human primary fibroblasts (IMR90, BJ), and MEFs. Inhibition of TR

function led to appearance of end-to-end fusions visible in anaphase and metaphase

cells. It was deduced that prior to fusion, the deprotected chromosome lost a singl
stranded G-overhang, but not the double-stranded TTAGGG repeat array and the

fusions were formed through a covalent ligation of the DNA strands. DNA ligase IV w

responsible for the ligation since MEFs deficient in this ligase were also deficie
fusion formation. Division with deprotected telomeres led to induction of genomic
instability visualized mainly as translocations.

TRF2 most likely protects telomeres by stimulating formation or stabilization of t
loops at chromosome ends. T-loops, in turn, are thought to conceal the very end of
telomere. The protective function of TRF2 has been uncovered using a dominant

negative allele TRF2ABAM. Expression of TRF2ABAM efficiently removes endogenous TR
from telomeres as evidenced by using immunofluorescent staining; however, it is
impossible to say how complete this dominant negative effect is and some telomeres
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m a y contain residual T R F 2 .

Therefore, cells null for the protein might exhibit an even

more dramatic telomere deprotection phenotype. Based on the phenotype of the
TRF2ABAM-expressing cells, it is very likely that a mouse deficient in TRF2 might not be
able to develop properly. Thus, a conditional KO system needs to be employed to
examine the null phenotype of TRF2 in a true in vivo mouse system or in mouse
embryonic stem (ES) cells.

The deprotection phenotype observed in cells expressing jRF2ABAM was
characterized by persistence of the double-stranded telomeric DNA. It is interesting to
compare this phenotype to deprotection phenotypes seen in other organisms. Lack of
Cdc13p leads to rapid degradation of the C-strand of the telomere in S. cerevisiae,
whether as deficiency of Potl in S.pombe results in rapid degradation of both the C and
the G strands of the telomere. Why is it that a telomere devoid of TRF2 seems to be
inert towards the degradation processes? One possibility is that TRF2 is needed to
anchor the degradative machinery to the telomere. Thus, without TRF2 being present at
the telomere when jRF2ABAM is expressed, the proteins responsible for the degradation
cannot be recruited there either. This results in maintenance of the double-stranded
telomeric DNA.

Although TRF2 is shown to be a crucial protective agent at the telomere, its

activity does not exclude other protective factors acting in concert or in parallel pathway
to protect the end. An excellent candidate for such an activity is the newly-discovered
hPotl, an ortholog of S. pombe Potl, lack of which leads to clear telomere deprotection
in fission yeast (Baumann and Cech 2001). Since the human protein has biochemical

activities of a single-stranded binding protein with specificity for the TTAGGG repeats, it
might protect the G-overhang at specific times in the cell cycle when the t-loop needs to
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be dissolved, for example during the replication process. Alternatively, hPotl could bind
to the single-stranded DNA in the D-loop, which has been shown to be present at the
base of the t-loop (Griffith et al. 1999). The distinction between the two possibilities
might be made using electron microscopy, as well as the immunofluorescent approach.
It will be also essential to know if the presence of Potl on telomeres depends on the
TRF2. This might be done by inspection of telomeric localization of Potl in the cell lines
expressing TRF2ABAM or TRF2AB. Based on the finding that the deficiency of Potl in S.
pombe leads to the degradation of the double stranded telomeric DNA, one could
speculate that the removal of human Potl would also result in such event. However, it is
also possible that the lack of Potl will result in phenotypes that resemble the phenotypes
of TRF2ABAM or TRF2AB-expressing cells. Overall, the chromosomal events leading to
the deprotection after Potl removal might be more easily studied in human cells than in
the yeast cells.

More biochemical analysis of TRF2 will be necessary to fully understand how the
presence of this protein leads to formation or stabilization of the t-loops. Although
current knowledge suggests that TRF2 forms homo-oligomers and not dimers like TRF1,
it is not clear at this point how such oligomers might form. The crystal structure of the
whole protein might aid in answering this question. Moreover, study of the binding
partners of TRF2 and their participation in t-loop formation and resolution will be also
necessary to fully understand how the protected state is achieved and maintained at the
telomere throughout the cell cycle.

The dynamics of the t-loop formation and dissolution throughout the cell cycle
need to be studied in detail. One of the times that t-loops need to be dissolved is in S
phase. TRF2 does not seem to be differentially regulated at any stage of the cell cycle
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(Karlseder, J. and de Lange, T , unpublished); however, one of the components of the
TRF2 complex, NBS is differentially regulated. Arrival of NBS at telomeres coincides
with S phase (Zhu et al. 2000), and it is possible that this changes the activity of the
Mrel 1 complex and subsequently results in opening of the t-loop.

Deprotection of telomeres by expression of jRF2ABAM allele led to inhibition of
growth in human primary fibroblasts. Induction of growth arrest was dependent on the
activities of the p53 and the Rb pathways, but it did not depend on the activity of the
ATM kinase. The genetic requirements for the arrest are thus unlike the ones observed
for the induction of apoptosis after TRF2 inhibition. Entry into apoptosis requires
function of the ATM kinase and the p53 protein and does not involve the Rb pathway
(Karlseder et al. 1999).

It is clear that some cells are predisposed to react to damage by apoptosis and
some by growth arrest (Di Leonardo et al. 1994; Yeargin and Haas 1995); however,
such discrepancy in the signaling pathways into arrest or apoptosis is curious. It is
possible that apoptosis response requires a very strong activation of the checkpoint and
that ATM pathway is necessary for the achievement of the necessary strength. When it
is absent, other proteins are able to substitute some of the activity; however, they might
be unable to reach a level of function normally supplied by the ATM kinase. This results
in lack of apoptosis and presumed growth arrest. In cells that normally do not undergo
apoptosis (for example human fibroblasts) signaling through the substitute kinases is
enough for induction of the arrest.

Another possibility is that the kinetic requirements of activation of apoptosis and
arrest are different. Induction of apoptosis is usually a fast event. This event depends
on p53 and most likely the downstream effectors like Bax (Miyashita et al. 1994). The
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p16 induction, which s e e m s to play a role in the growth arrest, is induced more slowly
(Robles and Adami 1998). The proposal is that once the Rb pathway is induced,
apoptosis is averted and the growth arrest ensues. This hypothesis can be restated to
suggest that the growth arrest is a dominant response. However, because it is induced
slowly, it might be defeated by the apoptotic response, which would remove the cells
before they could arrest. One prediction of this hypothesis would be that the
simultaneous and fast induction of the Rb pathway together with the generation of
damage that normally would lead to apoptosis would result in inhibition of the apoptotic
response and lead to growth arrest.

High similarity of TRF2ABAM-induced growth arrest and growth arrest naturally
occurring at the end of the replicative life-span of human primary fibroblasts has led to a
proposal that critically short telomeres existing in pre-senescent human primary cells
might be unable to recruit sufficient TRF2, resulting in signaling into arrest. As
discussed in Chapter 2, the pathways leading to senescence are not very well defined at
this point and further studies delineating the requirements for the growth arrest after
TRF2ABAM expression might be useful in understanding telomere directed senescence.

Besides protecting the telomere and guarding against premature senescence of
human primary cells, TRF2 is also clearly involved in telomere length regulation.
Expression of TRF2 leads to telomere shortening and telomere length changes do not
depend on the presence of telomerase. Thus TRF2 appears to control the shortening
activities at the telomere. There are a number of ways TRF2 might be able to influence
the telomere shortening. TRF2 might be able to regulate nucleases involved in telomere
shortening or it could influence the shortening rate by affecting the replication through
the terminus. The first proposal is highly testable once the putative nucleases are
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known.

Based on the telomere loss phenotype after expression of the TRF2AB, it w a s

proposed that a factor interacting with the basic domain could be involved in the
regulation of the putative nuclease. Discovery of this putative factor should lead to
elucidation of the mechanism of how TRF2 affects the shortening rate of the telomeres.

The ability of TRF2 to influence telomere shortening does not exclude the
possibility that this molecule is also responsible for recruitment of the regulators of
telomere elongation. Based on the current data, it is actually very likely that TRF2,
through its interacting partner Rapl, is able to influence telomere elongation. Direct
studies of Rapl, will clarify the role of the TRF2 complex in regulation of telomere
lengthening activities.

The basic domain was shown to be important for the proper function of TRF2 at
telomeres. It has been proposed that this domain functions through interacting with yet
unknown factors. Knowledge of these proteins will be important to fully understand the
phenotypes of rapid telomere deletion and chromosome breakage in cells expressing
TRF2AB. Studies of such a factor will be also necessary to show whether TRF2AB is a
hypomorphic or a gain of function allele of TRF2. The two phenotypes observed in
TRF2AB-expressing cells are proposed to be created through the same mechanism, in
which a nick followed by replication results in telomere deletion or internal breakage.
However, through further studies it may be revealed that the two phenotypes occur
through different mechanisms. Finally, it is interesting to point out that the TRF2ABexpressing cells have some characteristics of harboring deprotected telomeres and it
remains to be seen it this deprotection is caused by loss of telomeric DNA.

The intriguing possibility that telomere dysfunction can lead to deregulation of the
cell cycle even in otherwise wild type cells was suggested by genome wide reduplication
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observed in cells expressing TRF2ABAM and TRF2AB and in cells with critically shortened
telomeres. The reasons for a connection between telomere status and entry into S
phase are not obvious. These phenotypes as well as the centrosomal localization of
TRF2 suggest that the telomeric complex may have an unanticipated role in regulating
the centrosomal cycle.

Overall, studies of the human telomeric protein TRF2 have increased our
understanding of the telomere function. Studies in human cells with their beautiful,
condensed chromosomes have resulted in the detailed examination of the outcomes of
telomere dysfunction. Ability to observe chromosomes and telomeres directly gave an
opportunity to find telomeric DNA at the sites of end-to-end fusions after inhibition of
TRF2 and allowed for observation of single chromatid deletions after expression of
TRF2AB. Such ability, in combination with molecular techniques currently available,
including the retroviral delivery of genes and the KO model systems, make mammals a
very powerful addition to the traditional organisms of Tetrahymena or yeasts utilized to
study telomeric complexes.
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M a t e r i a l s

a n d

M e t h o d s

Cell culture:

Primary cells. Human primary fibroblasts IMR90, WI38, HS68, and packaging
cells (PhoenixEco and Ampho) were obtained from the ATCC. They were grown in

Dulbecco Modified Eagle medium (DMEM) supplemented with 100 units of penicillin pe

ml, 0.1 mg streptomycin per ml, L-glutamine (2 mM), non-essential amino acids (0.1
mM), and 15% (v/v) FBS (Hyclone) for primary cells or 10% (v/v) FBS for packaging
cells. Fibroblasts from Ataxia Telangiectasia (A-T) patients (AG02496, AG04405,
AG03058) and controls (AG03057) were obtained from Coriell Cell Repositories and
cultivated as above, except that the media contained 20% (v/v) of FBS.

Cells were passaged by treatment with trypsin and seeding at 1x106 cells per 10
cm dish. Cell numbers were determined by counting a 1:20 dilution of the cell
suspension using a Coulter Counter. Population doublings were determined by a

formula: PD=PD at plating+[ln (# of harvested cells/# of plated cells)/ ln(2) ]. Fo

logarithmically growing cells were collected from a 15 cm plate (around 7x106 cell
resuspended in 1 ml of 2xA freezing media (2xA is made by combining 40 ml FBS

[Hyclone], 0.4 ml gentamycin stock solution [stock solution is 50 mg/ ml gentamycin

Sigma], 4 ml HEPES stock solution [stock solution is 1M HEPES, {pH 7.6} ], and 156 ml

L15 media [Sigma], and sterilization through a 0.2 urn filter). Subsequently 1 ml of

freezing media were added (2xD is made by combining 40 ml PVP stock solution [stoc

solution is 100 mg PVP [Sigma #P2307] per ml of HEPES buffered saline],.30 ml DMSO

[Sigma], 4 ml HEPES stock solution [stock solution is 1M HEPES, {pH 7.6} ], and 126 m

L15 media [Sigma], and sterilization through a 0.2 um filter) and the cell suspensi
aliquoted into 2 cryogenic vials. The vials were placed in a Styrofoam box at -80°C.
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After at least one day, but no more than 3 months, the cells were moved to liquid
nitrogen.

HTC75 and its derivatives. HTC75 is a hygromycin-resistant HT1080-derived

clonal cell line that stably expresses the tetracyclin-controlled transfected acti
(Gossen and Bujard 1992; van Steensel and de Lange 1997). Cells were grown in
DMEM supplemented with 10% (v/v) bovine calf serum free of Tetracyclin or its

derivatives (HyClone), penicillin-streptomycin, L-glutamine, non-essential amino ac
and either Hygromycin (90 ng/ml) or G418 (150 ng/ml). Drugs were alternated every
other week. Cells were passaged at 1:16 when they reached 80% confluence. Non-

induced and induced cells were grown in parallel with or without doxycycline (Sigm

100 ng/ml). After induction, P12, P33, P4, and P7 cell lines expressed untagged full

length TRF2; T4, T19, and T22 cell lines expressed myc-tagged TRF2ABAM; S13 and S19
cell lines expressed flag-tagged TRF2AB, and B27 did not express any exogenous
proteins and served as control.

Mouse cells. Primary Lig4+/+p53-/- and Lig4-/- p53-/- MEFs were obtained from
the Alt laboratory (Frank et al. 2000). They were grown in DMEM supplemented with
10% (v/v) fetal calf serum, non-essential amino acids, glutamine, and antibiotics.

passage (p3 for experiment #1 and p5 for experiment #2) cells were used for infect

Other cells. Hela 1.2.11 and HeLa 2 were grown in DMEM supplemented with

penicillin-streptomycin, L-glutamine, non-essential amino acids, and 10% (v/v) bovi
calf serum (HyClone).
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Plasmids and retroviral vectors

Standard techniques were used for cloning. TRF2 constructs were generated by

PCR from a full-length cDNA clone (clone 16-1, (Broccoli et al. 1997)). The pUHD 10

Tet-vector was used to clone TRF2 alleles for transfection into HTC75 cells. pBabe
pLPCpuro, and pWZLhygro (gifts from Scott Lowe, CSHL) were used to clone N-

terminally myc tagged and untagged alleles of TRF2. The untagged versions were used

in most of the experiments and there were no expression level or phenotypic differ
between infections with the three different vectors. pBabeTag was a gift from Greg
Hannon and did not express SV40 small T antigen. PLXSNeoHPV16E6,
pLXSNeoHPV16E7, and pLXSNeoHPV16E6E7 (Halbert et al. 1991),(Kiyono et al. 1998)
were gifts from Denise Galloway, and pWZLp53175H mutant (p53DN) from Scott Lowe
(Serrano et al. 1997).

Stable transfections of HTC75 cells (performed by Bas van Steensel)

The empty vector pUHD10-3 and the pUHD10-3-derived constructs for expression of th
TRF2 alleles were each cotransfected with neomycin resistance plasmid pNY-HI (H.
Tommerup and T. d. L., unpublished data) into cell line HTC75 using the calcium

phosphate coprecipitation. Transfected cells were grown in the presence of doxycyc

(100 ng/ml) and G418 (600uo,/ml). For each construct, approximately 25 G418-resista

cell lines were isolated by ring cloning and tested for expression of TRF2 polypep

after 24 hr of induction by omission of doxycyclin from the media (doxycyclin acts

repressor of gene expression in this system). Expression of TRF2ABAM and TRF2AB was
determined by immunofluorescence microscopy and western blotting using anti-FLAG
antibody M2 (Eastman Kodak or Sigma); expression of wild-type TRF2 was determined
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by gelshift assays using a TTAGGG-repeat probe and by western blotting using antibody
508 or 647.

Retroviral infections

Procedures were as described (Serrano et al. 1997). Phoenix cells were plated
at 5x106 cells per 10 cm plate and transfected on the following day using calcium
phosphate precipitation in the presence of 100 p,M chloroquine per ml. For the

transfection, 20 ng of DNA prepared by the CsCI method were combined with 62.5 nl o
2 M CaCI2 and sterile water to 500nl and added dropwise into 500nl of 2xHBS (50 mM
HEPES [pH 7.05], 10 mM KCI, 12 mM Dextrose, 280 mM NaCl, 1.5 mM Na2HP04) while
making bubbles. This solution was added directly to plates already containing 8 ml
media with chloroquine. The media were replaced with fresh 8 ml of media without

chloroquine after 5 hours and replaced with 6 ml of media approximately 12 hours la

Media containing retroviral particles were collected for two days (30 ml total- fir

collection 6 ml, subsequent collections, 4 ml each) starting 24 hours after transfe

and kept on ice in the cold room. The supernatant was not spinned prior to filteri

a new tube through a 0.45 nm filter. To avoid contamination with the packaging cell
fresh cap was used to close the conical tube with the filtered supernatant. The

supernatant was supplemented with 3 ml of FBS and 4 ng polybrene per ml and used fo

three infections (every 5 hours) of a 15 cm plate of fibroblasts plated the day be

2.5x106 cells per plate. The following evening cells were placed under selection w
ng of puromycin per ml, 90 n9 of hygromycin per ml, or 600 n9 of G418 per ml,

depending on the vector used. Selection was completed after 3 days for puromycin, 5
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days for hygromycin, and 2 weeks for G418 treatment. Expression of proteins after
selection was confirmed by immunofluorescence or western blotting.

Transient transfection by electroporation

8x106 logarithmically growing cells were resuspended in 800 nl of transfection
buffer (21 mM Hepes [pH 7.05], 137 mM NaCl, 0.7 mM Na2HP04, 5 mM KCI, 6 mM
glucose) and mixed with 15 n9 of plasmid in an electroporation cuvette. Cells were
electroporated at 300 mV with 960 nF capacitance. The time constant was between 10
and 13 miliseconds. The debris was removed with a pipette tip and one-third of the

remaining cells were added to a 10 cm dish with media overlaying autoclaved covers

for immunofluorescence. For protein extractions two-thirds of the cells were plate

10 cm dish with appropriate media. All transient transfections were analyzed after
hours.

Growth curves and BrdU labeling

On the 4th day of puromycin selection following retroviral infection, for each day

of the growth curve, cells were plated in duplicate at 3x104 cells per well in a s

plate. On the subsequent days, the cells were washed, trypsinized and counted using
Coulter counter. For BrdU labeling, the method was adapted from the in situ cell

proliferation kit (Roche), (Gratzner 1982). One day prior to labeling (day 4, 9, and

cells were plated on autoclaved coverslips at 1x105 cells per well of a six-well p

total of 3 ml of media. 24 hours later BrdU (Roche) was added to a final concentra

10 nM (from a 100 nM stock made in media) without replacing the original media. Af
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an 1 hour incubation

(or a 5 hour incubation for the A-T cells), the coverslips were

washed once with PBS, fixed in 70% (v/v) ethanol in 50 mM glycine buffer (pH 2.0) f
45 minutes at room temperature, washed twice in PBS, denatured for 10 min in cold

(4°C) 4 N HCI, washed 3 times in PBS 5 min each, and blocked in PBG (0.2% [w/v] Col
Water Fish Gelatin [Sigma], 0.5% [w/v] BSA [Sigma] in PBS). This was followed by a

hour incubation with affinity purified antibody 647 against TRF2 (Zhu et al. 2000)
1:1000-1:2000 in PBG, three 5 minute washes each in PBG and a 45 minute incubation
with a TRITC-conjugated donkey anti-rabbit secondary antibody (Jackson) at 1:100
dilution in PBG and FITC anti-BrdU antibody (Becton Dickinson) at 1:4 dilution in
Following a 5 minute wash in PBG, 5 minute wash in PBG supplemented with 0.2 ng of
DAPI per ml, another 5 minute wash with PBG, and a rinse with PBS, coverslips were
embedded in 90% (v/v) glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine

(Sigma) per ml and sealed with nail polish. Such dual labeling allowed scoring for

positive cells that were also expressing TRF2 alleles of interest. The numbers wer

normalized using the formula: (% of BrdU positive cells in TRF2 or TRF2ABAM-expres
cells/ % of BrdU positive cells in control vector cells) x100%.

Fluorescence activated cell sorting (FACS) analysis
Cells were collected from a 10 cm plate by trypsinization, spun down at 1000
rpm, washed in 5 ml PBS, spun down again and resuspended in 100 nl of phosphate

buffered saline (PBS). While vortexing, 2 ml of ice cold 70% (v/v) ethanol were add

dropwise and the suspension was stored at 4°C at least overnight. 30 min before FAC

the cells were spun down and resuspended in propidium iodine (PI) mix (500 n' PBS,
nl RNase [of stock solution of 10 mg/ml], 25 nl PI [of stock solution of 1 mg/ml]),

197

incubated for 30 min at 37°C before analyzing on a Becton Dickinson FACS-SCAN II.
Analysis was done without gating.

P-gal assay

The procedure used was adapted from (Dimri et al. 1995). Cells were plated in 2

well chamber glass slides (Lab-Tek. #177380) at a density of 1-3X104 cells per cha

On the second or third day after plating, the cells were washed in phosphate-buffe

saline (PBS) (pH 7.2), fixed for 5 min in 2% (v/v) formaldehyde/0.2% (v/v) glutara

solution in PBS , washed again in PBS, and stained with 1 mg X-gal per ml of 150 mM
NaCl, 2 mM MgCI2, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 40 mM NaPi (pH 6.0, pH 4.0
or pH 7.0) for 6-12 hr at 37°C.

Immunofluorescence and microscopy

Cells were plated at a density of 1x106 in a 10 cm plate on autoclaved coverslips.

In preparation for immunofluorescence they were rinsed with phosphate-buffered-sal

(PBS) and fixed in 2% (w/v) formaldehyde in PBS for 10 minutes at room temperature,
or in ice-cold methanol for 10 minutes at -20°C. If the cells were fixed with
formaldehyde, they were washed once with PBS, permeabilized in 0.5% (v/v) NP40 in

PBS for 10 minutes, washed again in PBS, and incubated with PBG (0.2% [w/v] cold f

gelatin, 0.5% [w/v] BSA in PBS) for 20 minutes to block non-specific binding. If c
were fixed in methanol, no permeabilization was necessary, and cells were washed 3
times for 5 minutes each in PBS and incubated with PBG for 20 minutes. Coverslips
were then incubated for 2 hours at room temperature in a humidified chamber with a
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primary antibody appropriately diluted in P B G (dilutions were highly dependent on the

antibody but typically they were around 1-500 to 1:2000 for polyclonal anti TRF1 a
antibodies, and 1:20 for monoclonal anti p53 and Tag antibodies). Subsequently,
coverslips were washed 3 times 5 minutes each with PBG, and incubated with FITC or

TRITC conjugated sheep-anti-mouse or donkey-anti-rabbit antibodies (Jackson) dilut
1:100 in PBG. Following a 5 minute wash in PBG, 5 minute wash in PBG supplemented
with 0.2 ng of DAPI per ml, another 5 minute wash with PBG, and a rinse with PBS,
coverslips were embedded in 90% (v/v) glycerol/10% (v/v) PBS containing 1 mg pphenylene diamine (Sigma) per ml and sealed with nail polish. Pictures were taken
an Axioplan Zeiss microscope with a Photometries digital camera or on an Axioplan2
Zeiss microscope with a Hamamatsu digital camera supported by OpenLab software.

Methanol: glacial acidic acid metaphase spreads
Cells grown to -50-70% confluence in a 15 cm dish were incubated in 0.1 ng of
demecolcin per ml of medium for 90 min to 4 hr depending on the experiment. Cells
were harvested by trypsinization, and spun down at 1000 rpm for 5 minutes.

Sometimes, in order to enrich for mitotic cells, just after addition of trypsin pl
hard on the side and the detached cells were collected and spun down as above. The
supernatant was completely removed and cells were gently resuspended in 5 ml of

0.075 M KCI. After 7 minutes of incubation at 37°C, the cells were again spun down
1000 rpm for 5 minutes and the supernatant was decanted. The cells were gently

resuspended in the remaining fluid by tapping. 1 ml of freshly prepared fixative (

[vol/vol] methanol: glacial acidic acid) was added dropwise to the cells while the

was being tapped. The tube was filled up with fixative and stored overnight or lon
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before dropping cells onto slides. W h e n ready to prepare spreads, the cells were spun
down at 1000 rpm for 5 minutes and the supernatant was replaced with approximately
500 nl of fresh fixative (this volume was adjusted to achieve a slightly cloudy

suspension). The cells were dropped on the (room-temperature) water-wetted slide, a

dried for a couple of seconds, washed with fresh fixative, and placed for about a m
on water-soaked paper towels positioned on a heat block warmed to 70-80°C. If

spreads were to be used for fluorescence in-situ hybridization (FISH) they were le

overnight in a chemical hood to age and used at that point or stored at 4° for lat

For staining of chromosomes with 4',6'-diamidino-2-phenylindole (DAPI), without FIS

cells were used immediately without aging. Slides were incubate for 5 minutes in 0
of DAPI per ml of phosphate-buffered saline (PBS), washed in PBS, and embedded in

90% (v/v) glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per m

Formaldehyde metaphase spreads

The procedure was essentially as described in (Compton et al. 1991). Cells
grown to -50-70% confluence in a 15 cm dish were incubated in 0.1 ng of demecolcin

per ml of medium for 90 min to 4 hr depending on the experiment. Cells were harves
by trypsinization, and spun down at 1000 rpm for 5 minutes. The supernatant was

completely removed and cells were gently resuspended in 300 nl of RSB buffer (10 mM

Tris-HCl, [pH 7.4], 10 mM NaCl, 5 mM MgCI2) and incubated at 37°C for 10 minutes. 5

nl of this cell suspension was gently pipetted onto a 22 mm square coverslip at the

bottom of a bucket of a RT6000 Sorvall tabletop centrifuge. The centrifuge was all
to reach 3000 rpm and was immediately stopped. The coverslip was removed and cells

spread on it were fixed with 2% (w/v) formaldehyde in PBS for 10 minutes, washed o
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with PBS, permeabilized in 0.5% (v/v) NP40 in P B S for 10 minutes, washed again in
PBS and used with a standard immunofluorescence protocol as described above.

Peptide nucleic acid (PNA) fluorescence in-situ hybridization (FISH) on metaphase
spreads

The method was adapted from (Lansdorp et al. 1996). The slide with
methanokglacial acidic acid metaphase spreads (prepared as above) were rehydrated

for 5 minutes in phosphate-buffered saline (PBS) (pH 7.4 throughout this procedure)
fixed for 2 minutes in 4% (v/v) formaldehyde in PBS, washed 3 times for 5 minutes

in PBS, treated with 1 mg pepsin per ml of HCI acidified water (pH 2.0) for 10 min

37°C, washed twice for 2 minutes each in PBS, fixed again in 4% (v/v) formaldehyde
PBS, washed 3 times for 5 minutes each in PBS, dehydrated in an alcohol series (5

minutes in 70% (v/v) ethanol, 5 minutes in 95% (v/v) ethanol, and 5 minutes in 100%

(v/v) ethanol) and air-dried. A small amount (-50-100 nO of a hybridization mix (

Tris [pH 7.2], 70% (v/v) deionized formamide, 0.5% (w/v) blocking solution [Boehri
Mannheim], 0.5 ng Peptide-Nucleic Acid (PNA) probe per ml) was placed on the

coverslip. The coverslip was then picked up by turning the slide upside down, touc

the hybridization mix, and immediately turning the slide back up. This assured tha
were no bubbles that would interfere with hybridization. The DNA was denatured by

placing the slide at 80°C for 3 minutes, and the probe was allowed to hybridize for

hours in a humidified chamber at room temperature in the dark. Subsequently, the s
was washed 2 times, 15 minutes each in 10 mM Tris [pH 7.2], 70% (v/v) deionized

formamide, 0.1% (w/v) BSA, washed 3 times 5 minutes each in 0.1 M Tris-HCl [pH 7.4]

0.15 M NaCl, 0.08% (v/v) Tween and dehydrated in an alcohol series as above. If the
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P N A probe was FITC conjugated ( F I T C - C C C T A A C C C T A A C C C T A A , synthesized by

Biotech GmbH) the DNA was counterstained with 4',6'-diamidino-2-phenylindole (DAPI
by adding 0.2 ng of DAPI per ml to a second 5 minute wash (see above), followed by
washing for the third time, dehydration, air-drying and embedding in 90% (v/v)
glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per ml. If the
PNA probe was biotynylated (bio-OO-CCCTAACCCTAACCCTAA, synthesized by

PerSeptive Biosystems) the DNA was not counterstained at this point. After dehydra

steps the slides were incubated with PBG (0.2% [w/v] cold fish gelatin, 0.5% [w/v]

in PBS) 2 times for 10 minutes each to block non-specific binding, and then incuba

for 30 min at 37°C with fluorescein-conjugated avidin (AVIDIN DCS-FITC, Vectorlabs
diluted 1:400 in PBG. The slides were washed in PBG for 5 minutes, in PBG

supplemented with 0.2 ng of DAPI per ml for 5 minutes, with PBG alone for 5 minutes
and with PBS for 5 minutes. Spreads were then embedded in 90% (v/v) glycerol/10%
(v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per ml and sealed with nail

polish. Pictures were taken on Axioplan Zeiss microscope with a Photometries digit
camera or on Axioplan2 Zeiss microscope with a Hamamatsu digital camera supported
by OpenLab software. Ambiguous abnormalities seen in the pictures were assessed
directly under the microscope.

Multiplex fluorescence in situ hybridization (M-FISH) (performed by Anna Jauch in
Heidelberg)
M-FISH was performed as described (Speicher et al. 1996; Eils et al. 1998) with
minor modifications. Briefly, five pools of flow-sorted whole chromosome painting
(kindly provided by Ferguson-Smith, Cambridge, UK) were amplified and labeled by
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D O P - P C R using five different fluorochromes: FITC, Cy3, Cy3.5, Cy5, and Cy5.5,
repectively. About 100 ng of each probe was precipitated in the presence of 30 ng
DNA, dissolved in 10 nl hybridization mixture (15% (w/v) dextrane sulfate, 2xSSC)
hybridized for 48 hours. Microscopic evaluation was performed using a Leica DMRXA
microscope (Leica, Wetzlar, Germany) equipped with a Sensys CCD camera
(Photometries, Tucson, AZ, USA) with a Kodak KAF 1400 chip. Images for each
fluorochrome were acquired separately using highly specific filter sets (Chroma

Technology Corp., Brattleboro, VT, USA) and processed using the Leica MCK software
(Leica Microsystems Imaging Solutions Ltd., Cambridge, UK).

D N A extraction

The procedure was based on (de Lange 1992). Around 1x107 cells were

harvested by trypsinization on the indicated days, washed in cold PBS, collected by

centrifugation, resuspended in 1 ml of TNE (10 mM Tris [pH 7.4], 100 mM NaCl, 10 mM
EDTA) and squirted into 1 ml of TNES (10 mM Tris [pH 7.4], 10 mM EDTA, 100 mM

NaCl, 1% (w/v) SDS) freshly supplemented with 100ng proteinase K per ml placed in a
15 ml phase lock heavy tube (Eppendorf) pre-spun as suggested by the manufacturer.

After an overnight incubation at 37°C, the lysate was extracted with 2 ml of phenol

chloroform: isoamyl alcohol (25:24:1 [vol/vol/vol]), and the DNA in the aqueous fra

was precipitated by mixing the lysate with 2 ml iso-propanol and 0.22 ml 2 M NaAce
(pH 5.2). The spooled DNA was added to 0.3 ml of TNE supplemented with 100 ng
RNAse per ml, incubated for 30 min at 37°C, gently resuspended with a wide tip and
incubated for 2 more hours at 37°C. 0.3 ml of TNES supplemented with 100 ng

proteinase K per ml were added, and the incubation at 37°C was continued for anoth
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hour. This D N A solution was extracted with 0.6 ml of phenol: chloroform: isoamyl

alcohol (25:24:1 [vol/vol/vol]), and the DNA was precipitated by mixing the aqueous
phase with 0.6 ml iso-propanol and 60 nl of 2 M NaAcetate (pH 5.2). The DNA was

spooled and resuspended without shearing in 100 nl of TE (10 mM Tris HCI [pH 7.4],
mM EDTA). DNA was cleaved with a combination of Hinfl and Rsal or Mbol and Alul

restriction enzymes as indicated in the text and quantified by fluorometry using H
33258.

D N A electrophoresis and Southern blots with a telomeric probe

The procedure was based on (de Lange et al. 1990). 1.5-3 ng of digested DNA was
fractionated on a 0.7% (w/v) agarose gel in 0.5x Tris-borate- EDTA (TBE) in the

presence of some ethidium bromide. During the run, the gel was photographed to che

for equal loading of samples. After the run, the gel was photographed, soaked in 0
HCI for 30 minutes, in denaturating solution (1.5 M NaCl, 0.5 M NaOH) twice for 30

minutes each, and in neutralizing solution (3 M NaCl, 0.5 M Tris-HCl, [pH 7.0]) twi
30 minutes each, rinsed in 20x SSC (3 M NaCl, 0.3 M Sodium Citrate [pH 7.0] and
blotted overnight in 20x SSC onto a nylon membrane (Hybond). Subsequently, the DNA
was crosslinked to the membrane using UV, membrane was rinsed in water and was

prehybridized in Church buffer (0.5 M NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 7% (w/v)

SDS, 1% (w/v) BSA) for 45 min at 65gC, hybridized overnight at 65°C with a telomeri
probe prepared as described below, and washed 3 times 15 minutes each in Church
wash (40 mM NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 1% (w/v) SDS). The membrane
was exposed overnight on the phosphorimager. To make a telomeric probe,
pSP73.Sty11 plasmid was digested with EcoRI, and the 800bp fragment corresponding

204

to the telomeric repeats was isolated using QIAEXII (Qiagen) and diluted to about 20 ng
DNA per p,l. To label the probe, 10pl of this insert were combined with 5 ng of

(CCCTAA)3 oligonucleotide in a total volume of 39 pi, boiled for 5 min, cooled dow
one minute and mixed with 5 nl of 10xOLB (0.5 M Tris HCI [pH.6.8]. 0.1 M MgOAc, 1
mM DTT, 0.5 mg Bovine Serum Albumin per ml, 0.6 mM dATP, 0.6 mM dGTP, 0.6 mM
dTTP), 5 nl of a-32P -dCTP (3000 Ci/mmol), and 1 pi of Klenow polymerase. Labeling
reaction was performed for 90 minutes at room temperature and was stopped by

addition of 50 nl TES (10 mM Tris-HCl, 10 mM EDTA [pH 8.0], 0.1% (w/v) SDS), loaded

onto a Sephasdex G-50 fine column made in a 3 ml syringe packed to the top with the

resin, washed with 1000 pi of TES, eluted with 800 n' of TES, incubated at 100°C f
min, and added to 30 ml of Church buffer. The probe was filtered through a 0.2 pm
syringe filter. Half of the probe was used for a 20 cm x 20 cm membrane.

In-gel G-overhang assay

The procedure was adapted from (Hemann and Greider 1999) with multiple
changes. 5 ng of digested DNA was fractionated on a 0.7% (w/v) agarose gel in 0.5x

Tris-borate-EDTA (TBE) in the presence of some ethidium bromide. During the run, th
gel was photographed to check for equal loading of the samples. After the run, the
was dried on two pieces of Whatman 3MM paper for 1 hour at 50°C with vacuum
resulting in a paper-thin gel that could be treated like a membrane. The gel was

removed from the paper by soaking it in water and without denaturing was prehybrid

in Church buffer (0.5 M NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 7% (w/v) SDS, 1% (w/v)

BSA) for 45 min at 55°C, hybridized overnight at 55°C with an oligonucleotide probe

prepared as described below, and after hybridization washed 3 times 20 min each in
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S S C at room temperature. If there was a very high signal in the background, the gel
was washed twice more, 20 minutes each in 4x SSC, and 0.1% (w/v) SDS at 57°C. The

gel was exposed overnight in the phosphorimager cassette. Subsequently, the gel was
denatured for 25 minutes in a denaturating solution (1.5 M NaCl, 0.5 M NaOH),

neutralized for 25 min in a neutralizing solution (3 M NaCl, 0.5 M TrisHCI [pH 7.0]
after rinsing with water and 45 min prehybridization at 55°C in Church buffer,

hybridization was repeated using the same probe that was used for the hybridizatio

with the native gel. The wash steps were identical to those given above for the na

gel. To make a probe for the G-overhang, 50 ng of TELC oligonucleotide (CCCTAA)4 or
50 ng of TELG oligonucleotide (TTAGGG)4, which served as a strand-specificity

control, were mixed with 1 n' of T4 polynucleotide kinase buffer (NEB), 2nl of wate
of 32P-gamma-ATP (6000 Ci/mMol, 10 mCi/ml), and 1 \i\ of T4 polynucleotide kinase

(NEB), and incubated at 37°C for 45 minutes. After adding 90 pi TES (10 mM Tris-HCl
10 mM EDTA [pH 8.0], 0.1% (w/v) SDS), the reaction was loaded onto a Sephadex G-25

fine column made in a 3 ml syringe packed to the 3 ml mark with the resin. The colu
was washed with 700 nl of TES and the labeled oligonucleotide was eluted with 800

TES and used after addition of 15 ml of Church buffer and filtering through a 0.2 n
filter. The same probe was used for hybridization with native and denaturing gels.

Alkaline gels
This procedure was based on (McDonell et al. 1977). 1.5-3ng of DNA were
ethanol precipitated, and resuspended in 50 mN NaOH, 1 mM EDTA, mixed with 0.2
volumes of 6 x alkaline loading buffer (300 mM NaOH, 6 mM EDTA, 18% (v/v) Ficoll,
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0.15% (w/v) bromocresol green, 0.25% (w/v) xylene cyanol FF) and run on a 0.5% (w/v)
alkaline agarose gel in 50 mM NaOH and 1mM EDTA (pH 8.0) for 27 hr at 50 V at 4°C

with two changes of running buffer. The gel was subsequently treated like describe
section about Southern blotting or G-overhang assay. Markers were prepared by
digesting a TTAGGG repeat bearing 2.6 kbp pTH5 plasmid (de Lange et al. 1990) with
Hindlll and self religation of the cut plasmid.

Estimation of telomere length

The median length of the telomeric restriction fragments was determined by
using ImageQuant software after scanning with a Phosphorlmager and was not
corrected for dependence of signal intensity on telomere length.

Cell extracts

For buffer C-extracts, cells grown in 10 cm dishes were harvested by scraping in

5 ml cold phosphate-buffered saline (PBS) and centrifugation at 1000 rpm for 5 min
Cell pellets were resuspended in 4-6 volumes (50-200 nO ice-cold buffer C (20 mM
Hepes-KOH pH 7.9, 420 mM KCI, 25% (v/v) glycerol, 0.1 mM EDTA, 5 mM MgCI2, 1 mM

dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 0.2% (v/v) Nonidet

40, 1 ng °f leupeptin, pepstatin, and aprotinin per ml, incubated for 30 min on ice

centrifuged 10 min at 14,000 g at 4°C. The supernatant was dialyzed for 2 hrs agai
buffer D (20 mM Hepes-KOH [pH 7.9], 100 mM KCI, 20% (v/v) glycerol, 0.2 mM EDTA,
0.2 mM EGTA, 0.5 mM DTT, and 0.5 mM PMSF) at 4°C, snap-frozen in liquid nitrogen
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and stored at -80°C. Protein concentrations were determined using the Bradford assay
(BioRad, Hercules, CA) using bovine serum albumin as a standard.

For whole cell lysates, cells were harvested by trypsinization, washed in cold

PBS, counted, collected by centrifugation, and resuspended at 1x10" cells per nl o
Laemmli loading buffer (Laemmli loading buffer is made by combining 4 ml Buffer B

below], 8 ml glycerol, 2 ml p-mercaptoethanol, 16 ml SDS stock solution [stock solu

is 10% (w/v) SDS in water], 2 ml bromophenol blue stock solution [stock solution is

(w/v) bromophenol blue in water], and 8 ml H20. Buffer B is made by combining 7.6 g

Tris base, 5 ml SDS stock solution [stock solution is 10% (w/v) SDS in water], 5 ml

concentrated HCI, and 30 ml of H20, adjusting the pH to 6.8 and adjusting the total
volume to 50 ml with H20). The DNA was sheared by passing several times through a
25 G 5/8 needle.
For westerns visualizing ATM, the cells were harvested by trypsinization, washed
in cold PBS, counted, collected by centrifugation and the extract was prepared by
sonicating 5x106 cells in a 250 n' cold buffer containing 50 mM Tris HCI, pH 7.5,
NaCl, 10% (v/v) glycerol, 1% (v/v) Tween 20, 50 mM NaP-glycerophosphate, 1 mM NaF,
1 mM NaV04, 0.1 mM DTT, 0.5 mM PMSF, 0.5 pg/ml Leupeptin. The extract was
centrifuged 10 min at 14,000 g at 4°C and the pellet was discarded.

Western blotting
For buffer C extracts, 30 ng were separated on a 9% (w/v) SDS-polyacrylamide

gel (Sambrook et al. 1989) and transferred to nitrocellulose by electroblotting fo
at 90 V at 4°C or overnight at 100 mA at room temperature. Membranes were stained
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with Ponceau S (20 mg/ml in H20) (Sambrook et al. 1989) for 2 min to verify that equal

amounts of protein were fractionated in each lane. For whole cell extracts, 15 nl o

extract were fractionated on SDS-polyacrylamide gels and transferred onto nitrocel
or PVDF (Millipore) (for anti E7 and anti ATM westerns) membranes. Blocking and

incubation with primary and secondary antibodies was performed in 5% (w/v) milk an
0.1% (v/v) Tween in PBS. Antibodies were as follows: anti-TRF2- 647, 508 or mouse

anti-TRF2 (Cat# 05-521, Upstate Biotechnology), anti p53-1801 (Levine lab), HDM2-3F
(Levine lab), anti p21-F-5 (Santa Cruz Biotechnology), anti Rb (cat# 14001A,
PharMingen), anti p16-NCLp16 (Novocastra laboratories), anti cyclin A- cat#sc-239

(Santa Cruz), anti Y-tubulin-clone GTU88 (Sigma), anti SV40 Tag-PAB416 (Levine lab)
anti E7-Clone 8C9 (Zymed), ATM antibody 2C1 (GeneTex). After incubations with
secondary antibodies (Amersham) all blots were developed using the ECL kit
(Amersham)

R N A isolation

Total RNA was isolated as described (Auffray and Rougeon 1980). 1x107 cells

were washed in PBS, lysed in 3 M LiCI/6 M urea, sonicated, and incubated on ice for

hours. RNA was collected by centrifugation in a microcentrifuge at maximum speed fo

20 min at 4°C, treated with proteinase K (50 mg/ml) in 200 pi 10 mM Tris-HCl (pH 7
10 mM EDTA, 100 mM NaCl, 1% (w/v) SDS for 10 min at 37°C, extracted with

phenol/chloroform/iso-amylalcohol (25:24:1), and precipitated with isopropanol in t
presence of 0.2 M Na-acetate pH 5.5.
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RNase protection

The hTERT sequence was subcloned from pCI Neo-hEST2-HA (a gift from R. A.

Weinberg; (Meyerson et al. 1997)) into pcDNA3 (Invitrogen). A Styl fragment contain

part of the hTERT sequence (nucleotide 3229-3452) and flanking vector sequences wa

purified and used in the MAXIscript in vitro transcription reaction (Ambion) using
UTP (800 Ci/mmol, 10 mCi/ml). The template for the hTR RNase protection probe was

similarly prepared by digesting pGRN78 (Kim et al. 1994) with Xbal, and the p-actin
probe was obtained from Ambion. The P-actin probe was labeled to 200-fold lower

specific activity than the hTERT and hTR probes by diluting out the radiolabeled U
with cold UTP. RNase protection reactions were performed using solutions from the

Direct Protect Lysate Ribonuclease Protection Assay Kit (Ambion) with 20 ng of tot
RNA (isolated as described above) instead of cell lysates.

T R A P assay
The assay was essentially performed as described (Broccoli et al. 1995). 0.5 ng

protein of buffer C extract was mixed with 49 nl of premixed 5 n' of 10X buffer B (
mM Tris HCI [pH 8.3], 15 mM MgCI2, 630 mM KCI, 0.05% (v/v) Tween 20, 10 mM
EGTA, 1 mg BSA per ml), 2.5 mM dNTPs, 5 nl TS primer labeled as below, 0.05 nl T4

gene 32 protein, 2 units of Taq polymerase and water. The reaction was incubated at
room temperature for 30 minutes to allow extension of the TS primer by telomerase.

Subsequently, telomerase was inactivated by heating at 65°C for 3 minutes, and aft
addition of 1 n1 of reverse primer CX, PCR was done for 27 cycles at 94°C for 30
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seconds, at 50°C for 30 seconds, and at 72°C for 1 minute. RNase digestions were
done in parallel to the untreated reaction by addition of 0.2 ng DNase-free RNAse

the telomerase extension reaction. Each experiment also contained a negative contr
reaction where one pi of buffer C was used instead of the extract.

TS primer (0.1 ng) was radioactively labeled by mixing with 2 nl of T4
32
polynucleotide kinase buffer (NEB), 4 nl of water, 12 nl of y- P-ATP (6000 Ci/mMol, 10
mCi/ml), and 1 nl of T4 polynucleotide kinase (NEB), and incubating at 37°C for 45
minutes. After adding 10 ng of unlabeled TS primer, and TES (10 mM Tris-HCl, 10 mM

EDTA [pH 8.0], 0.1% (w/v) SDS) to 100 pi, the reaction was loaded onto a Sephadex G
25 fine column made in a 3 ml syringe packed to the top with the resin. The column

washed with 1000 pi of TES and the labeled oligonuclotide was eluted with 800 pi of
TES and extracted with phenol:chloroform:isoamyl alcohol (25:24:1), ethanol
precipitated and resuspended in 500 nl double-distilled water.

For some experiments (Figure 3-6) the Trapeze telomerase detection kit
(Intergen) was used according to the manufacturer's instructions.

t-loop assay
2x108 cells were collected from about 50 15 cm plates by trypsinization, washed

with PBS and carefully resuspended in 20 ml of homogenization buffer (10 mM Tris-H
[pH 7.5], 15 mM NaCl, 60 mM KCI, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM spermine, 0.5
mM spermidine, 0.2% (v/v) NP-40 (IPEGAL), 5% sucrose [w/v]). The cells were
incubated on ice for 15 minutes, centrifuged at 1300 g (3800 rpm in the table-top

centrifuge) in the cold for 15 min. The buffer was discarded and the nuclei were g
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resuspended in 16 ml of fresh homogenization buffer, spun down as above, and

resuspended in 3 ml of homogenization buffer. 750 pi of 1 mg 4'-aminomethyltrioxsa
(AMT; SIGMA) per ml was added and the mixture was placed in a 10 cm dish on ice.
The DNA was crosslinked by exposing the nuclei to 365 nm UV light for 30 minutes.
The hand-held UV light was positioned 2 cm away from the sample which was being

mixed with a tiny stirring bar. The crosslinked nuclei were collected, snap frozen
nitrogen, and sent for analysis to Jack Griffith. Further processing and analysis
done as described (Griffith et al. 1999). Nuclear suspensions were treated with
proteinase K in the presence of SDS, and DNA was isolated by phenol/chloroform
extraction and ethanol precipitation. The deproteinized sample was suspended in 9

10 mM Tris (pH 7.5), 1 mM EDTA (TE) and cleaved with Alul and Mbol for 12 hr at 37°

During the final hour, RNase (Pharmacia) was added to 20 ng/ml. The sample was then

extracted one time with phenol:chloroform:isoamyl alcohol, precipitated with ethano

suspended in 3 ml of TE. The sample was applied to a 2.5 x 100 cm Biogel A5M column

(Biorad) and eluted at a flow rate of 0.2 ml/min. Fractions of 0.6 ml were taken a
OD260 of each determined. The droplet variation of the Kleinschmidt method

(Kleinschmidt and Zahn 1959) was used for surface-spreading DNA. A 50 nl aliquot o

DNA in TE was mixed with ammonium acetate (pH 7.9) to a final concentration of 0.25
M. Cytochrome C, Sigma Inc.) was added to 4 ng/ml and the drop placed on
Parafilm Semifor 90 s. A parlodion-covered EM grid was touched to the drop and
then dehydrated through two washes of 80% (v/v) ethanol followed by air drying and
rotary shadowcast with platinum-paladium (80:20).
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